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Abstract
Disease due to Neisseria meningitidis can kill a healthy child or a young adult
within few hours from the first symptoms of illness. Following the epidemic of
meningitis during the 1960's, the incidence of meningococcal disease in
Greece declined steadily until 1988. From 1988, the number of cases
reported to the Ministry of Flealth increased; in the first 6 months of 1990,
there were 102 cases compared with 87 for all of 1989. This increase was of
concern to the public health authorities. The last major survey of
meningococci in a Greek population was published in 1979 before elucidation
of some of the genetic and environmental factors affecting carriage and
development of disease and before the availability of serotype and subtype
reagents used in epidemiological studies of these bacteria in north-west
Europe and the Americas.
The objectives of the thesis were to answer the following questions:
1.Are genetic and environmental factors associated with carriage among
Greek children and young adults similar to those found in north-west
Europe?
2. Are strains with serogroups, serotypes and subtypes associated with
disease in north-west Europe isolated from patients and carriers in Greece?
3. Are the antibiotic sensitivities of meningococci isolated from patients and
carriers in Greece similar to those observed in north-west Europe?
4. Are the genetic clones associated with disease in north-west Europe
present among meningococcal strains in Greece and other Balkan
countries?
Among military recruits and primary and secondary school children active
smoking or exposure to cigarette smoke were significantly associated with
carriage of meningococci. In both populations the rate of carriage was higher
among the 15-19 year age range; similar results were reported for studies in
v
Britain and the Faroe islands. The results obtained from the epidemiological
studies (recruits and schoolchildren) showed that viral upper respiratory tract
infection in general is not a predisposing factor for colonisation and that
specific viral infections (e.g., RSV and influenza) need to be investigated.
Lower socio-economic group was not associated with carriage in Greek
school children but with smoking habits of members of the house closely
involved in child care.
While the subtype reagents were able to differentiate strains from both
patients and carriers, the serotype antibodies did not react with the majority of
strains. The serogroup, serotype and subtype combinations associated with
outbreaks in north-west Europe were not found among over 500 isolates
examined. The studies on meningococcal strains isolated from patients in
Greece and Romania were the first to identify significant phenotypic and
genetic differences between meningococcal strains isolated in north-west and
southeast European countries. These results indicate that there is a need to
develop new reagents for epidemiological work in eastern Europe. These
findings have important consequences for the future development of
vaccines against serogroup B since major efforts are directed towards
production of vaccines based on the serotype/ subtype antigens.
Penicillin-insensitive isolates accounted for nearly half those isolated from
children with meningococcal disease (46%) and there was a higher proportion
of these among carrier isolates (19.1% from schoolchildren 36.7 % from
recruits) than that found in Britain (3%).The identification of increased levels of
penicillin insensitive isolates in Greece probably reflects the lack of control of
antibiotic usage. The intermediate value of 20% for Romania might reflect
changes in prescribing patterns or availability of antibiotics following political
changes since 1989.
vi
This work provided a major basis for monitoring meningococcal disease in
Greece and in other Balkan countries and resulted in the establishment of a
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Disease due to Neisseria meningitidis can kill a healthy child or a young adult
within a few hours of the first symptoms of illness; consequently, it has been a
major focus of investigation among scientists and clinicians working in
infectious diseases. Despite recent advances in understanding the
pathogenesis and immunobiology of the meningococcus and the development
of effective vaccines against certain meningococcal serogroups, serious
infection with this pathogen remains worldwide health problem.
1.2. History of meningococcal disease
The history of meningococcal disease from its first recognition has been
reviewed by Apicella (1990). Epidemic cerebrospinal meningitis was first
clearly described by Gaspard Vieusseux in 1806 as a disease that had raged
in Geneva during the spring of 1805. A clinical syndrome of meningococcal
meningitis was also described by Elias Mann and Lothario Danielson from
a small town in Massachusetts in 1804. The epidemic form of cerebrospinal
meningitis and recognition of this disease was later described by others,
(Hirsch, 1886; Debre and Netter 1911; Dopter, 1921). The discovery of the
causative organism that led to the true differentiation of this disease from
other forms of meningitis was made by Weichselbaum in 1887 who named
this organism Diplococcus intracellularis meningitidis because the cocci that
he found were in the leukocytes in pus from meningitis patients. The later
names pseudo-meningococcus (Kutcher, 1906) and parameningococcus
(Dopter, 1914) were regarded as synonymous. The Society of American
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Bacteriologists (Bergey, 1926) renamed this species Neisseria intracellulars in
the 1926 edition of Bergey's manual.
Kiefer (1896) and Albrecht and Ghon (1901) found that healthy persons could
become carriers of the meningococcus. Serotypes of the meningococcus were
first recognized by Dopter in 1909. This laid the basis for serum therapy in the
treatment of meningococcal infection by Flexner in 1913. Glover was the first
to note that the carrier rates in military recruitment camps rose with periods of
crowding, and he believed they were associated with an increased incidence
of cases. In 1928-1930 as well as in 1941 significant national and worldwide
epidemics occurred.
in 1937, sulfonamide therapy radically altered the outcome of meningococcal
infection and replaced serum in its treatment . Prophylaxis with sulfonamides
eradicated the carrier state and provided a simple and safe method for the
prevention of epidemics, particularly in the crowded environments of military
barracks. Increasing sulfonamide resistance among meningococci was
recognized in 1941-1943 by Schoenback and Phair but did not become a
clinically significant problem until the meningococcal epidemics in 1963 in two
military bases in California (Gauld et al., 1965, Bristow et al., 1965). With the
subsequent world-wide emergence of resistant strains and with the absence
of effective chemoprophylaxis, renewed interest in immunoprevention led to
the development of safe and effective vaccines against the groups A, C, Y and
W-135 meningococcal serogroups for older children and adults (Artenstein et
al., 1970, Peltola etai, 1978).
Many problems still exist in understanding the pathogenesis, prevention and
treatment of meningococcal infection. These include the susceptibilities of
certain populations to this infection, its sporadic epidemic nature, the
mechanisms responsible for carrier eradication by antibiotics, the reasons for
the fulminant nature of the infection, the poor immunogenicity of the group C
vaccine in children under the age of 2 years and the inability of humans to
3
develop effective long lasting antibody to the group B polysaccharide vaccine.
Until these and many other questions are answered, meningococcal infections
will continue to be a scourge among human populations.
1.3. Characteristics of N. meningitidis.
1.3.1. Culture and identification of N. meningitidis.
N. meningitidis is a Gram-negative diplococcus of approximately 0.6 x 0.8 p in
diameter. The adjacent sides are flattened to produce the typical kidney bean
shape. Because the organism tends to readily undergo autolysis, considerable
size and shape variation can be seen in older cultures. The organism is
considered fastidious in its culture requirements, thus necessitating the use of
appropriate media and growth conditions. Problems in reliable culture of these
bacteria include nutritional factors and the presence of substances toxic to the
meningococcus in the medium. On solid media, the meningococcus grows as
a transparent, non-pigmented, non-hemolytic colony approximately 1-5 mm in
diameter. Colonies are convex and if large amounts of polysaccharide are
present, they will appear mucoid rather than smooth. Optimal growth
conditions are achieved in a moist environment at 35-37° C in an atmosphere
of 5-10% carbon dioxide. The organism will grow well on a number of media
bases including blood agar base, trypticase soy agar, supplemented chocolate
agar and Mueller-Hinton agar. Confirmation of the identity of this organism is
dependent on carbohydrate utilization (Table 1.1). The meningococcus will
metabolize glucose and maltose without gas formation but fails to metabolize
sucrose or lactose. Indole and hydrogen sulfide are not formed. In addition,
the organism contains cytochrome oxidase, which oxidizes the dye
tetramethylphenylenediamine (TMPD) from colorless to deep pink.
4
Table 1.1. Carbohydrate utilization of various Neisseria species
G M S L F
N. gonorrhoeae + - - - -
N. meningitidis + + -
'
- -
N. lactamica + + - + -
N. subflava + + - - +
N. perflava + + + - +
N. sicca + + + - +
N. flavescens * * - - -
Brahamella
catarrhalis
G= Glucose, M= maltose, S= sucrose, L= lactose, F= fructose,
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1.3.2. Antigenic structure of the meningococcus
The antigenic characteristics of meningococci have been of value in
examining pathogenesis of the disease, development of classification systems
for epidemiological studies and development of vaccines. N. meningitidis
possess a typical Gram-negative cell envelope consisting of a cytoplasmic
membrane, a peptidoglycan layer and a cell membrane (outer membrane)
containing lipooligosaccharides (LOS) and proteins (Figure 1.1). Many
meningococci bear a polysaccharide capsule and surface appendages
known as pili (Davis et al., 1980, DeVoe et al., 1974).
Pili are hair-like surface appendages which play an important role in the
attachment of N. meningitidis to the mucosal surface of the nasopharynx.
They show marked intra- and inter-strain variability, both quantitatively and
qualitatively. The majority of meningococci isolated from patients with
meningococcal disease produce a polysaccharide capsule which is
considered to be a major virulence property because it allows the
meningococcus to evade host defense mechanisms and to survive in the
bloodstream (Quagliarello et al., 1992). Directly underneath the capsule lies
the outer membrane which contains a number of proteins and
lipooligosaccharides (DeVoe et al., 1982, Zollinger et al., 1977, Poolman et
al., 1982). Based on their molecular weights, the major outer membrane
proteins (OMPs) are categorized in to five distinct classes (Tsai et al.,
1981) (Table 1.3)
The lipooligosaccharides (LOS), also known as endotoxins, form a major
constituent of the meningococcal outer membrane (Poolman et al., 1980(a),
Griffiss et al., 1988). They play an important role in the development of
endotoxic shock (Morrison et al., 1983).
6
Figure 1.1. Schematic presentation of outer membrane structure
PS : Polysaccharide
LOS : Lipooligosaccharide
OMP : Outer Membrane Proteins
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1.3.3. Variation in surface antigens and their application to strain
differentiation
The principle antigens that have been used for strain differentiation are the
capsule, LOS and the outer membrane proteins.
1.3.3.1. Capsular antigens and serogroups.
Shortly after identification of the meningococcus as the etiologic agent in
epidemic meningitis and recognition of the carrier state, methods were
developed for detection and differentiation of meningococci. It became
apparent that antigenicaliy diverse meningococci existed. Because different
laboratories were involved, a complex nomenclature evolved that was not
resolved until the mid-1950s when serogrouping based on capital letters
simplified the epidemiological investigations. (Apicella 1990).
The capsular polysaccharide (CPS) antigens are the basis for classification of
Neisseria meningitidis into serogroups (Frasch et al., 1985). At present, there
are 12 known serogroups: A, B, C, X, Y, Z, 29E, W-135, H, I, K and L (Ashton
etai, 1983, Evans et al., 1968, Shao-Qing et al., 1972, Slaterus et al., 1961).
The capsules consist of a high molecular weight anionic polysaccharide and
are found in strains isolated from the blood and cerebrospinal fluid of patients
with meningitis. Uncapsulated strains rarely cause disease. Serogroups A, B,
and C have been shown to constitute greater than 90% of the isolates from
patients, with group B alone accounting for 50-70% of the cases. Studies on
the structure of these capsules began as early as 1933 (Bhattacharjie et al.,
1975; Bhattacharjie et al., 1976; Gotschlich et al., 1981; Jennings et al., 1978;
Liu et al., 1971 a, b). The results of these studies are partly summarized in
Table 1.2.
8
With the exception of those of group B, all purified CPS with a molecular
weight of 100 kDa or more have been found to be immunogenic. (Gold et al.,
1977; Jennings et al., 1981; Wyle et al., 1972). Purified, high molecular weight
group B capsular polysaccharide is poorly immunogenic in humans (Wyle et
al., 1972). Its structure is identical to that found in the capsule of Escherichia
coli K1, (Kasper et al., 1973), a major cause of neonatal meningitis,
suggesting a common mechanism by which these polymers avoid stimulating
the host defenses.
Table 1.2. Structure and composition of the meningococcal capsular
antigens of group A, B, C, Y, and W135.
Serogroup Structure Linkage
A Linear homopolymer of N-acetyl-
mannosamine phosphate
alpha 1- 6




C Linear homopolymer of N-acetyl-
o-acetyl-neuraminic acid 1
alpha 2-9
Y Linear copolymer of glucose-N-
acetyl-o-acetyl-neuraminic acid
alpha 2-6




Also o-acetyl negative strains
2
sometimes o-acetyl positive strains
(Bhattacharjee et al., 1975; 1976 ; Jennings et al., 1981)
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The serogroups H, i, K and L have never been isolated from patients (Lambert
et al., 1991). Meningococci that do not have a capsule are classified as non-
groupable if they do not react with any of the serogroup reagents, or
autoagglutinable if they spontaneously agglutinate in the absence of
antibodies.
1.3.3.2. Outer membrane proteins, serotypes and subtypes.
Meningococcal outer membranes contain from two to five major proteins
which can be demonstrated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Using chymotryptic I125 peptide mapping, it was
found that each of the major outer membrane proteins of one strain had
different peptide maps; proteins of approximately the same molecular weight
from different serotypes were structurally related. The unique portions of
peptides were in the hydrophilic moieties, whereas the common peptides
shared among the strains, were in the hydrophobic parts of the protein (Tsai et
al., 1981). The major outer membrane proteins (OMPs) are therefore
categorized into five different structural classes according to their apparent
molecular weights , designated as classes 1 through 5. All meningococcal
strains have either class 2 or class 3 principal OMP. The class 2/3 proteins
have variable hydrophilic regions which are surface exposed and are
responsible for the serotype specificity (Frasch et al., 1973; Frasch et al.,
1976; Poolman et al., 1980a). These exist as trimers and function as porin
membranes (Lynch et al., 1984). The class 1 outer membrane protein is
surface exposed and is shared by all serogroups and types but shows
quantitative variability in expression (Frasch et al., 1985). The class 5 OMP
shows interstrain and intrastrain heterogeneity. A single strain can express
one, two or no class 5 proteins; the variability is not only quantitative but also
qualitative (Poolman et al., 1980b). The class 4 protein is present in all strains
in association with the class 2/3 porin; it appears to be highly conserved
(Frasch et al., 1985). Table 1.3 summarizes the characteristics of the major
cell surface OMP classes of N. meningitidis.
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Table 1.3. Characteristics of the major cell-surface outer-membrane





Trypsin sensitive, not found in a few strains,
quantitatively variable, deoxycholate insoluble
2 40,000-42,000
Deoxycholate insoluble, trypsin resistant,
exists as a trimer, functions as a porin,
quantitatively predominant.
3 37,000-39,000 Similar to the class 2 protein, class 2 and 3
proteins mutually exclusive.
4 33,000-34,000 Trypsin resistant, found in all strains, 2-
mercaptoethanol modifiable.
5 26,000-30,000
Heat modifiable, deoxycholate soluble, very
sensitive to proteolytic enzymes, highly
variable in expression and MW, more than
one class 5 protein may be simultaneously
expressed
Antigenic variations in the class 2/3 OMPs and class 1 OMPs form the
base for serotyping (Table 1.4) and subtyping (Table 1.5) respectively.
11




Class 2 OMP 2a
2b
4
Class 3 OMP 14
15
16
It has demonstrated that the class 1 OMP harbors 2 variable regions (VR1
and VR2), each determining a distinct set of subtypes (Van der Ley et al.,
1991, McGuinness et al., 1990). The subtypes that have been recognized
to date are determined by epitopes, either of VR1 or VR2 (Table 1.5)
Meningococci that have a class 1 OMP can be characterized by a
combination of subtypes of the two different variable regions. Well known
subtype combinations are P1.7,1 and P1.7,16. Subtype P1.5 of VR1 is often
found in combination with P1.2 of VR2 (P1.5,2) (Abdillahi et al., 1988, Kayhty
et al., 1989a; Wedege et al., 1990; Ashton et al., 1991; McGuinness et al.,
1991).
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Table 1.5. Correlation between class 1 protein variants and subtype.















Serotypes and subtypes are designated by an Arabic number, but the
subtype number is preceded by the prefix "P1". Both serotyping and
subtyping can be performed in a whole-cell ELISA using monoclonal
antibodies (mAbs) (Abdillahi et al., 1987). Some meningococci, however, do
not react with the currently available set of mAbs and they are labeled non-
typable.
1.3.3.3. Lipooligosaccharides (LOS) and immunotypes
In 1985, a scheme was proposed for the characterization of N. meningitidis
isolates (Frasch et al., 1985) based on a combination of serogroup, serotype,
subtype and lipopolysaccharide (LPS) serotype. The name of the last of these
was changed to lipooligosaccharide (LOS) immunotype (IT) (Tsai et al., 1987).
Mandrel and Zollinger were the first to identify eight serologically distinct LOS
classes (immunotypes L1 to L8) among group B and C meningococci by
hemagglutination and solid-phase radioimmunoassay inhibition (Mandrell et
al., 1977; Zollinger et al., 1977).
LOS of group A meningococci showed little cross-reactivity with LOS of
serogroup B and C strains, and additional serotypes (L9 to L11) were added
(Zollinger et al., 1980). Serotypes L10 and L11 were uniquely associated with
group A strains; serotype L9 cross-reacted with L7, and to a lesser extent, with
L3, L4 and L6 of groups B and C. Type L8 was occasionally found on group A
strains. Currently, 11 immunotypes are distinguished; L1 through L11 of
which L3, L7 and L9 are closely related immunochemically (Zollinger et al.,
1977; Poolman et al., 1982; Zollinger ef al., 1980; Mandrell et al., 1977). The
chemical structures of the terminal structures of L1-L6 and L8 have been
elucidated (Jennings et al., 1987; Dell et al., 1990; Difabio et al., 1990;
Schneider et al., 1991). Recently, two new LOS immunotypes (L12 and L13)
were described among meningococci of serogroup A, but it is not yet clear
whether they represent unique LOS structures. LOS types L9-L11 are found
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among serogroup A meningococci and L2 -L4 among serogroups B and C
(Kim eta!., 1988; Achtman et ai, 1992; Saiih et al., 1990).
The LOS immunotype is considered to be a virulence determinant (Jones et
al., 1992). Isolates of immunotypes with a terminal lacto-N-neotetraose unit
(L2, L3, L4, L5, L7 and L9) are capable of endogenously sialylating their LOS.
This renders them seroresistant by reducing the effectiveness of the
alternative complement pathway (Mandrell et al., 1991; Tsai et al., 1991).
Theoretically, serosensitive strains should be isolated more often from carriers
and this was found to be the case in Britain (Jones et al., 1992). It is possible
for a carrier strain of the L1/L8 group to shift to the L3 group during
colonization, enabling the isolate to invade the host defense mechanisms and
cause disease (Scholten et al., 1994).
Recent investigations have evaluated the applicability of the whole-cell ELISA
(WCE) for LOS immunotyping with mAbs by developing an algorithm for the
assessment of immunotypes based on the WCE results (Scholten et al.,
1994). It was shown that the serotypes 4 and 15 and the subtypes P1.4, P1.5,
P1.15, P1.16 and P 1.7.16 were associated with the immunotypes of the
L3/L1/L8 category and the serotypes 2a and 2b with the immunotypes L2 and
L4. The first category was typical of serogroup B and the second of serogroup
C (Scholten et al., 1994). Knowledge of the distribution of LOS immunotypes
among serogroup B meningococci is of particular interest, because the LOS
is being investigated as a potential vaccine (Poolman et al., 1990).
LOS immunotyping has been used to follow the spread of group A disease
(Griffiss 1983), but its usefulness has been limited by uncertainty as to the
structural basis of LOS antigenic diversity and the presence of multiple
serotypes on the same organism ( Zollinger et al., 1977; Zollinger et al., 1980).
This has necessitated the use of arbitrary criteria for the assignment of
immunotypes and created a critical need for standardized sera. Serogrouping,
serotyping and subtyping have proved useful for studying the epidemiology of
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meningococcal disease, but LOS immunotyping is not regularly incorporated
into these studies. LOS immunotyping has been hindered by the complexity of
the methods involved (Zollinger et al., 1977; Poolman et al., 1982); and there
is still no mAb available for every immunotype. The interpretation of
immunotyping results is difficult because meningococci often express several
immunotypes and their expression can be influenced by growth conditions
(Zollinger et al., 1980; Poolman et al., 1985; Mandrell et al., 1991; Tsai et al.,
1991)
The assays used to assign LOS immunotype are poorly suited for use in
developing countries, where the bulk of meningococcal disease occurs
(Peltola 1983). Although it is part of the full characterization of N. meningitidis,
immunotyping is not regularly performed and the immunotype is often omitted
from the phenotype description. Table 1.6 summarizes the meningococcal
surface structure used for meningococcal phenotyping.
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TABLE 1.6. Surface structures of Neisseria meningitidis used
for meningococcal characterization (phenotyping)
Surface structure * Designation Labels
CPS Serogroup A, B, C, X, Y, Z, 29E,
W-135, (H, I, K, L)






P1.1, P1.2, P1.3, P1.4
P1.6, P1.9, P1.10, P1.14,
P1.15, P1.16
LOS Immunotype L1 through L11
* CPS = Capsular polysaccharide; OMP = Outer membrane protein
VR = Variable region ; LOS = lipooligosaccharide
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Phenotyping has proved to be a valuable tool for studying the spread of
meningococcal disease (Ashton et al., 1991; Achtman et al., 1992; Froholm et
al., 1991a,b ; Poolman et al., 1986; Fallon et al., 1988; Samuelsson et al.,
1992; Wang et al., 1992). Phenotype antigens have also been used to
develop vaccines for prevention of meningococcal disease due to serogroup
A, C, W135 and Y in adults and older children and serotype, subtype and LOS
antigens are being investigated for their use in development of vaccines
against serogroup B.
1.3.4. Genotypes
Genetic relationships of different meningococcal isolates have been assessed
by multilocus enzyme electrophoresis and restriction fragment length
polymorphism (Selander et al., 1986; Foxetal., 1991).
In multilocus enzyme electrophoresis, also called electrophoretic typing, the
pattern of isoenzyme variants of several common cytoplasmic enzymes is
used to estimate the genetic content of meningococcal isolates. Isoenzyme
variants are determined by using specific enzyme stains after starch gel
electrophoresis (Selander et al., 1986). Based on the results of the
electrophoretic migration of each enzyme, each isolate is then assigned a
multidigit score. Each multidigit score obtained, forms an electrophoretic
type (ET) designated by an Arabic number (Selander et al., 1986). The
various ETs are labeled from 1 to the total number of different ETs detected
among the isolates tested.
The designation of ETs is nominal and varies from survey to survey and ET
numbers allocated in different surveys are not usually similar or
interchangeable unless the ET numbers of one survey are adapted to
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those of another. Each separate ET represents a clone with a particular
genetic background. On the basis of the isoenzyme variants of the different
enzymes, the genetic relationship of the ETs of the isolates is assessed by
the use of multivariate statistical methods (Selander et al., 1986), and
clusters (or lineages) of clones that are genetically closely related can be
distinguished (Achtman et al., 1992; Crowe et al., 1989; Salih et al., 1990;
Froholm et al., 1991; Wang et al., 1992 ; Caugant et al., 1986 a,b ; Caugant et
al., 1987; Caugant et al., 1990).
Restriction fragment length polymorphism (RFLP) is another method for the
assessment of genetic relationships among meningococci (Fox et al.,
1991). The procedure involves extracting cellular DNA and fragmenting it
with restriction endonucleases. The fragments are subsequently separated by
electrophoresis. After hybridization with a DNA probe, the fragments which
contain the sequence to which the probe is directed are visualized. By the
use of the probe, the number of DNA bands is restricted, which helps
facilitate the interpretation of the DNA patterns. The choice of the probe
is based on repeated DNA sequences found in various parts of the
chromosome. In order to characterize all possible meningococcal strains, it is
essential to select a probe with broad specificity. RFLP types are
designated according to the various RFLP patterns found in the population of
isolates under consideration. RFLP results are similar to those obtained by
electrophoretic typing (Fox et al., 1991).
Phenotypic similarity does not always imply genotypic similarity and isolates
that are genetically closely related, can be of different phenotypes (Fox et al.,
1991; Caugant et al., 1986 a, b ; Caugant et al., 1987; Caugant et al., 1990). A
new meningococcal strain in a particular geographical area, however, is
often homogenous with regard to both the genotype and phenotype during




1.4.1. Classification of meningococcal disease
The clinical manifestations of meningococcal disease are varied. This can
range from transient fever and bacteremia to fulminant disease with death
ensuing within hours of the onset of symptoms.
Bacteremia without sepsis can follow an upper respiratory illness or viral
exanthem. After recovery and frequently after discharge without specific
antimicrobial therapy, the results of blood cultures are reported as positive for
N. meningitidis.
Meningococcemia without meningitis is characterized by the patient being
septic with signs of leukocytosis, skin rashes, generalized malaise, weakness,
headache. Hypotension can develop on admission to hospital or shortly
thereafter.
Meningitis with or without meningococcemia is characterized by
headache, fever and meningeal signs are present with a cloudy spinal fluid.
The meningoencephalic presentation is a clinical state in which patients are
profoundly ill with meningeal signs and septic spinal fluid.
1.4.2. Surface components and pathogenesis of meningococcal disease
Different surface components of meningococci contribute to colonization and
invasion across the mucosal surfaces (e.g. pili and OMPs), survival within the
blood stream (capsule) and eliciting the physiological responses that result in
damage to the host (LOS, peptidoglycan).
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1.4.2.1. Attachment and invasion across epithelial cells.
Although meningococci can be isolated from about 10% of most populations,
very few individuals develop meningococcal disease. Although the
nasopharynx is important in the maintenance of the organism in the
environment, the factors that determine attachment of meningococci
predominantly to this site rather than to other mucosa surfaces are poorly
understood.
To attach and invade host mucosal epithelium effectively, bacteria must
escape the effects of IgA, avoid the ciliary clearance mechanisms of the
nasopharyngeal mucosa, bind to the apical membrane and then cross to the
basolateral side of the mucosal epithelial cells. The evasion of mucosal IgA
actively secreted by plasma cells is an important first step. All clinical isolates
of S. pneumoniae, H. influenzae and N. meningitidis secrete IgA proteases
which cleave the proline-rich hinge region of IgA and render it nonfunctional,
thereby facilitating bacterial attachment to epithelium. Infection of cultured
human nasopharyngeal tissues with N. meningitidis results in injury of ciliated
epithelial cells and loss of ciliary activity.
Once past the protective mucus barrier and ciliary mechanisms, meningococci
bind selectively to non-ciliated epithelial cells in the underlying tissue. For N.
meningitidis, as for other gram-negative bacteria, binding is dependent on the
presence of finger-like projections (pili) on the surface of the bacteria. Pili are
found on 80% of primary meningococcal isolates from the nasopharynx of
carriers as well as from cerebrospinal fluid of meningitis patients (DeVoe and
Gilchrist 1975). Attachment of pilate meningococci differed among epithelial
cells from different sites; there was more attachment to nasopharyngeal and
buccal epithelial cells compared to cells from the urethra or anterior nasal
epithelium. Pili have been identified on N. meningitidis and are associated
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with enhanced attachment to the host cells and increased virulence
(Silverblatt and Cohen, 1979). While pili probably play a role in colonization
of mucosal surfaces, non-pilate strains more easily escape phagocytosis, and
systematic meningococcal isolates are less pilate than pharyngeal strains.
It has been suggested that the presence of the capsule decreases the
adherence of meningococci to mucosa and human erythrocytes (Craven and
Frasch, 1978). Outer membrane proteins and lipooligosaccharide might also
influence the attachment of N. meningitidis to human cells. N. meningitidis was
found to be toxic for human epithelial cells due to a heat-stable component of
outer membrane vesicles, suggesting that lipooligosaccharide plays a major
role in toxicity.
In cell and organ cultures, meningococci adhere to the microvilli of non-
ciliated ceils of human nasopharyngeal mucosa. The microvilli restructure
and surround the bacteria. This is accompanied by a rapid decrease in
ciliary action and sloughing of the ciliated epithelial cells. Meningococci
attached to the non-ciliate cells were endocytosed within vesicles and passed
through the cells into the subepithelial tissues (Stephens et at, 1991).
Dunn and coworkers found that N. meningitidis, N. gonorrhoeae, N. lactamica
and N. sicca also damage human endothelial cells (Dunn et al., 1995). The
degree of toxicity observed correlated with their relative level of adherence to
cultured cells. In contrast, the Opc-dependent increased adherence did not
result in increased toxicity for endothelial cells, suggesting that pili have a
synergetic effect, contributing to the overall damage. Although the Opa
proteins increase bacterial attachment and invasion of endothelial cells, Opc
is the most effective protein in increasing bacterial interactions with these
cells. Opa-mediated interactions are also eliminated or significantly reduced
in variants expressing capsules or those with sialylated lipopolysaccharide
(Virji etal., 1993).
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1.4.2.2. Survival in the blood
The bacteremia associated with meningitis is usually assumed to follow
nasopharyngeal colonization and is the intermediate step before invasion of
the central nervous system (CNS). Once the mucosal barrier is crossed,
bacteria must overcome additional host defense mechanisms. Capsules are
important surface antigens which effectively inhibit neutrophil phagocytosis
and complement mediated killing by the alternative complement pathway. This
enhances blood stream survival and facilitates intravascular replication
leading to high bacterial densities.
1.4.2.3. Invasion of the central nervous system (CNS)
It has been suggested that meningococci can survive within human
monocytes which could facilitate their entry into the CNS as monocytes can
cross into the central nervous system (Perry et at, 1985). It has been
proposed that there might be a parallel between the "Trojan horse"
mechanism of invasion used by Streptococcus suis in pigs (Williams and
Blakemore, 1990) and meningococci in humans (Twite et at., 1994).
A major research effort has elucidated the mechanism by which cytokines
facilitate the passage of leucocytes, particularly neutrophils and monocytes
across the endothelium into the CSF. The adherence of leucocytes to
endothelium of venules has been viewed as the initial step in tissue
inflammation; however, pre-incubation of the monolayers with either
interleukin-1 or tumor necrosis factor (TNF) induces a time-and dose-
dependent increase in the adherence and transendothelial passage of
neutrophils (Mooser et at, 1989). This adherence is mediated by specific
transmembrane glycoproteins expressed on the endothelial cells that interact
with specific counterparts on the neutrophils. Three families of adhesion
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molecules can mediate these interactions: the immunoglobulins; the integrin
family; and the selectin family.
Local production of inflammatory cytokines (interleukin-1 and TNF) and other
mediators within the CSF in response to bacterial replication or lysis induces
selectin-mediated adherence of neutrophils to endothelium. With continued
cytokine stimulation, the down-regulation of the early selectin-adhesin event is
coordinated with the introduction of beta-2 integrin-mediated adherence to
neutrophils. This switch appears to be regulated by endothelial derived
interleukin-8 is released by the endothelium in response to stimulation by
interleukin-1. The neutrophils that successfully migrate into the CSF can
subsequently be stimulated by the same locally produced cytokines (TNF, and
interleukin-1, interleukin -6 and interleukin-8) to degranulate and release toxic
oxygen metabolites and other inflammatory derivatives in the intermediate
milieu of the microvasculature. These substances appear to alter the blood-
brain barrier by inducing an increase in the vesicular uptake of circulating
albumin as well as a more dramatic paracellular leakage of albumin through
open intercellular junctions, leading to vasogenic brain edema.
1.4.2.4. Host responses to the pathogen
Endotoxin and peptidoglycan induce inflammatory responses and LOS is
considered the most important inducer of inflammatory processes in the CSF
and in the development of septic shock (Quagliarelo and Scheld 1992;
Morrison et a!., 1983). Meningococci are capable of releasing parts of their
outer membrane ("blebs"),which contain high concentrations of LOS (DeVoe
et a/., 1982; Quagliarello et al., 1992). LOS induces a cytokine cascade; TNF
and interleukin-1 are thought to be the two main host inflammatory mediators
involved.
Inflammation appears one to three hours after intracisternal inoculation of
meningococcal LOS in experiments carried out in rabbits; and the release of
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TNF, interleukins 1 and 6 into the CSF was observed. The most direct
evidence that cytokines are responsible for damage in meningitis was
observed in experiments with rats in which direct inoculation of cytokines into
the CSF (interleukin-1a and interleukin-1(3) induced inflammation and impaired
the integrity of the blood-brain barrier. (Quagliarello et al., 1992; Brandtzaeg
et al., 1989). The result is a brain oedema, increased intracranial pressure and
an alteration of the cerebral blood flow (Lambert 1991; DeVoe et al., 1982;
Peltola etal., 1983; Spanjaard et al., 1987; Beaty et al., 1987).
When intracranial pressure increases it can result in a life-threatening cerebral
herniation. Given the rigid confines of the skull and spine, intracranial pressure
is directly related to the volume of the brain, CSF, and cerebral blood.
Alterations in cerebral blood flow may have an additional and even critical role
in the ultimate sequelae of meningitis. Cerebral blood flow increases at first
and then decreases - a phenomenon that appears to be related to the
generation of oxygen intermediates in the microvasculature (Tureen et al.,
1990; Pfister et al., 1990). These changes in blood flow are related to the loss
of cerebrovascular autoregulation, such that cerebral blood flow fluctuates
directly with the mean arterial blood pressure (Pfister et al., 1990). With the
loss of cerebrovascular autoregulation induced by bacterial meningitis, the
brain is at risk from either hyperfusion or hypotension.
Systemic effects include acute vasculitis and focal myocardial necrosis with
hemorrhage and neutrophil infiltration. Purpura is also a consequence of
acute vasculitis, fibrin plugging of the arterioles and capillaries leading to
hemorrhage in the skin. The mucus membranes of the oral cavity, the
conjunctival and serosal surfaces and occasionally the glomeruli and adrenal
glands are also affected.
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1.4.3. Case fatality rate and sequelae
The crude case-fatality rate (CFR) of meningococcal disease ranges from 2-
14% (Kayhty et al., 1989a; Wedege et at., 1990; Samuelsson et al., 1992;
Peltola et al., 1983; Greenwood et al., 1979; Fallon et al., 1984; Spanjaard et
al., 1987; Weihe et al., 1988; Halstensen et al., 1987; DeWals et al., 1984;
Palmer et al., 1992; Havens et al., 1989). Fatalities may be directly due to
cerebral damage (cerebral infarcts and herniation due to brain edema), but
result more often from pronounced endotoxic shock (Lambert et al.,
1991; Quagliarello et al., 1992; Brandtzaeg et al., 1989). Depending on the
definitions and circumstances, the reported CFRs among meningitis patients
range from 10-11%, whereas those among septicemia patients range
from 9-41% (Samuelsson et al., 1992; Peltola et al., 1983; Greenwood et al.,
1979; Fallon et al., 1984; Spanjaard et al., 1987; Salmi et al., 1976;
Halstensen et al., 1987; DeWals et al., 1984; Palmer et al., 1992). Despite
the improvement of clinical care during the past 4 decades, the CFR of
meningococcal disease has remained essentially unchanged (Havens et al.,
1989).
Of the patients who do recover, 3-13% are left with severe sequelae
(Cartwright et al., 1986; Peltola et al., 1983; Fallon et al., 1984; Spanjaard et
al., 1987). Sequelae may result directly from the infective process in the
meninges or from hemodynamic and hemostatic complications (Lambert et
al., 1991). Common sequelae are loss of hearing or even complete
deafness, severe skin necrosis leading to scars and contractures or
necessitating amputation, paralysis of a cranial nerve, hemi-paresis, seizures
and mental retardation (Cartwright et al., 1986; Peltola et al., 1983; Spanjaard
eta!., 1987).
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Several surface characteristics of N. meningitidis, such as the serogroup and
the serotype, have been found to be associated with an unfavorable
outcome of meningococcal disease (Fallon et ai, 1984; Spanjaard et a!.,
1987); however, the results of these reports were conflicting. For example,
in Scotland from 1972-1982 more fatalities were associated with disease due
to isolates of serogroups A and C, compared with serogroups B and W-135
(Fallon ef a/., 1984). In the survey in the Netherlands from 1959-1981, this
association was reversed; isolates of serogroup W-135 and uncommon
serogroups showing the highest CFRs, followed by those of serogroups B,
C, A (Spanjaard et al., 1987a). The uncommon serogroups (X, Y, Z, 29E, W-
135) and non-groupable isolates are considered to be opportunistic
pathogens because they seem to cause disease predominantly among
immunocompromised patients (Spanjaard et al., 1987, Fijen etal., 1989).
1.4.4. Epidemic and endemic meningococcal disease
Epidemics of meningococcal disease have been reported regularly worldwide.
These are mainly due to a particular meningococcal clone or a limited
number of closely related clones (Crowe et al., 1989 ; Salih et al., 1990;
Samuelsson et al., 1992 ; Wang et al., 1992 ; Caugant et al., 1986b ; Caugant
et al., 1990 ; Sacchi et al., 1992 ; Olyhoek et al., 1987; Knight et al., 1990).
The attack rate of epidemic meningococcal disease is usually in the range of
10 to 1000 per 100,000. In major African epidemics, the nationwide attack rate
ranges from 100 to 800 per 100,000, but the local attack rate in affected
villages or cities may exceed 1,000 cases per 100,000 persons. Conversely,
during the epidemics which occurred in the 1970s in Finland and Norway the
annual incidence was only 15-25 per 100,000 population. The ratio between
epidemic and mean endemic incidence rates is generally higher in developing
countries than in developed populations (Peltola et al., 1982).
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Risk factors related to disease or outbreaks are not completely understood. A
combination of conditions (environment, host and organism) are necessary for
an epidemic to occur. These include : immunological susceptibility of the
population (perhaps due to loss of herd immunity to the prevalent strain);
special climatic conditions (dry season, dust storm); low socioeconomic status;
and transmission of a virulent strain. Acute respiratory tract infections may
also contribute to the development of meningococcal epidemics (Moore et al.,
1990).
The risk of epidemic meningococcal disease differs between serogroups.
Serogroups A, B, and C can cause outbreaks. Other serogroups (D, E29, X,
W135, Y and Z) have so far not been associated with outbreaks. In most
developing countries epidemics are usually caused by meningococci of
serogroup A. With the exceptions of Russia and Romania in which epidemics
of serogroup A occur, in Europe and America meningococci of serogroups B
and C were more prevalent.
The appearance of a new meningococcal clone with a new phenotype
(B:2b:P1.2) was responsible for the 1966 epidemic in the Netherlands
(Caugant et al., 1990 ; Poolman et al., 1980a). Meningococci of the
phenotype B: 15: P1.7,16 caused a protracted epidemic in Norway that
started in 1974 (Bovre et al., 1977; Lystad et al., 1991). This phenotype
was the main representative of a complex of meningococcal clones (ET-
5 complex), which has slowly spread to the south of Europe and to America.
Epidemics or local outbreaks in other parts of the world due to clones of the
ET-5 complex were often of other phenotypes e.g. B:4:P1.15 in Cuba and
B:15:P1.3 in Chile (Caugant et al., 1986 b).
Meningococcal disease is endemic in both developing and
industrialized countries (Peltola et al., 1983). Endemic attack rates of
meningococcal disease in developed countries with temperate climates range
from 1 to 5 per 100,000 population. In developing countries, particularly in the
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sub-Saharan arid area, the incidence rate between epidemics varies greatly
(from less than 10 to over 20 per 100,000). In Western Europe most cases of
meningococcal disease are reported during the winter months, but in
(sub)tropical areas the incidence of meningococcal disease is highest during
or at the end of the hot dry season (Lambert et al., 1991; Peltola et at., 1983 ;
Greenwood et a!., 1979). Desiccation of the mucosal surface during these
periods has been assumed to facilitate the invasion of nasopharyngeal
meningococci (Lambert et al., 1991).
During endemic periods many different phenotypes and clones are found
among serogroup B and C isolates (Kayhty et al., 1989a; Froholm et al.,
1991a; Poolman et al., 1986; Calain et al., 1988; Froholm et al., 1991a). These
two serogroups share many serotypes, subtypes and immunotypes
(Zollinger et al., 1977; Poolman et al., 1982). Serogroup A isolates are rather
homogenous with regard to both the phenotype and genotype (Achtman et
al., 1992 ; Crowe et al., 1989 ; Salih et al., 1990 ; Wang et al., 1992 ; Zollinger
eta!., 1980).
1.4.5. The meningococcal carrier state
Early observations on the carrier state have been reviewed in depth by
Apicella (1990). Asymptomatic carriage of N. meningitidis in the nasopharynx
in otherwise healthy humans has been recognized since 1896. Before the
elucidation of distinct meningococcal serogroups, Dopter found organisms in
the nasopharynx that had all the characteristics of meningococci but that
failed to agglutinate with anti-meningococcal serum prepared from strains
isolated from spinal fluid. He labeled these parameningococci. In 1908,
Bruns and Hohn noted a close relationship between the carrier rate in a
population and the onset, rise and decline of an epidemic. Glover noted the
same association in the British Army military camps during the World War I.
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He suggested that when the carrier rate exceeded 20%, the community was in
danger of an epidemic usually due to the predominant carrier serotype.
The transmission of meningococci from carrier to carrier is via the respiratory
route. The rate of spread of bacteria through a population has been the
subject of a number of studies. During epidemics in military camps, the rate of
acquisition can be very rapid. In non-epidemic situations, both military and
civilian, the rate of acquisition can be considerably slower and the carriage
can exist for prolonged periods of time. Rake demonstrated that carriers fell
into three groups, chronic, intermittent and transient and that chronic carriers
could be constantly colonized for up to 2 years.
The carrier state is an immunizing process. Indirect evidence for this
phenomenon is the fact that while military recruits have a high frequency of
meningococcal carriage and disease, seasoned veterans have a much lower
carriage rate and a disease incidence no different from the civilian population.
In military recruits, anti-meningococcal antibodies have been shown to persist
for a minimum of 4-6 months after exposure. These antibodies are of the
three major immunoglobulin classes IgA, IgG and IgM (Goldschneider et al.,
1969 a, b). Reller et at. (1973), demonstrated the development of bactericidal
antibodies to the meningococcus in 38 military recruits who became colonized
with non-groupable meningococcal strains. Bactericidal antibody to the
homologous strain was present in 39% of these men, and a proportion also
developed antibodies that were directed against heterologous strains. These
same investigators found greatly enhanced (10- to 100- fold increase)
bactericidal activity to known pathogenic strains A, B, C and Y after
colonization with non-groupable meningococci. This suggested that these
organisms are as capable of stimulating cross-reactive antibody as groupable
meningococci through either an initial or anamnestic response.
Carrier rates in open populations range from 5% to 30% (Peltola et al.,
1983; Cartwright et al., 1987; Blackwell et al., 1990b). The serogroups B,
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C, YandW-135 are common among carriers and meningococci of the
serogroups X, Z and 29E, as well as non-groupable meningococci, are
found almost exclusively among carriers (Peltola et al., 1983 ; Greenfield etal.,
1971; Cartwrightetal., 1987).
Carriage of meningococci of serogroup B is usually characterized by long
duration (median 9 months) and low acquisition rates (i.e., the incidence of
carriage) (Lambert et al., 1991; Broome et ai, 1986). Serogroup A, however,
has been found to be less prevalent among carriers, but high acquisition
rates and a rapid turn over has been demonstrated (Lambert et al., 1991;
Hassan-King etal., 1979 ; Broome etal., 1986).
1.4.6. Developmental, genetic and environmental factors affecting
carriage and susceptibility to meningococcal disease
1.4.6.1. Age and development of antibodies to meningococcal disease
Goldschneider et al. demonstrated that the percentage of people having
bactericidal activity against N. meningitidis in their serum is inversely
proportional to the incidence of meningococcal meningitis during the first 12
years of life (Goldschneider et al., 1969 a, b). Due to maternal transfer of
antibodies at birth, approximately 50 % of infants have bactericidal antibody to
meningococci. The prevalence of bactericidal antibody decreases after birth
and reaches its nadir between 6 and 24 months of age; thereafter, a linear
increase in antibody titer occurs until the age of 12.
The nature of these responses in humans has been studied in children in
relation to the cellular basis of the immune response to polysaccharide. In
healthy human infants, the antibody responses to several polysaccharide
antigens are delayed in ontogeny (Smith et al., 1973; Borgono et al., 1978).
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Precursors of B cells expressing specificity for different polysaccharide
antigens such as a-1,3-dextran (Howard and Hale 1976) and levan (Bona et
al., 1979) have been shown to appear late in ontogeny, whereas precursors to
some proteins have been detected on the day of birth. Polysaccharides have
traditionally been characterized as T-independent antigens, capable of
activating B cells without T cell help, producing mainly IgM antibody. Young
children make little or no antibody to such T-cell independent antigens
(Anderson and Betts 1989).
Cross-reactivity has been clearly demonstrated between neonatal tissues
and the group B capsular polysaccharide. By using monoclonal antibodies
specific for this capsule it has been shown that cross-reactivity exists between
central nervous system, cardiac, liver and renal glycoproteins (Finne et al.,
1987) of the infant rat and the group B polysaccharide. As the animal
matures, the cross-reacting antigens persist in the central nervous system.
These studies suggest that the poor immunogenicity of this polysaccharide
may be due to the fact that it resembles host antigens.
Goldschneider et al., (1969a,b) examined the effect of carriage on
development of anti-meningococcal antibodies in children. Non-typable
strains, identified among children in carrier studies contain antigens cross-
reactive with the encapsulated strains. Bactericidal antibodies to these strains
develop after nasopharyngeal colonization. Serogroup-specific antibodies also
arise as a result of carriage. The bulk of anti-meningococcal antibodies
collected in 1968 were directed against the capsular polysaccharide. In
addition, these studies showed that the antibody was primarily directed
against the serogroup C meningococcus which was prevalent in the
population at the time of collection. This is in contrast to the low level of
antibody directed against the capsular polysaccharide of the group A
meningococci which had not been prevalent in the population for 10-15 years.
It would appear that the bulk of protection in the pooled antibodies to the C
meningococcus is directed towards the capsule, while protection against
32
group A meningococcus is afforded by antibodies cross-reactive with other
antigens.
1.4.6.2. Genetic factors
1.4.6.2.1. Complement properdin deficiencies.
Recurrent episodes of meningococcal disease are usually associated with
deficiencies of the complement system. Absence of the sixth complement
component was demonstrated in a patient with meningococcal meningitis (Lim
et al., 1976). In an earlier study, at least one of the patients with recurrent
meningococcal disease lacked C3 (Alper et al., 1970). Other studies indicated
that human deficiency of C8 has been found in some persons with
disseminated gonococcal infections and that this complement component is
required for serum bactericidal activity against gonococcus (Petersen et al.,
1976). Ellison and coworkers, have evaluated the complement system in 20
patients with first episodes of serious systemic meningococcal infection;
complement deficiency was detected in 6 (30%) of the patients. Half of the
patients had deficiencies in a terminal complement protein(s) while the rest
had deficiencies of multiple factors associated with underlying disease states
(Ellison et al., 1983). This bactericidal defect could be corrected by vaccination
of such population; vaccinating individuals deficient in late complement
components may shift the burden of host defense from serum bactericidal
activity to phagocytosis (Ross et al., 1984).
Inherited complement deficiency states have been found in association with
10% -30% of the sporadic adult cases of meningococcal disease (Ross and
Densen 1984). An intact classical complement pathway might be important in
resisting infection with N. meningitidis especially in families with properdin
deficiency (Sjoholm and Nilsson 1985). Individuals with inherited deficiency of
properdin have a functional classical pathway of complement and vaccination
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might be protective (Sonderstrom et at., 1989). Complement-dependent
phagocytosis requires complement activation only through C3.
1.4.6.2.2. Blood group antigens, secretor status and susceptibility to
infectious agents - epidemiology.
There is a large body of epidemiological evidence for associations between
ABO blood groups and secretor status with susceptibility not only to infectious
disease but also to other conditions (Mourant, et al., 1976; Blackwell, 1989d).
Examples of the reported association between infectious diseases and ABO
blood groups are listed in Table 1.7 and secretor status in Table 1.8. Many of
the associations between ABO blood groups and diseases were severely
criticized by Wiener (1970) who stated that if an hypothesis could not be
formulated to explain the findings, they were most likely due to chance.
Associations between ABO blood groups and infectious diseases were
excluded from these criticisms as many microorganisms have antigenic
components cross-reactive with ABH antigens. It was suggested that the anti-
A and anti-B isohemagglutinins acted as "natural" antibodies exhibiting
bactericidal or opsonizing activities against bacteria expressing cross-reactive
antigens.
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Table 1.7. Association between ABO blood groups and susceptibility to
infections




Influenza A 0 Potter, 1969
M. tuberculosis B Viskum, 1975
S. pyogenes (Group A) not O Haverkorn and Goslings, 1969
S. pneumoniae not B Reed et ai, 1974
Oral cavity
Candida albicans (carriage) 0 Burford-Mason et at., 1988
Periodontal disease 0 and AB Pradhan et a!., 1971
Gastrointestinal tract
E. coli B Socha et at., 1969
Salmonella and E. coli B and AB Robinson et al., 1971
Vibrio cholerae O Barua and Paguio, 1977
Urinary tract
E. coli B Cruz-Coke and Paredes, 1965
B/AB Kinane et al., 1982
Genitourinary tract
N. gonorrhoeae B Foster and Labrum, 1976
no association Johnson et al., 1983
Chlamydia trachomatis B Blackwell, (unpublished
observation)
Blood borne infections
Malaria A Gupta and Chaudhuri, 1980
Coccidioides immitis B Derensiski et al., 1979
Table reproduced from Blackwell (1989c) with modifications.
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Table 1.8. Association between non-secretors and susceptibility to
diseases
Infectious agent/ disease Reference
Non-secretors
Respiratory tract





Haverkorn and Goslings, 1969
Glynn et al., 1959
Blackwell et at., 1986a
Blackwell et al., 1986a




Chaudhuri and Das-Adhikary, 1978
Reviewed by Mourant et al., 1976
Urinary tract
E. coli Kinane et al., 1982




Thorn et al., 1989
Holbrook and Blackwell, 1989
Autoimmune diseases
Ankylosing spondelytis Shinebaum et al., 1987
Insulin dependent diabetes mellitus Blackwell et al., 1987a
Grave's disease Collier et al., 1988
Secretors
Respiratory virus disease Raza et al., 1991
Human immunodeficiency virus
(heterosexual transfer)
Blackwell et al., 1991
Table reproduced from Blackwell (1989c) with modifications.
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In contrast to N. gonorrhoeae for which there is an association with blood
group B, there have been no associations found between ABO blood groups
and meningococcal disease in studies in Scotland, Iceland or Nigeria
(Blackwell eta!., 1986a; 1989b).
The majority of individuals have the water-soluble glycoprotein form of their
ABO blood group antigens in their body fluids (saliva, urine and ovarian cyst
fluid). Non-secretor individuals do not express their ABO blood group antigens
in the body fluids. Because the secretor gene (Se) is inherited in a Mendelian
dominant pattern, the predicted proportion of these phenotypes within a
population is secretors 75-80% and non-secretors 20-25%. This ratio can vary
widely in different ethnic groups and some geographically isolated populations
(Mourant et al., 1976).
Epidemiological evidence from different studies in Scotland, Iceland and
Nigeria suggest that there is an association between non-secretion and
susceptibility to invasive disease caused by meningococci, pneumococci and
type b H. influenzae (Blackwell et al., 1986 a,b). In areas where there have
been prolonged outbreaks of meningococcal disease and where the secretor
status of the population has been determined (Northern Nigeria, Iceland),
there are unusually high proportions of non-secretors (Blackwell et al., 1990a).
In the United Kingdom a similar pattern was found in Stonehouse
(Gloustershire) (Blackwell et al., 1989a) and Plymouth (Blackwell and Weir,
1990b) where there have been prolonged outbreaks due to the B: 15:P1.7,16
strains and among a school population in which an outbreak of meningitis due
to a B:4:P1.15 strain occurred (Blackwell et al., 1990a).
Several hypotheses have been suggested to explain the apparent increase in
susceptibility of non-secretors : a) Lea, usually expressed in greater quantities
on epithelial cells of non-secretors, is a receptor for some strains of
meningococci; b) there are differences between levels of the C3 component of
complement of secretors and non-secretors; c) non-secretors have less
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efficient total or specific immune responses; d) secretors have more inhibitory
activity of non-antibody components in their body fluids compared with non-
secretors.
1.4.6.2.3. Evidence that Lewis3 is a receptor for bacteria
One hypothesis put forward to explain the prevalence of non-secretors among
patients with certain bacterial or fungal infections is that some strains of
microorganisms have adhesins that bind the Lea antigen which is usually
expressed in greater quantities on epithelial cells of non-secretors compared
with secretors (Blackwell 1989a,b; Blackwell et al., 1992). Among older
children and adults, the proportion of individuals whose erythrocytes are
agglutinated by anti-Lewis3 is generally 20-25%. Between the ages of 2-4
months, approximately 80-90% of infants express the antigen on their
erythrocytes (Issit, 1986), but this declines to the levels expected for adults by
18-24 months. Lewis3 antigen on epithelial cells is adsorbed from secretions
and Lewis3 is readily detectable in body fluids of infants (Blackwell et al., 1992;
Raza etal., 1991).
Pre-treatment of epithelial cells with monoclonal anti- Le3 significantly reduced
binding of S. aureus, and the binding of these bacteria was correlated with the
amount of Lewis3 detected on the epithelial cells of different donors (Saadi et
al., 1993). Essery et al. demonstrated microbial surface antigens that bind
Lewis3 antigen on strains of several bacterial species tested to which non-
secretors appear to be more susceptible than secretors: S. aureus (100%); N.
meningitidis (53%); H. influenzae (62%); (Essery et al., 1994). Protein
adhesins that bind Lewis3 have been isolated by affinity purification with
synthetic Lewis3 from S. aureus (Saadi et al., 1994) and Helicobacter pylori
(Alkout et al., 1995).
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1.4.6.2.4. C3 component of the complement system of secretors and
non-secretors
The structural gene for the third component of the complement system (C3), is
in the same linkage group as the secretor gene. It was shown that there were
significant differences in the levels of C3 in secretors compared with non-
secretors in children. Among the 100 children in the study with C3 levels
below the lower of the normal range, 7 of the 8 individuals were non-
secretors. (Blackwell 1989d).
1.4.6.2.5. Differences in total and specific levels of antibodies.
Protective immunity to disease due to N. meningitidis is associated with the
presence of an intact complement system and opsonizing or bactericidal
antibodies specific for the invading strain (Goldschneider et al., 1969a,b; Lee
eta!., 1978).
The lower immunoglobulin levels found in non-secretors compared with
secretors were suggested to contribute to the increased susceptibility of non-
secretors to rheumatic fever and rheumatic heart disease (Grundbacher et al.,
1972) It was suggested that specific immune responses at the mucosal
surfaces of non-secretors might be compromised compared with that of
secretors, as they were found in earlier studies to have lower levels of serum
and salivary antibodies (Waissbluth and Langman 1971).
To test this hypothesis, total and specific levels of serum IgG, IgA and IgM for
secretors and non-secretors was compared in a collection of sera obtained as
part of investigations of an outbreak of meningococcal disease in a Scottish
secondary school. Results from serum antibodies assessed indicated that
there was no correlation between levels of serum IgM in relation to carriage;
but there were significant lower levels of IgM in saliva of non-secretors. This,
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might contribute to susceptibility to colonization, particularly among infants
under the age of 12 months in whom secretory IgM is the major class of
antibody on mucosal surfaces (Zorgani et al., 1992).
1.4.6.2.6. Inhibitory effect of secretor and non-secretor saliva.
Colonization of mucosal surfaces by bacteria is, in part, determined by the
capacity of the host to block attachment of adhesins on the microorganism
that bind specific receptors on epithelial cells. The ability of the host to resist
infection or colonization by microorganisms is partly dependent on the
presence of a fully functional mucosal immune system. Although IgA is the
most abundant immunoglobulin in exocrine secretions such as tears, saliva
and milk, IgG and IgM are also found in these fluids (Brandtzaeg et al., 1970;
Smith et al., 1989). IgM can also function as a true secretory immunoglobulin
(Brandtzaeg et al., 1981), reaching the mucosal surface by the identical
secretory-component mediated transcellular pathway that transports IgA. The
full protective potential of secretory IgA is not present in the infant at birth
(Haworth et al., 1966; Berg 1968). Adult levels of secretory IgA are not
reached until after 1 year of age (Burgio et al., 1980; Mellander ef al., 1984). It
has been suggested that in infants the presence of IgM compensates partially
for the low levels of IgA (Mellander et al., 1984). IgM to polio virus and E. coli
has been found in infants (Mellander et al., 1984; Mellander et al., 1986a).
Relatively small amounts of 19S IgM are found in normal secretions, but the
concentration is much increased in infants and in individuals with selective IgA
deficiency (Brandtzaeg, 1971; Savilahti, 1973). It was originally thought that
19S IgM antibodies in serum and secretions were identical (Brandtzaeg et al.,
1978); but it has been shown that IgM in secretions is associated with SC
although only 60-70% of the molecules retain the SC after purification
(Brandtzaeg, 1975). Various antibody activities have been shown for IgM in
nasal secretions (Ogra et al., 1974) and salivary fluids (Mellander et al., 1984;
1986a,b). Evidence from measurement of antibody activity to antigens to
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which infants are naturally exposed (Mellander et al., 1984; 1986 a) or to
which they have been immunized (Carlsson et al., 1985; Smith et al., 1986)
indicates that IgM antibody is also present in whole saliva early in life. IgM has
been detected in saliva of some infants who were as young as one month of
age (Glesson et al., 1982; Smith et al., 1989).
Zorgani et al., demonstrated that non-secretors had lower levels of total
salivary IgM and salivary IgM specific for Neisseria lactamica and five strains
of meningococci (Zorgani et al., 1992). Two years later, the effect of salivary
components on attachment of meningococci to epithelial cells was assessed
with the aid of a flow cytometry assay (Zorgani et al., 1994). A significant
inhibition of bacterial binding by saliva was demonstrated and this inhibition
was significantly greater with saliva from secretors compared with saliva from
non-secretors. It was also demonstrated that after removal of antibodies, the
absorbed preparation still retained significant levels of inhibitory activity. In
addition, significant inhibitory activity was demonstrated with purified IgA and
IgM, but there was no significant difference between the activities of IgA and
IgM.
1.4.6.3. Environmental factors affecting meningococcal carriage and
disease
1.4.6.3.1. Cigarette smoke
Although symptom-free nasopharyngeal carriers are the usual source of
meningococcal infection, little is known about the factors that determine
carriage. Carriage rates are high in young adults, in people who live in
conditions of severe overcrowding and in military recruits in the absence of
overcrowding. In the very young and the very old carriage rates are low
(Cartwright et al., 1989) . One of the factors that could increase the likelihood
of carriage is exposure to environmental pollutants including cigarette smoke.
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Stuart and colleagues found an association between carriage and smoking in
their studies (Stuart et al., 1989). The risk of carriage associated with active
smoking increased with the number of cigarettes smoked daily; there was an
increased risk of carriage with heavier smoking. Although the biological
mechanisms are not yet known, interference with ciliary activity by cigarette
smoke might predispose to colonisation of the nasopharynx by N. meningitidis
(Crofton etai, 1981; Stephens et al., 1991).
Passive exposure to cigarette smoke can also account for an increased risk of
meningococcal carriage in those who live with smokers and for the increased
risk of meningococcal disease in children who live with smokers (Haneberg et
al., 1983; Stuart et al., 1988). This higher risk of carriage could be due to the
greater chance of acquiring meningococci from contact with smokers and not
to a direct effect of passive smoking ( Stuart et al., 1989; Blackwell et al.,
1990a).
Smoking in teenagers is associated with carriage and could contribute to the
increase in prevalence of meningococci carriage and in meningococcal
disease attack-rates in this age group (Cartwright et al., 1987; Blackwell et al.,
1990a; Fraser et al., 1973). The high attack rates and high carriage rates in
military recruits (Aycock et al., 1950; Fraser et al., 1973) could also be due
partly to a higher prevalence of smoking (Cummins et al., 1981) and to heavier
smoking (Crowdy, 1981) in military populations than in the corresponding
civilian population.
1.4.6.3.2. Respiratory infections
Associations between meningococcal infection and preceding viral respiratory
infections have been reported. Young and coworkers investigated an outbreak
of meningococcal infection in an elderly population, most of whom had
serologic evidence of influenza (Young et al., 1972). Goldstein and associates
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have shown that pulmonary clearance of meningococci is diminished in
animals previously exposed to an virulent encephalomyelitis virus (Goldstein
et al., 1972). Meningococcal upper respiratory tract infections (pharyngitis)
associated with contacts of patients and as a prior symptom in cases of
serious meningococcal disease have been described by several authors
(Tobin etal., 1956; McCracken, 1976).
The elderly are not usually susceptible to meningococcal infections but an
outbreak of meningococcal meningitis in a geriatric ward affected nearly one
third of the females (11/55), 27 of whom were suffering from A2 influenza virus
infections. A significant association between the two pathogens was also
shown by the serological evidence in these patients (Young et al., 1972). Data
from military training center covering a period from 1967 to 1971 indicated a
lag of 7-10 days between acute respiratory diseases necessitating
hospitalization and meningococcal disease (Edwards et al., 1977). It is not
clear from the study which pathogens were involved in the acute respiratory
diseases. Upper respiratory tract infections with adenovirus or mycoplasma
have been reported to be a risk factors for epidemic disease due to a group A
N. meningitidis (Moore et al., 1990).
In a survey of patients with meningococcal disease, 46% of 69 cases had
prodromal symptoms affecting the upper respiratory tract within 1 week before
onset of signs and symptoms of the disease (Olsen et al., 1979). An
investigation of house hold contacts of patients with meningococcal disease
showed a bacterial carriage rate of 61% among the individuals with upper
respiratory symptoms compared with only 14% among those with no
symptoms (Olsen et al., 1981).
Infections by adenovirus and influenza B virus were detected by isolation of
the viruses or by serological methods in the study involving 160 cases of
meningitis due to H. influenzae or N. meningitidis and 138 controls. The
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viruses were significantly associated with the bacterial disease (Krasinski et
al., 1987).
Cartwright et at. (1991) reported that the 38% of 53 meningitis patients of 10
or more years of age had high titres of antibodies against influenza A virus,
compared with 6% of individuals in a control group. Possible associations with
other respiratory tract viruses were not reported in this study. Analysis of the
data obtained from the questionnaires supplied to the patients and the control
group showed that a high proportion of meningitis patients suffered from a flu¬
like syndrome during the previous 2 months.
Young children are highly likely to be infected with respiratory syncytial virus
(RSV) during the first two years of life (Henderson et al., 1979), and in an
experimental model, RSV infection of a human epithelial cell line Hep-2,
significantly enhanced binding of meningococci of different serogroups and
serotypes ( Raza et al., 1994).
1.4.6.3.3. Socioeconomic conditions
The case fatality rate varies depending upon the prevalence of disease, the
nature of infection and the socioeconomic conditions of the society in which
the infections occur. During endemic situations in industrialized countries,
case fatality can be as low as 7 percent for meningitis and as high as 19
percent for septicemia without meningeal involvement (Andersen 1978).
During epidemic situations, mortality for meningitis can vary from 2 to 10% and
for septicemia can be as high as 70% in some Third World countries
(deMorais et al., 1974; Oberli et al., 1981). In Britain, smoking is more
prevalent among unskilled or partly skilled individuals compared with
professional groups (Wald et al., 1988)
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1.4.6.3.4. Demographic factors
The gathering of susceptible people is an important risk factor for outbreaks.
Travel and migration facilitate the circulation of virulent strains inside a
country or from country to country. Large population movements such as
war, play a major role in a spread of infection and disease and the highest
incidences of meningococcal disease were observed during the two world
wars (Hedrich, 1931; Priest et al., 1947). The outbreak which occurred in
Mecca in 1987, at the end of the pilgrimage period caused more cases among
pilgrims than among the Saudi population. In many countries, returning
pilgrims caused the occurrence of cases of meningococcal meningitis in their
immediate communities (Moore et al., 1988). In some countries the
occurrence of epidemics (Chad 1988, Marocco 1989, Sudan 1988) may have
been provoked by the introduction of a virulent strain of serogroup A
meningococcus imported by returning pilgrims (Moore et al., 1988). Other
large population displacements, e.g. those of refugees, may pose similar risks.
In the Czech Republic, introduction of a virulent strain of serogroup C
meningococcus caused an increase in the incidence of invasive
meningococcal disease in army camps in the eastern part of the country and
two local invasive meningococcal disease outbreaks in the civilian population.
A new clone was found (C:2a:P1.2) with unusual epidemiological and clinical
characteristics which had not been identified at least since 1973. This new
meningococcal clone was probably imported from Canada since there was a
good correlation with recent reports from Canada where the identical clone of
N. meningitidis serogroup C appeared (Kriz and Musilek, 1995).
These factors are of particular interest, as Greece is a major holiday
destination and also an immigration center for people from the former Soviet
Bloc (Albania, Russia)
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1.5. Treatment of meningococcal Infections
Chemotherapy for meningococcal infection began with the report of Schwenter
et al. (1937) that demonstrated that sulfonamides could be used successfully
in the treatment of meningococcal meningitis and meningococcemia (reviewed
by Apicella 1990). Early studies in 1942 by Feldman et al., found penicillin
administered in relatively low doses (120,000 units/day) was not as effective
as sulfonamides (reviewed by Apicella 1990). By using larger amounts of the
drug, it was demonstrated that the treatment results with penicillin were
identical to those with sulfonamides.
Penicillin therapy for the treatment of meningococcal infections is safe and
effective nowadays, although reports of penicillin-insensitive N. meningitidis
have come from Great Britain and Spain (Spot et al., 1988 ; Campos et al.,
1987). This relative resistance is due to a reduced affinity of penicillin binding
protein 3 in 11 serogroup B and 4 serogroup C N. meningitidis strains isolated
from CSF and blood during an epidemic in Spain ( Mendelman et al., 1988).
Chloramphenicol is an effective substitute for patients allergic to penicillin.
Third generation cephalosporins including cefotaxime, ceftriaxone and
ceftazidime have been used successfully in the treatment of pediatric cases of
meningococcal meningitis (Neu, 1987). The second generation cephalosporin
cefuroxime has also been successfully used in meningococcal meningitis
(Shaad et al., 1984). The duration of antibiotic therapy will vary somewhat
with the presentation and manifestation of the disease and with the response
of the patient. At present, when the meningococcus is sensitive to the agents
above, 7-10 days of therapy is usually sufficient.
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1.6. Prevention of meningococcal disease.
1.6.1. Chemoprophylaxis
Shortly after the introduction of sulfonamides for the treatment of serious
meningococcal disease, it became apparent that short courses of the
sulfadiazine resulted in the disappearance of meningococcal carriage for
prolonged periods of time (reviewed by Apicella 1990). As Feldman pointed
out, despite the arguments about the relationships, "if there are no carriers,
there are no cases", the use of sulfonamides to reduce carrier rates did
decrease the number of cases (Feldman, 1972).
Treatment of the meningococcal carrier state with sulfonamides eradicated
carriage quickly and for prolonged periods; after two doses of 3 and 2 g of
sulfadiazine the carrier rate dropped from 79 to 0 percent in 72 hours
(reviewed by Apicella 1990). On military bases and in closed environments
such as boarding schools, institutions and family units in which cases arose,
this form of chemoprophylaxis was effective in preventing the spread of
meningococcal infections.
With the recognition of widespread sulfonamide-resistant meningococci,
these agents have been abandoned for meningococcal chemoprophylaxis
except in instances where the meningococcal case strains are known to be
sulfonamide sensitive. The search for new agents for chemoprophylaxis has
been extensive. Penicillin has proved ineffective for several reasons; long-
acting mixtures do not eradicate the nasopharyngeal carriage, and while
massive doses cause people to become non-carriers, the carrier state recurs
promptly after discontinuation of treatment with the drug ( Feldman, 1972;
Artenstein et a!., 1967).
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Two antibiotics have emerged as candidates for meningococcal prophylaxis.
Minocycline and rifampicin have been shown to eradicate the carrier state
rapidly and this eradication persists for up to 6-10 weeks after treatment
(Guttler et al., 1971; Devine et at., 1971). Problems occur with both drugs.
Minocycline has been shown to cause vertigo, probably secondary to an effect
on the vestibular system ( Jacobson et al., 1975). Rifampicin treatment can
result in the emergence of rifampicin-resistant meningococci in 10-27% of the
patients treated ( Weidner et al., 1971).
A number of other agents active against the meningococci in vitro have been
tested and have failed to provide prophylaxis. These include erythromycin,
trimethoprim, cephalexin, tetracycline and nalidixic acid. Hoeprich studied a
number of these agents and speculated that the primary factor determining
effectiveness in the elimination of meningococcal carriage is the ability to
achieve bactericidal levels in tears and saliva ( Hoeprich, 1971).
Intimate contacts of patients with meningococcal disease, such as the
household contacts, have an increased risk of contracting meningococcal
disease (Meningococcal Disease Surveillance Group 1976; Cooke et al.,
1989). To protect these contacts, chemoprophylaxis is prescribed in many
countries, among which the United States and Great Britain (Anonymous
1990). It is assumed that by eliminating meningococci from the nasopharynx
of the household contacts the transmission of meningococci within the
household will be interrupted and secondary cases of meningococcal
disease will be prevented. However, the beneficial effect of these drugs for





Subsequent to the emergence of sulfonamide-resistant meningococci, an
intense effort was directed towards the development of a vaccine for the
prevention of meningococcal infections in high-risk populations such as
military recruits. The result was the development of the capsular
polysaccharide vaccines for serogroups A, C, W-135 and Y, (Frasch et al.,
1989). These vaccines elicit serogroup-specific immunity in older children
and adults, but the immune response in children under 2 years of age is
poor, especially the response to the C polysaccharide. In addition, because
of their T-cell independent nature, these vaccines do not induce
immunological memory and regular re-vaccination is necessary. Vaccine
trials in both Nigeria (Greenwood et al., 1980) and Gambia (Ceesay et al.,
1993), have shown that in children, meningococcal antibody levels decline to
background levels 2 years after immunization with meningococcal
polysaccharide vaccines.
Conjugation of the capsular polysaccharide of type b H. influenzae (Hib) to
protein carriers has been used successfully to induce T-cell dependent
responses to this carbohydrate antigen and long lasting immunity to invasive
Hib disease (Begue, 1993; Campbell et al., 1993 ; Eskola et al., 1993;
Paradiso et al., 1995 ; Kurikka et al., 1995 ; Mclntyre et al., 1995), There were
extremely low incidences of adverse effects (Makela et al., 1990; Kaythy et al.,
1989b; Madore et al., 1990; Ahonkai et al., 1990; Einhorn et al., 1986; Eskola
et al., 1987). From the above trials, it was shown that the decrease in Hib
disease incidence since 1992 is an effect of vaccination and greater than
would be expected from protection of vaccinated children alone. Invasive Hib
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disease is likely to become a rare cause of serious childhood infection
(Mclntyre et al., 1995). Conjugate Hib vaccines seem to be among the safest
vaccines ever proposed for routine use and immunogenicity studies in infants
suggest that they remain immunogenic when combined with diphtheria /
pertussis / tetanus for routine immunization of infants ( Moxon et al., 1990;
Eskola et al., 1993; Mulholland et al., 1993; Miller et al., 1995; Redhead et al.,
1994). Immunogenicity persists even in unfavorable contexts such as
individuals with sickle-cell anemia or a previous history of vaccine failure
(Guerin, 1994).
Conjugate vaccines for serogroup A and C polysaccharides are now under
investigation. The meningococcal capsular polysaccharide vaccines provided
unreliable for control of meningococcal disease in Africa. The objectives
were to immunize children during the course of their routine infant
immunization schedule with a T cell dependent meningococcal vaccine that
provided long lasting immunity that could be boosted by further immunization
or by nasopharyngeal carriage of meningococci. The development of a group
A plus group C meningococcal polysaccharide-protein conjugate vaccine
(Constantino et al., 1992) provided a possible means of achieving these aims.
Following a satisfactory pilot trial in which 20 Gambian infants were
immunized with two doses of a group A plus group C meningococcal
polysaccharide - CRM197 conjugate vaccine during the course of their routine
immunization program, the meningococcal conjugate vaccine has been
found to induce long-term immunological memory among 2-2.5 month old
infants (Twumasi et al., 1995). This vaccine, has been also officially given to
infants in Britain since October 1992 (Duerden et al., 1993; Musser et al.,
1994).
To date, no effective vaccine is available for protection against disease due
to meningococci of serogroup B, the most prevalent serogroup in developed
countries. The B polysaccharide has proved to be poorly immunogenic in
humans which might be due to its close resemblance to fetal human brain
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tissue (Finne et al., 1983). Other components of the bacteria are being
investigated as potential vaccines. The principal candidates are the class 1
and class 2/3 OMPs of the meningococcus (Poolman et al., 1990).
Experimental vaccines that consist of outer membrane vesicles (OMVs)
containing these OMPs have been developed (Frasch et al., 1989; Poolman
et al., 1990). The antibodies elicited by the OMPs in these vaccines are
subtype and serotype- specific (Poolman et al., 1990). The composition of the
experimental vaccines recently tested in Norway, Chile, Cuba and Brazil
(Zollinger et al., 1991; Sierra et al., 1991; Bjune et al., 1991, Cassio de Moraes
et al., 1992), was based on the serotype and subtype of the most
prevalent serogroup B phenotype in these countries : B:15:P1.7,16 in
Norway; B:15:P1.3 in Chile; B:4:P1.15 in Cuba.
The results of the Cuban trial among children aged 11-16 years were very
promising, but it should be kept in mind that the circumstances in Cuba,
an isolated island population with a very homogenous meningococcal subtype
distribution, were very favorable for this approach. They were not confirmed in
a case-control study of the efficacy of this vaccine in Brazil (Cassio de
Moraes et al., 1992). The Brazilian study showed poor reactions in younger
children. The Chilean vaccine provided low-level protection only (Zollinger
et al., 1991). The efficacy of the vaccine in the Norwegian trial as well as in
trials carried out in Iceland among teenagers was low and the authors
concluded that the effect was insufficient to justify a public vaccination
program (Bjune et al., 1991; Carlone et al., 1994).
These field trials in humans with such vaccines have demonstrated at least
partial protection against group B infection. The vaccines consist of outer
membrane vesicles prepared from one particular strain; since many of the
major outer membrane proteins (OMPs) show a high degree of variation
among different strains, a large proportion of the protective antibodies induced
is expected to be strain-specific. In many countries, however, the serogroup B
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meningococci show marked heterogeneity with regard to serotype and
subtype (Kayhty et al., 1989b; Froholm et a!., 1991b; Calain et al., 1988;
Palmer et al., 1992) and for those countries the above mentioned vaccines are
only of limited value.
Vaccines derived from a number of different strains has limitations such as
high amounts of toxic LOS and non-protective OMPs. Not all outer membrane
components are needed or wanted in a vaccine. An alternative was
construction of a bivalent class 3-deficient strain carrying two different copies
of the por A gene; outer membrane complexes (OMCs) prepared from it
induced bactericidal antibodies against strains of both subtypes present,
P1.7,16 and P1.5,2 (Van der Ley et al., 1992). Thus, by genetically removing
one OMP and adding another, an improved vaccine strain was constructed. In
a recent development a multivalent outer membrane vesicle vaccine was
prepared by removing unwanted outer membrane components and at the
same time improving the range of protection. This was accomplished through
transformation with plasmid constructs made in E. coli and their homologous
recombination into the meningococcal chromosome. Deletion of the cps locus
resulted in loss of expression of the group B capsular polysaccharide as well
as the lacto-N-neotetraose structure in lipopolysaccharide. Deletion of the
porB gene abolished expression of the class 3 outer membrane protein.
Additional copies of the porA gene, encoding the immunodominant class 1
outer membrane protein, were inserted into one of the opa genes (encoding
class 5 proteins) and into the rmpM gene (encoding class 4 OMP). The result
of such construction was the construction of three trivalent strains each of
which expressed a different combination of class 1 epitopes (van der Ley et
al., 1995).
This trivalent vaccine, has been successfully tested in laboratory mice
inoculated with 3 different meningococcal strains of known subtypes. These
strains, isolated during the Belgian and Dutch epidemics constituted 83% of
strains isolated during these epidemics. At present, a vaccine trial is been
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undertaken in Holland against serogroup B that contains subtypes of the class
1 OMPs. The vaccine that contains subtypes of OMPs class 3, is under trial in
Norway (Delving et al., 1995).
Another approach to vaccine development was the study of the class 3 OMP,
as a potential target for bactericidal and opsonic antibodies in humans.
Synthetic peptides spanning the class 3 OMP from the vaccine strain
(B:15:P1.7,16:L3,7) were synthesized. The results showed that the significant
part of the humoral response to the meningococcal class 3 OMP elicited by
vaccination with the Norwegian OMV vaccine was directed against a single
continuous epitope (Delvig et al., 1995). The problem with these vaccines is
that linear peptide vaccines do not induce antibody. In order to overcome this
problem, there is a need of a 3-dimensional structure by using circular
peptides (Hoogerhout et al., 1995).
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1.7. Objectives of the present study
Following the epidemic of meningitis during the 1960s, the incidence of
meningococcal disease in Greece declined steadily until 1988. Since 1988,
the number of cases reported to the Ministry of Health has increased; in the
first 6 months of 1990, there were 102 cases compared with 87 for all of
1989 (Table 1.9).
Table 1.9. Incidence of meningococcal disease in Greece.
YEAR NO CASES DEATHS
NO (%)
1968 1064 48 (4.5)
1973 765 39 (5.1)
1978 286 18 (6.3)
1983 102 9 (8.8)
1985 105 6 (5.7)
1986 88 7 (7.9)
1987 85 4 (4.7)
1988 76 2 (2.6)
1989 87 6 (6.9)
1990 134 1 (0.7)
This apparent increase in disease due to N. meningitidis was of concern
to the public health authorities. The last major epidemiological survey of N.
meningitidis in a Greek population was carried out before elucidation of
some of the genetic and environmental factors affecting carriage and
development of disease (Kalapothaki et a!., 1979) and before the availability
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of serotype and subtype reagents used to examine meningococci in north¬
west Europe and the Americas.
In contrast to countries in northern Europe, there were no studies on
carriage of meningococci among school children in Greece or assessment of
factors associated with carriage of these bacteria among children in any
country in southeast Europe. The work presented here was carried out to
answer the following questions:
1. Are genetic and environmental factors associated with carriage among
Greek children and young adults similar to those found in northwest
Europe?
2. Are strains with serogroups, serotypes and subtypes associated with
disease in northwest Europe isolated from patients and carriers in Greece ?
3. Are the antibiotic sensitivities of meningococci isolated from patients and
carriers in Greece similar to those observed in north west Europe?
4. Are the genetic clones associated with disease in northwest Europe present
among the meningococcal strains in Greece and other Balkan countries?
The information collected would provide a basis on which decisions could be
made for initiation of preventive measures if the increasing numbers of cases
reflected the beginning of a prolonged outbreak or an epidemic of
meningococcal disease in Greece.
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2. General materials and methods
2.1. Isolation - culture and storage of N. meningitidis.
2.1.1. Media
Modified New York City Medium (MNYC) was used for the isolation of
meningococci from throat swabs and boiled blood or chocolate agar (CA) was
used for further culture.
2.1.1.1. Modified New York City Medium (MNYC) (Young ef a/., 1978)
The medium was prepared as 10 litre batches by dissolving 360 g of G.C.
agar base (Oxoid) in 8560 ml distilled water. After autoclaving at 121° C for 15
min. the medium was allowed to cool to 50°C and the following supplements
were added: Lysed human blood (1000 ml); glucose (10% )(100 ml); yeast
dialysate (250 ml), colistin (6 mg/ml)(10 ml); lincomycin (1 mg/ml) (10 ml);
amphotericin (1 mg/ ml) (10 ml); trimethoprime (5 mg/ml) (10 ml). Blood was
lysed with 50 ml saponin. All supplements were stored in vials at -20°C and
allowed to thaw slowly before adding to the media.
2.1.1.2. Cooked blood agar or "chocolate agar".
Columbia agar base (Oxoid CM 331) was prepared by suspending 39 gin
1 I of distilled water and heating to boiling point. The agar was then sterilized
at 121°Cfor15 min. and 10% of defibrinated horse blood was added. The
medium was shaken gently and 20-25 ml of the medium was dispensed
aseptically to each plate.
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2.1.2. Conditions of incubation
All plates were incubated at 37°C, in a humid atmosphere containing 5-10%
C02. On primary cultures, the majority of strains grew within 16-18 hr;
however, if the colonies were very small (less than 1 mm), the plates were
incubated for an additional 24 hr.
2.1.3. Long Term Conservation
Freezing at -80°C : Brain Heart Infusion Broth (Oxoid CM 225) was prepared
by dissolving 37 g in 11 of distilled water and sterilized by autoclaving at
121°C for 20 min. The broth was supplemented with sterile glycerol (2%) and
dispensed aseptically in 1 ml aliquots into "Nunc cryotubes" with screw caps.
A heavy suspension of a 18-24 hr culture of meningococci was prepared in
these tubes and were frozen as quickly as possible, by putting them into the
racks of the freezer at -80°C.
The frozen strains were cultured after thawing for a few minutes at 37°C by
placing one loopful of the suspension on plates of CA or MNYC media and
streaking for isolated colonies.
2.2. Identification
2.2.1. Macroscopic examination
N. meningitidis developed, in 18 to 24 hours, greyish colonies, with regular
edges which can appear smooth or mucoid, if there is heavy capsule
production ; 1 to 1.5 mm in diameter.
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2.2.2. Microscopic examination
Gram's stain was carried out on individual colonies and Gram-negative
diplococci further identified as described below.
2.2.3. Cytochrome oxidase
The test was carried out with tetramethyl-p-phenylenediamine chloride
which turns purple upon oxidation by the cytochrome C system. The materials
and reagents used were filter paper (Whattman) and tetramethyl-p-phenylene-
diamine chloride (Difco) diluted in distilled water.
The presence of cytochrome oxidase was demonstrated by two ways:
1. dropping the reagent directly on the colonies obtained on the culture
medium.
2. transferring a loopful of culture onto filter paper soaked with the reagent in
an empty sterile Petri-dish.
A positive reaction occurred within 5-10 seconds. The reaction was
considered negative if no colour was produced within 60 seconds.
2.2.4. Rapid carbohydrate utilization test
This test was based on the method described by Young et al., 1979. The
Rapid Carbohydrate Utilization Test (RCUT) buffer contained : 0.1 M K2HP04
(40 ml) mixed with 0.1 M KH2P04, (12 ml), KCI (8% w/v) (100 ml); phenol red
(10 ml) (1% w/v); distilled water (838 ml). The pH of the buffer was then
adjusted to 7.1-7.15, dispensed in 20 ml aliquots and stored at -20°C.
Solutions (10% w/v) of the following sugars were prepared in the buffer,
glucose, maltose, sucrose, lactose, fructose. All sugars were stored at -20°C
in 4 ml aliquots.
Ampicillin (500 mg) was dissolved in 3 ml of RCUT buffer prior to preparing
microtitre trays.
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To each well of a microtitre plate, 1000 pi of RCUT buffer was added. The
individual sugar solutions (25 pi) and 25 pi of the ampicillin solution were
added to the appropriate wells. The trays were stored in sealed polyethylene
bags at -20°C.
A suspension of the organism to be tested was prepared in 200 pi of RCUT
buffer and 25 pi was added to six wells of a microtitre plate containing the
individual sugar solutions, and ampicillin. Each plate was incubated in a 37°C
water-bath and the colour change was inspected after 1 hr. The microtitre
plate was then returned to the water bath and re-examined after a further
three hours. Known isolates of N. meningitidis and N. gonorrhoeae were
included as controls. The sugar utilization patterns of the various Neisseria
species were listed in Table 1.1.
2.3. Detection of biood group antigens
2.3.1. ABO biood group
Slide agglutination with monoclonal anti-A and anti-B antibodies (Scottish
National Blood Transfusion Service) were used to determine ABO blood
group. Blood samples (20 pi) were mixed with monoclonal anti-A (20 pi) and
anti-B (pi) (Scottish National Blood Transfusion Service) on clear glass slides
racked gently to mix and examined for agglutination (Table 2.1.).
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Table 2.1. ABO blood group agglutination pattern.





2.3.2. Detection of Lewis antigens in blood specimens
Monoclonal anti-Lewis3 (anti-Le3 ) and anti-Lewisb (anti-Leb ) antibodies
(Scottish National Blood Transfusion Service) were used in tube agglutination
test. The blood specimens (20 pi) were transferred to small test tubes to
which 20 pi of monoclonal anti-Le3 or anti-Leb were added. The tubes were
incubated for 1 hr at room temperature and agglutination was recorded. If
agglutination was not present in either test tube, the test tubes are
incubated overnight at 4°C and the results were recorded the next day.
Non-secretors can express only Le3 and secretors express Leb antigens.
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2.3.3. Detection of Lewis antigens in saliva specimens (Raza et ai, 1991)
2.3.3.1. Buffers
2.3.3.1.1. Coating buffer.
In 11 distilled water, 1.59 g Na2C03 (Analar BDH), 2.93 g. NaHC03 (Analar
BDH) and 0.20 g. NaN3 (sodium azide) (Sigma) were dissolved. The pH was
adjusted to 9.6 and stored at 4°C.
2.3.3.1.2. Blocking buffer
Phosphate buffered saline (PBS) contained 8.16 g Na2HP04 (BDH), 3.99 g
NaH2P04 2H20 (BDH) and 6.08 g NaCI (BDH) dissolved in 2 I of distilled
water. After adjustment of the pH to 7.2, 100 ml aliquots were made, and 1 g
of the bovine serum albumin (BSA) was added to each and stored at+4°C.
2.3.3.1.3. Substrate
Phosphate citrate buffer (0.1 M) was prepared by dissolving citric acid (21.0
g) (BDH), and Na2HP04 (14.2 g) (BDH) in 1 I distilled water. The pH was
adjusted to 5.0 and the buffer was stored at +4°C. For the substrate
preparation, orthophenylene-diamine (40 mg) was dissolved in phosphate
citrate buffer (100 ml). For activation, 40 pi of H202 (30%) (Sigma) was
added immediately prior use.
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2.3.3.1.4. Stopping solution
Sulfuric acid (50 ml of 18.76 M) (BDH) was added slowly to 350 ml distilled
water in a fume cupboard (final concentration 12.5%).
2.3.3.1.5. Washing solution.
Washing buffer was prepared by dissolving NaCI (16.0 g) (BDH); KH2P04 (0.4
g) (BDH); Na2HP04 (2.3 g) (BDH); KCI (0.4 g) (BDH); and Tween 20 (1 ml) in
2 I distilled water. The buffer was kept at 4°C.
2.3.3.2. Method
Leaand Leb blood group antigens were detected in saliva by the ELISA method
outlined in Fig 2.1. Wells of polystyrene microtitre plates (Dynatech, Billinhurst,
Sussex) were coated overnight at 4° C with 100 pi of monoclonal anti- Lea
diluted 1/25 (Scottish National Blood Transfusion Service) or monoclonal anti-
Leb diluted 1/20 (Scottish National Blood Transfusion Service) in coating
buffer. All further procedures were carried out at room temperature except
when stated otherwise. The wells were washed 3 times with washing buffer
and blocked with 150 pi of blocking buffer for 15 min. The buffer was removed
and the wells were washed 3 times. Dilutions of saliva from known secretors
and non-secretors were used in each plate as controls. The test wells
contained 100 pi of the specimens (saliva) which had been boiled for 30 min.
to inactivate enzymes, bacteria or viruses. Samples of saliva were diluted
1/100 in blocking buffer for detection of Lea and 1/20 for detection of Leb .
After incubation for 60 min., the wells were washed 3 times and 100 pi of
polyclonal goat anti-Lea antibody (Behring, Marburg, West Germany) (1/500 in
blocking buffer) or 100 pi of anti- Leb antibody (Behring) (1/250) were added to
the wells of the appropriate plates. After 30 min. incubation, the wells were
washed 3 times and 100 pi of horseradish peroxidase-conjugated donkey anti-
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goat immunoglobulin (Scottish Antibody Production Unit), (1/250 in blocking
buffer) were added. After overnight incubation at 4° C, the plates were washed
three times and 100 pi of activated substrate solution were added to each well.
The colour was allowed to develop for 10-15 min., and the reaction was
stopped by adding 50 pi of stopping solution to each well.
Absorbance at 490 nm was measured with an ELISA plate reader (Dynatech).
Samples were tested in duplicate and readings were averaged. The average
reading obtained for the test samples was compared with that of controls
added in the same plate. Values equal to or above that of control were
considered to be positive. The subjects from whom the samples were obtained
were classified as non-secretors if only Lea was detected, or as secretors if
Leborboth Leaand Leb antigens were detected.
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Figure 2.1. ELISA for detection of Lewis antigens.
Incubated
0/N at 4' C
+ Washed
Incubated


































The serogroups are determined by slide agglutination of the bacteria with
commercially available polyclonal antisera (Wellcome Diagnostics).
2.4.1. Method
Cultures grown for 18 hr on selective medium were tested for agglutination. A
pool was prepared with antisera for screening. The isolates were first tested
by the most common serogroups for agglutination by anti-A, anti-B, anti-C,
and anti-Y. One loopful of bacterial culture was mixed with a drop (20 pi) of
the pool and with a drop of 0.9% NaCI solution as a negative control. Isolates
agglutinated by the pool were tested with the individual antisera to determine
the serogroup.
If agglutination appeared, it was immediate (less than one min.). As the
agglutination can occasionally be difficult to see with the unaided eye, those
that were not obviously agglutinated were examined with a magnifying glass.
In the case of serogroups A and C, the clusters were bigger, with a clear
background. In the case of serogroup B, agglutination was equally fast, but
the agglutinate was more fine-structured.
If there was no agglutination with the sera for serogroups A, B, or C, the
isolates were screened with the second pool of grouping sera for Y, 29E and
W135.
If there was still no reaction the strain was recorded as non-groupable.
2.4.2. Interpretation
If agglutination was positive for only one serogroup: the serogroup was
determined and recorded.
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If agglutination was positive with several sera but not in the saline solution, the
strain was recorded as polyagglutinable.
If agglutination was positive with both pools and with the NaCI solution the
bacteriological characteristics of the strain were re-checked. If the result was
confirmed twice, the strain was recorded as autoagglutinable. In the case of
no agglutination with sera, nor with the NaCI solution, the strain was
recorded as non-agglutinable.




Washing solution contained 0.025% w/v Tween 80 dissolved in tap water
2.5.1.2. PBS buffer (pH 7.2)
PBS contained Na2HP04.2H20 (1.6 g); NaH2P04. 2H20 (0.28 g) and NaCI
(8.2 g) dissolved in 11 distilled water.
2.5.1.3. Casein - Tween-80 buffer
Casein - Tween-80 buffer contained casein hydrolysate (3 g) Tween- 80 (0.1
ml) dissolved in 11 PBS. The buffer was used for blocking non-specific
binding, diluting mAbs and diluting the conjugate.
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2.5.1.4. Sodium Acetate Buffer ( 1.1 mM)
Sodium Acetate Buffer was prepared by dissolving sodium acetate (0.18 g.) in
2 I of distilled water. The pH was adjusted to 5.5 by adding saturated citric
acid solution prepared by dissolving citric acid (130 g) in 100 ml distilled
water.
2.5.1.5. Protein A Peroxidase Conjugate (Sigma P-8651)
The conjugate was prepared by dissolving one vial of the conjugate in Casein-
Tween 80 buffer (1 ml). Aliquots (100 pi) of each vial were stored at -20°C.
2.5.1.6. 3,3',5,5 tetramethyl-benzidine (TMB)
The stock solution was prepared by dissolving TMB (0.6 g) in 100 ml
dimethyl sulphoxide (Sigma D-5879) and kept in dark bottles at room
temperature. The TMB solution prepared prior to use contained sodium
acetate buffer stock solution (10%) (10 ml); hydrogen peroxide (30%)(250 pi)
TMB 1.5% (stock solution) (1.5 ml) and distilled water (88.5 ml).
2.5.1.7. Sulphuric acid (2N)
For terminating the reaction the stopping solution was prepared by adding
H2S04 (10 ml) to distilled H20 (170 ml) in a fume cupboard.
2.5.2. Preparation of the monoclonal antibodies.
The 15 monoclonal antibodies obtained from RIMV (Bilthoven, The
Netherlands) were diluted in Casein-Tween 80 buffer. The dilutions for each
of the monoclonals are listed in Table 2.2.
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Table 2.2. Monoclonal antibody dilutions
Monoclonal antibody Dilution
1 1 : 400
2a 1 : 4,000
2b 1 : 4,000
4 1 : 4,000
14 1 : 10,0000
15 1 : 4,000
P1.1 1 : 2,000
P1.2 1 : 4,000
P1.4 1 : 2,000
P1.6 1 : 2,000
P1.7 1 : 2,000
P1.9 1 : 1,000
P1.10 1 : 6,000
P1.12 1 : 4,000
P1.14 1 : 4,000
P1.15 1 : 2,000
P1.16 1 : 2,000
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2.5.3. Method
A suspension of each isolate tested was prepared in PBS and the
concentration adjusted to 3 of the McFarland scale. The suspensions were
placed in a 56°C water-bath for 45 minutes. Aliquots (100 pi) of each
bacterial suspension were placed into individual wells of a series of flat-
bottom, 96-well PVC microtitre plates (Greiner). The plates are allowed to
evaporate overnight at 37°C. The remaining bacterial suspension was kept at
-20° C.
The coated plates were washed 3 times with 0.025% (v/v) Tween-80 in tap
water. The monoclonal antibodies were diluted in casein-Tween buffer to
block non-specific binding. The plates were incubated for 1 hr at 37°C.
After washing, 100 pi of the protein A-peroxidase conjugate diluted 1:500 in
Casein-Tween buffer was added to each well and the incubation was
repeated as above. The plates were washed as above and freshly-prepared
substrate (100 pi) was added to detect the bound antibodies. After a 10
min. incubation at room temperature, the reaction was terminated by the
addition of 2 M H2S04 (50 pi /well). The optical density was read at 450 nm
with a Titertek Multiscan (Flow Laboratories). Standard meningococcal strains
expressing the serotype or subtype antigens were included as controls for
each experiment.
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2.6. Agar dilution method for the determination of the Minimum
Inhibitory Concentration (M.i.C.)
2.6.1. Materials and reagents
2.6.1.1. Medium. Muller-Hinton agar (38 g) (Oxoid), was dissolved in 11 of
distilled water by gentle heating. Aliquots (49 ml) were made and the bottles
autoclaved at 121°C for 15-20 min.
2.6.1.2. Antibiotics. The antibiotics used and their respective diluents are
shown in Table 2.3.
Table 2.3. Antibiotics used for MIC test and their respective diluents.
Antibiotic Source Diluent
Penicillin G (PN) Sigma PBS
Erythromycin (ER) Abbot Methanol
Tetracycline (TC) Sigma Distilled water
Sulphamethoxazole (SU) Sigma 0.1 M NaOH
Rifampicin (RF) Lepetit Methanol
Cefaclor (CF) Serva Distilled water
Ciprofloxacin (CP) Merck Distilled water
Each stock antibiotic solution was filtered through Millipore filters (pore size
0.45 pm). The range used for all the antibiotics was 0.015-256 mg/l. Two-fold
dilutions of the stock solutions were prepared in sterile distilled water; 1 ml of
the each dilution was added to 49 ml Muller-Hinton agar (42° C) and the
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bottle inverted gently to mix. The antibiotic - containing agar was poured into
two petri-dishes (90 mm diameter).
2.6.1.3. Phosphate Buffered Saline (PBS) (0.15 M)
PBS was prepared from the following solutions: solution A, Na2HP04 (42.58
g), distilled water (2 I) (pH = 9) ; solution B, KH2P04 (10.25 g), distilled water
(500 ml) (pH = 6); solution C, NaCI (8.76 g) distilled water (1 I) (pH = 6). To
obtain a pH of 7.2, 2 I of solution A was mixed with 1 I of solution C.
Approximately 500 ml of solution B was added until the pH reached 7.2. The
solution was dispensed into aliquots, autoclaved for 15 minutes at 115°C; and
stored at room temperature.
2.6.2. Method
The strains under investigation were cultured on MNYC medium at 37°C for 24
hr. Each strain was suspended in 5 ml PBS (pH=7.0), to a turbitidy of 0.5
McFarland scale (106-107 CFU/ml).The antibiotic-containing medium was
inoculated with a Steers-type multiple inoculating device (Mast), 36 strains
per Petri dish. The plates were incubated at 37°C for 48 hr.
Readings were carried out at 24 and 48 hr. The MIC was the lowest
concentration at which no growth was observed after both readings.
Each time the MIC test was performed, strains of known MIC values were
always included, such as Staphylococcus aureus, E. coli and Pseudomonas
aeroginosa to check the potency of the antibiotic used.
For each test, medium with no antibiotic was always used before and after
each series of media-containing antibiotics in order to check for
contaminants.
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3. Factors affecting carriage of Neisseria meningitidis
among Greek military recruits
3.1 Introduction
The present work was prompted by an increase in the number of cases of
meningococcal disease reported to the Ministry of Health. (Table 3.1). The
last major survey on meningococcal carriage and the characteristics of these
bacteria in Greek population had been undertaken before elucidation of
some of the genetic and environmental factors affecting carriage as well as
before the serotype and subtype antibodies were available (Kalapothaki et
al., 1979), and there was no information about antibiotic sensitivities of
meningococci as carriage of these bacteria in a Greek population.





1968 1064 48 (4.5)
1973 765 39 (5.1)
1978 286 18 (6.3)
1983 102 9 (8.8)
1985 105 6 (5.7)
1986 88 7 (7.9)
1987 85 4 (4.7)
1988 76 2 (2.6)
1989 87 6 (6.9)
1990 134 1 (0.7)
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Epidemiological studies have shown that non-secretors, individuals
incapable of secreting the glycoprotein form of their ABO blood group
antigens, are significally over-represented among patients with
meningococcal disease (Blackwell et al., 1986a ; Blackwell et at., 1988) and
among carriers in a school population (Blackwell et al., 1990a). Prolonged
outbreaks have occurred in countries such as Iceland and in areas of Britain
(Blackwell et al., 1989a; Blackwell and Weir 1990b) where the proportion of
non-secretors is significally higher than the proportion (20-25%) predicted
for European populations (Mourant et al., 1976). Environmental factors have
also been suggested to play a role in susceptibility to meningococcal disease
(Haneberg et al., 1983; Stuart et al., 1988) or carriage of the bacteria.
Smoking or passive exposure to cigarette smoke has been associated with
isolation of Neisseria meningitidis from healthy asymptomatic adults and
teenagers (Blackwell et al., 1990a ; Stuart et al., 1989). Virus infections have
been suggested as predisposing factors for susceptibility to meningococcal
disease (Krakinski et al., 1987; Moore et al., 1990) and to carriage of
potentially pathogenic bacteria (Musher et al., 1981).
It was decided to assess the following questions by examining military recruits
as there is usually a higher incidence in carriage in this population and the
recruits examined came from all the regions of Greece.
i. Is isolation of meningococci associated with non-secretion in the
populations examined ?
ii. Is smoking associated with carriage in closed population?
iii.Are upper respiratory tract or other infections factors contributing to
carriage of meningococci?
iv. Are there geographical regions in Greece in which there are higher
proportions of non-secretors and is the prevalence of meningococcal disease
increased in these areas?
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3.2. Subjects and methods
Greek military recruits (993) from two camps, one at Athens and another at
Avlona, were examined for carriage of meningococci during the third week of
July 1990. Ethical permission for the study was granted by the Ministry of
Defense. An explanation of the purpose of the study and the specimens
required was part of the questionnaire and each subject signed his
consent to participate in the study. The recruits came from all regions of
Greece except the Ionian islands and had been in the camps from 3 to 5 days
at the time of the study. Throat swabs, blood and saliva specimens were
obtained. Throat swabbing was carried out by the same four members of the
team on both occasions. Blood was not obtained from a number of recruits
who fainted because of the unusually high temperature (41 °C). Each recruit
filled in a questionnaire providing information on age, occupation, places of
residence and birth, smoking habits, and recent infections (Appendix 1). Also,
their educational level was assessed (Table 3.2). In Greece, for
epidemiological studies, socioeconomic category is assessed by the number
of years of education and the highest level of school attended (Trichopoulos et
at., 1982).
Table 3.2. Education levels in Greece.




4 Higher National Diploma 15
5 University 17
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A member of the research team checked the form to ensure all categories had
been completed and to answer any questions. This information and results
of laboratory examinations were coded for confidentiality and stored in a
Database 3 plus data base. The information on the data base was recalled
and checked with the original questionnaire.
ABO blood group and Lewis antigens were determined by the methods
described in Chapter 2.
The blood specimens were centrifuged on the day of collection and the
plasma stored at -20°C.
Throat swabs were plated directly onto modified New York City medium
(Young et al., 1978) and isolation and characterization of meningococci was
carried out as described in Chapter 2.
Two-way frequency tables were analyzed by y2 tests with Yates' correction in
the case of 2x2 tables. Multiple logistical regression was used to examine
the association between carriage rates and other factors adjusted for each
other.
3.3. Results
3.3.1. Isolation of N. meningitidis
N. meningitidis was isolated from 254 (25%) of the 992 recruits examined.
The carriage rate differed significantly between the two camps. There were
79 isolates obtained from 432 recruits (18%) in the camp at Athens compared
with 175 from the 560 (30%) at Avlona (x2= 17.54; P<0.0005).(Table 3.3)
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Athens 432 79 18.2
Avlona 560 175 31.2
Total 992 254 25.6
3.3.2. ABO and Lewis blood groups
Distribution of ABO and Lewis blood group phenotypes: There was no
difference in the distribution of the ABO blood groups between the two
camps (Table 3.4).
Table 3.4. ABO Blood groups of the recruit population.
ABO Blood Group [n (%)]
Recruit Camp
Athens
A B AB O
186 (44.8) 63 (15.2) 15 (3.6) 151 (36.4)
Avlona 217 (40.0) 77 (14.2) 28 (5.1) 220 (40.6)
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Among the recruits who expressed Lewis antigens, there was a significantly
higher proportion of Lea/non-secretors in the camp at Avlona, 144/542 (26%),
compared with that in the camp at Athens, 63/415 (15%) (x2=14.96,
P<0.0005) (Table 3.5)
Table 3.5. Lewis blood group antigens of the recruit population
Lewis phenotype
n (%)
Location Lea Leb Lea+b+ Leab"
Athens 63 (15.4) 323 (77.8) 5(1.2) 24 (5.8)
Avlona 144 (26.6) 353 (65.1) 41 (7.5) 4 (0.7)
3.3.3. Age and education
The ages of the two populations differed significantly. The median age was
19 for both camps; however there was a higher proportion of recruits under
19 in the camp at Avlona (4%) compared with that at Athens (1%) (x2=12.96,
P<0.001). There was also a significant difference in the level of education of
the recruits in the two camps, particularly at the two extremes. Among the
recruits at Avlona 14% had only 6 years of schooling compared with 7%
among those in Athens; and, only 2% of the recruits at Avlona had attended
university while 7% of those at Athens had done so (x2=30.32, df=4,
P<0.0005) (Table 3.6)
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n (%) n (%)
Total
(%)
1 31 (7.4) 76 (14) 107 (11.1)
2 103 (24.5) 170 (31.3) 273 (28.4)
3 230 (55) 260 (47.9) 490 (50.1)
4 24 (5.7) 27 (5.0) 51 (5.3)
5 29 (6.9) 10 (1.9) 39 (4.0)
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3.3.4. Smoking
There was no significant difference between the proportion of smokers in the
Athens camp (62%) compared with Avlona (68%); but there were significantly
more heavy smokers (>30 cigarettes a day) in Avlona (x2=27.64, df=4,
P<0.0005) (Table 3.7).
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0 166 (38) 182 (32)
1-10 53 (12) 63 (11)
11-20 127 (29) 133 (24)
21-30 62 (14) 96 (17)
>30 23 (5) 86 (15)
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3.3.5. Prevalence of other infectious diseases
Only 59 of the recruits reported symptoms of upper respiratory tract infections
(URTI) within the previous 2 weeks, 21 of the 432 at Athens (4.9%) and 38 of
the 561 (6.7%) at Avlona.
3.3.6. Factors associated with carriage of meningococci
There was no difference in the proportions of carriers among the four ABO
blood groups. The proportion of carriers among Lea/ non-secretors (22% at
Athens, 32% at Avlona) was higher than that among Leb/secretors (17% at
Athens, 30% at Avlona), but the differences were not significant. The
proportion of carriers was significantly higher among smokers and was
greatest among those smoking more than 30 cigarettes per day (x2=23.19,
df=4, P<0.0005).
Although the proportion of carriers was significantly increased among
smokers in both camps (Athens x2=5.42, df=1, P<0.05; Avlona x2=9 05,
df=1, P<0.01), when the data for carriers were analyzed there was no
significant difference between the two camps associated with numbers of
cigarettes per day (x2=9.482, df=4, P>0.05) (Table 3.8).
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No (%) No (%) No (%) No (%)
0 166 (38) 20 (27) 182 (32) 36 (22.5)
1-10 53 (12) 10 (13) 63 (11) 19 (12)
11-20 127 (29) 26 (35) 133 (24) 40 (25)
21-30 62 (14) 15 (20) 96 (17) 29 (18)
>30 23 (5) 4 (15) 86 (15) 36 (22.5)
Total 431 75 560 160
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Meningococci were isolated from 17 (29%) of the 59 recruits who had
symptoms of URTI, 2 of the 21 (9.5%) at Athens and 15 of the 38 (39.5%) at
Avlona (Table 3.5). Among the 15 at Avlona from whom meningococci
were isolated, 6 (40%) were Lea/non-secretors compared with 4 (20%)
Lea/non-secretors among the 20 with recent symptoms of URTI but from
whom no meningococci were isolated. The numbers of recruits with symptoms
of URTI were too small for statistical analysis.
Multiple logistic regression analysis identified three main factors which
were significantly associated with carriage: smoking (P<0.001); age less
than 19 years (P<0.01) and the camp in which the recruits were based
(P<0.01). Various combinations of categories were tested for difference in
carriage rate when adjusted for these three factors but no other variables
were found to be significant.
3.3.7. Regional variations in ABO and Lewis blood group antigens
There was no difference in the distribution of the ABO blood groups in the
two major population centres, Athens and Eastern Macedonia. There was,
however, a significantly higher proportion of Lea/non-secretors, 54/183
(29.5%) among the recruits from Eastern Macedonia compared with those
from Athens, 35/235 (15%) (x2=12.25, P<0.0005).
3.4. Discussion
The proportion of carriers (25%) among the Greek recruits examined in this
study, was similar to that found for a British military establishment (23%)
(Pether etai, 1988) but slightly lower than that found in the 1970s for Greek
military recruits (33%) (Kalapothaki et al., 1979). The significant difference in
the proportion of carriers between the two camps, 18% at Athens compared
with 30% at Avlona (P<0.0005), was not anticipated.
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Smoking (Blackwell et al., 1990a; Stuart et at., 1989), passive exposure to
cigarette smoke (Stuart et al., 1989), secretor status (Blackwell et al.,
1990a) and age (Cartwright et al., 1987) have all been reported to be
associated with carriage of meningococci. The distribution of the ABO blood
group phenotypes did not differ between the two camps and were similar to
the survey carried out on Helicobacter pylori for the Greek population (Mentis
et al., 1990) and that reported by Hirzfeld and Hirzfeld in 1919. Several of the
factors examined in the study varied between the two camps. Compared
with the recruits at Athens, among those at Avlona where there was a
significantly higher proportion of carriers of meningococci, there were
significantly more heavy smokers, non-secretors, younger recruits (less than
19 years old), and recruits of lower socioeconomic groups as assessed by
years of education.
Smoking was the factor most strongly associated with carriage in both
univariate and multivariate analyses. It has been suggested that the
higher proportion of smokers and heavy smokers among military personnel
(Crowdy et al., 1981) might contribute to the increased prevalence of
meningococcal disease and the higher rates of carriage among military
recruits. The proportions of smokers in the two camps, 57.7% and 63.4%
were higher than the 47% found in the previous study among male Greek
patients referred for gastroscopy (Mentis et al., 1990). In Britain smoking is
associated with socioeconomic status; unskilled individuals are more likely
to smoke than those in professional groups (Wald et al., 1988). A similar
pattern was observed among the recruits; those with fewer years of
education were more likely to be smokers.
In a previous study of teachers and pupils in a Scottish secondary school
following an outbreak of meningitis, an association between non-secretion
and carriage of meningococci was found (Blackwell et al., 1990a). In the
present study, in both camps, the proportions of non-secretors were
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increased among carriers but these differences were not significant.
Assessment of both host and parasite characteristics might elucidate the
differences in association with secretor status. The majority (35.5%) of
serotypable strains among the 121 isolates in the Scottish study were serotype
4; and 55% of the carriers of this serotype were non-secretors. Only 9
(1.8%) isolates in the present study were serotype 4, but 37.5% of the
carriers of serotype Y were non-secretors. The proportion of non-secretors
among carriers of serotype 14 isolates was 25% and 22% for the Scottish
and Greek populations. A similar pattern was observed for non-serotypable
isolates (Chapter 5).
The multiple logistic regression analysis identified age (those less than 19
years of age) to be significant variable (P<0.01). This agrees with the
findings for carriers in the Stonehouse survey. The highest proportion of
carriers was found in the 15-19 year age group (Cartwright et al., 1987).
There is evidence that viral infections can predispose individuals to
carriage of potentially pathogenic bacteria (Musher et al., 1981); and
binding of streptococci and staphylococci to cell surfaces is enhanced in
experimental models examining infection with influenza virus (Plotkowski et
al., 1984; Sanford et al., 1986). Infection by respiratory syncytias virus
enhanced binding of meningococci to a human epithelial cell line (Hep-2)
(Raza et al., 1994). The study was carried out in July when there was a low
prevalence of upper respiratory viral infections; however, of the 103
recruits with symptoms of virus infection, 19.8% were carriers. This was
particularly apparent among recruits at Avlona where the carriage was 30%
overall but nearly 40% among those with virus infections. In the recent study,
a higher proportion of patients with meningococcal disease had a history of
flu-like illness than age- and sex-matched controls; however, the differences
were not statistically significant (Cartwright et al., 1991).
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In two areas of Britain where there have been prolonged outbreaks of
meningococcal disease, the proportions of non-secretors have been
reported to be higher than the 20-25% predicted for European populations
(Blackwell ef a/., 1989a; Blackwell and Weir 1990). In this study we found
a significantly higher proportion of recruits from Eastern Macedonia were
non-secretors (29.5%) compared with the other centre of population,
Athens (15.3%). As there are anecdotal reports that meningococcal
disease is more prevalent in Macedonia, the number of cases reported to
the Ministry of Health from these two areas is now being closely monitored.
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4. Parental smoking and carriage of Neisseria
meningitidis among Greek schoolchildren
4.1 Introduction
In contrast to countries in northern Europe, there have been no reports on
carriage rates of N. meningitidis among children in Greece and there had
been no studies to assess risk factors associated with carriage of these
bacteria among children in any country in south-east Europe. The present
study had two objectives: the first was to determine if there was an increase
in the carriage rate of meningococci among school children in Athens,
particularly those with the serogroup B, serotype 2b, subtype P1.10
(B:2b:P1.10) phenotype isolated frequently from Greek children with
meningitis (Chapter 5). The second was to examine genetic and
environmental factors reported to be associated with meningococcal
disease and/or carriage of these bacteria in northern Europe: age
(Cartwright et al., 1987); sex (Cartwright et at., 1987; Olcen et at., 1991);
secretor status (Blackwell et al., 1990a); smoking or passive exposure to
cigarette smoke (Blackwell et al., 1990a; Stuart et al., 1988; Stuart et al.,
1989); lower socio-economic conditions (Cartwright et al., 1987; de Wals et
al., 1983); upper respiratory tract infections (Krakinski et al., 1987; Moore et
al., 1990; Olcen et al., 1981).
Smoking and passive exposure to cigarette smoke were of particular interest
as we had found active smoking was significantly associated with carriage
among Greek military recruits (Chapter 3) and the proportion of smokers
(62%) was higher compared with that among young men of a similar age
range in Britain (40%) (Wald et al., 1988).
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4.2. Subjects arid methods
Children (1038) from two areas of Athens were screened for pharyngeal
carriage of meningococci during December 1990 and January 1991. Four
schools were included in the study: a primary school and a secondary
school in the south of Athens (Area A) where housing costs were low; and a
primary school and a secondary school in the north of Athens (Area B)
where housing costs were high.
Saliva was collected from each child who participated, and a throat swab was
obtained. The throat swabs were plated directly onto modified New York City
Medium (MNYC) (Young et al., 1978); and the plates were stored at room
temperature for approximately 2-3 hours before incubation at 37° C (chapter
2). Colonies were examined for Gram-stain, oxidase production and sugar
utilization as described in Chapter 2.
The saliva was stored in insulated boxes and frozen within 3 hours of
collection. Secretor status was determined from the saliva by enzyme linked
immunnosorbent assays (ELISA's) for H antigen (Rahat et al., 1990), Lewis3
and Lewisb antigens (Raza et al., 1991). Secretors will have in their saliva H,
h g
type I, Lewis and variable amounts of Lewis while non-secretors will have
only Lewis3.
The parent or guardian of each child gave written consent for the child to
participate in the survey and filled in a questionnaire (Appendix 2)
providing the following information: age and sex of child; if the child had any
respiratory illness in the past week; number of individuals in the household;
smoking habits of members of the household; education level of parents. In
Greece, for epidemiological studies, socio-economic category is assessed by
the number of years of education and the highest level of school attended
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(Trichopoulos et al., 1982). Secondary school children were asked if they
smoked.
Two-way frequency tables were analyzed by Chi-squared tests with Yates'
correction in the case of 2x2 tables. Multiple logistic regression was used to
examine the association between carriage and other factors adjusted for each
other.
4.3. Results
4.3.1. Assessment of socio-economic/educational level of parents in the
two areas.
The two socio-economic indicators used, cost of housing and educational
level of the parents, were in agreement. In this study, educational level of each
parent was assigned to one of the five categories used in the study of the
recruits (Chapter 3). Compared with area A, in area B there was a
significantly lower proportion of parents in categories 1 and 2 and higher
proportions of parents who had received technical training or attended
university (y2= 474.52, df=4, P<0.0005).
Similar results were obtained when the data for mothers and fathers were
analyzed separately (Table 4.1).
89
Table 4.1. Educational level of parents in the two areas.
Education Category
ro/
NO 1 2 3 4 5
Mothers
Primary A 179 40 25 30 3 2 a
Primary B 141 21 14 35 7 23
Secondary A 373 43 17 17 2 1 b
Secondary B 324 17 14 40 8 21
Fathers
Primary A 180 38 28 20 12 2 c
Primary B 144 18 17 22 10 33
Secondary A 380 54 21 15 7 3 d
Secondary B 334 17 13 24 8 38
a. x2 = 45.93,
b. x2 = 198.66,
c. x2 = 60.34,
d. x2 = 190.88,
df = 4, P< 0.0005
df = 4, P< 0.0005
df = 4, P< 0.0005
df = 4, P< 0.0005
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4.3.2. Carriage of meningococci
The carriage rate was 60/1038 (5.8%) and the proportion of isolates
obtained from children in the two areas was similar. In area A, 30/565 (5.3%)
of the pupils were carriers compared with 30/473 (6.3%) in area B. The
proportion of carriers ranged from 2% at the primary school in area B to 8.2%
in the secondary school of the same area (Table 4.2).




Primary A 180 9 (5.0)
Primary B 144 3 (2.1)
Secondary A 385 21 (5.5)
Secondary B 328 27 (8.2)
Univariate analyses found no association between carriage and two genetic
factors examined, sex or secretor status: 32/560 (5.7%) girls were carriers as
were 28/478 (5.9%) boys; 11/227 (4.8%) non-secretors were carriers
compared with 49/473 (6.2%) secretors. There was no association between
carriage and educational level of either parent or numbers of individuals
per household and isolation of meningococci in either area. Among children
who were carriers, 33% had symptoms of colds compared with 26.5% among
children who were not carriers.
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Among children in secondary schools, 14% of 50 smokers were carriers
compared with 6.2% of 661 non-smokers (x2=3.34, df=1, P>0.05). The
proportion of girls who smoked was 5.9% compared with 8.5% for boys. In
secondary school A, 7.6% of children were smokers, and 5/30 (17%)
smokers were carriers compared 16/352 (4.5%) non-smokers (x =5.66,
df=1, P<0.025). In secondary school B, 6% of school children were smokers,
but only 2/20 (10%) smokers were carriers compared with 25/305 (8.2%) non-
smokers.
Carriage rates were higher among children from households where adults
smoked. Compared with the proportion of carriers from households in which
none of the adults smoked (11/311, 3.5%), the proportion of carriers was
significantly higher in those in which the mother or other carers (mainly
grandparents) smoked (33/431, 7.7% \-A.7Q, P<0.05). Children from
households where only the father smoked had an intermediate level of
carriage (16/296, 5.4%) which did not differ significantly from that in either of
the other two groups. Carriage rates in households where the mother or other
carers smoked did not depend significantly on whether only the mother, only
the other carers or both smoked. There were 15 carriers under 13 years, and
5 (33%) had mothers who smoked. There were 45 carriers over 12 years,
and 23 (51%) had mothers who smoked (x2=5.22, df=1, P<0.025). When
the figures were corrected for the children in this group who were smokers, 20
of the 38 (52.6%) carriers who were non-smokers had mothers who smoked
2
(X =5.19, df=1, P<0.025). Among the fathers, smoking was significantly more
prevalent among those with fewer years of education (x =29.89, df=4,
P<0.0005), but this association was not found among the mothers (x =8.92,
df=4, P>0.05). In area B where the educational level was higher, the
proportion of fathers who smoked was significantly lower 223/472 (47%)
compared with area A 345/560 (61%) (y2=20.77, df=1, P<0.0005). The
differences were not found for mothers in the two areas; in area A, 33%
were smokers compared with 38% in area B (Table 4.3).
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Women 1 2 3 4 5
smoker/total 130/395 68/177 117/ 299 14/47 30/109
(38) (38) (39) (30) (28)
Men2
smoker/total 22/357 115/196 113/205 47/88 71/186
(62) (59) (55) (53) (38)
Compared with non-smokers:
1 x2 = 8.92, df=4, P > 0.05
2 x2 = 29.89, df=4, P< 0.0005
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When the data on carriage were analyzed by multiple logistic regression
with reference to age, sex, school attended, respiratory infection, parental
smoking and the children's smoking habits, only age (P<0.01) and maternal
or other carer's smoking (P<0.05) remained significant. Older children and
those whose carers smoked were more likely to be carriers (Table 4.4).
Although the trend with age appeared stronger in those whose carers smoked,
this was not significant (interaction test in multiple logistic regression).
Table 4.4. Carriage rates in children classified by age and maternal
smoking. ( Figures are number/total (percent))
AGE


















The first objective of the study was to determine if there was an increase in the
carriage rate of meningococci among school children which might reflect
increased disease activity. The proportion of carriers (5.8%) did not differ from
that usually found during non-epidemic periods. None of the isolates from the
children expressed the B:2b:P1.10 phenotype commonly found among
children in Athens with meningococcal disease (Chapter 5).
This was the first study that assessed factors associated with carriage of
meningococci in a population in south-east Europe. Several factors identified
in studies of meningococcal carriage in northern Europe did not appear to
influence carriage in the Greek population examined. Among carriers in the
Stonehouse study (Cartwright et al., 1987) and in the Faroe Islands (Olsen et
al., 1991) , there was a higher proportion of males, but this was not observed
for children in a Scottish study (Blackwell et al., 1990a) or among Greek
children. It was suggested that the similar proportion of males and females
among Scottish children who were carriers might be due to the significantly
higher proportion of girls who were smokers (Blackwell et al., 1990a);
however, the proportion of Greek boys who smoked was slightly higher than
that of girls who smoked. In contrast to the Scottish study, which was carried
out following an outbreak of meningococcal disease, many of the children in
this survey were reluctant to answer questions about smoking; therefore, the
proportion of smokers is probably underestimated. Also in contrast to the
Scottish study, the proportion of non-secretors among carriers was not
increased.
The isolation rate in different age bands followed a pattern similar to that
found in the Stonehouse survey (Cartwright et al., 1987); and, age was the
most significant variable identified by multiple regression analysis.
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In a study of families of patients with meningitis, carriage of meningococci was
significantly associated with symptoms of upper respiratory infection (Olcen et
at., 1981). This was not observed among the school children in this study or
among Greek recruits (Chapter 3)
There was good agreement between the two indicators used to assess socio¬
economic levels; however, in contrast to the Stonehouse survey (Cartwright
et ai, 1987) and a longitudinal survey in Belgium (de Wals et at., 1983),
carriage rate was not greater in the area where socio-economic indicators
were lower. In a case control study, Stuart and colleagues found no
association between risk of carriage and social class (Stuart et at., 1988) .
They did find an increased carriage rate among individuals who lived with
smokers and the association between passive exposure to cigarette smoke
and meningococcal disease was noted among younger children who did
smoke. In contrast, among Greek children, the proportion of smokers among
mothers of older children (>12 years) who were carriers was significantly
increased.
For the fathers in this study and in our previous study of Greek military
recruits (Chapter 3) there was a significant correlation between educational
level and smoking similar to that observed in the United Kingdom (Wald et a!.,
1988).There were significantly more men who were smokers in area A where
educational levels were lower, but carriage was not associated with father's
smoking by either univariate or multivariate analysis.
In the United Kingdom, the pattern for socio-economic groups and smoking
are similar for men and women (Wald et at., 1988); however, there were no
differences in smoking patterns of women associated with educational levels
and no difference between the two areas of the city in the percentage of
mothers who smoked. Parental smoking, particularly smoking by the mother,
has been associated with upper and lower respiratory infection (Pershagen et
a!., 1986; Fleming et at., 1987) and impairment of ventilatory function (Pederira
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et at., 1985; Tager et al., 1983). If the mother's smoking is a significant factor
contributing to carriage among children , this might explain the similar carriage
rates for the two areas of Athens. The observation that carriage was also
significantly associated with the smoking by adults other than the father might
reflect the structure of many Greek families; grandmothers often live with
families with young children and are closely involved with child care. The
present study suggests that in Greece smoking by the mother or other family
members traditionally involved in child care might contribute to carriage of
meningococci.
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5. Serogroups, serotypes and subtypes of Neisseria
meningitidis isolated from patients and carriers in
Greece
5.1. Introduction
Monoclonal antibodies to outer membrane proteins 2/3 and 1 have been used
successfully to determine serotypes and subtypes of N. meningitidis in
epidemiological studies in northern and western Europe as well as in the
Americas (Poolman et at., 1986; Poolman et at., 1988; Abdillahi et al., 1988;
Wedege et al., 1990; Blackwell et al., 1990a). With the exception of results
from Italy (Mastrantonio et al., 1990), there was no information on these
antigenic characteristics for meningococcal isolates from patients and carriers
in south-eastern Europe. As the last major epidemiological survey of N.
meningitidis in Greece was published in the 1970s before the availability of
serotype and subtype reagents (Kalapothaki et al., 1979), this part of the
project had three main objectives: to determine if the serotype and subtype
reagents used in northern Europe and America can discriminate between
isolates of meningococci from south-eastern Europe; to determine if
serogroups, serotypes and subtypes of Greek isolates from patients with
meningococcal disease or carriers are similar to those in northern Europe
and to determine if particular phenotypes are associated with different
regions of Greece.
5.2. Materials and methods
Thirty-one isolates from children aged 1 month to 11 years with
meningococcal disease were obtained from the microbiology laboratory of
"Agiaia Kyriakou" Paediatric Hospital, Athens. The isolates were from
sporadic cases. Fifty-one isolates from school children aged 5-18 years
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who were carriers were obtained in surveys undertaken in Athens between
December 1990 and January 1991 (Chapter 4). A series of 496 isolates from
military recruits aged 16-30 years were obtained during July 1990 and Jan
1991 (Chapter 3) within 3-5 days of the arrival of the recruits at the camps;
recruits from all regions of Greece were represented.
The method for isolation and identification of N. meningitidis are detailed in
Chapter 2, as are the methods for the determination of serogroup, serotype
and subtype.
Information obtained from each recruit regarding area of residence and
socio-economic status was coded and entered into a Data Base 3 Plus
program (Chapter 3) together with the results of the throat swab and the
serogroup, serotype and subtype of the isolates (Chapter 3). Similar data
bases were prepared for information obtained from questionnaires returned
by parents of school children participating in the surveys (Chapter 4).
The results from the school children were compared with the meningococci
isolated following an outbreak in a Scottish secondary school caused by a
sulphonamide-resistant serogroup B serotype 4 subtype 15 (B:4:P1.15)
strain (Blackwell et al., 1990a), and results from the recruits were
compared with published results for 133 isolates obtained from carriers
among Norwegian military recruits (Wedege et al., 1990).
5.3. Results
5.3.1. Patients
The antigenic phenotypes of isolates from patients are shown in Table 5.1.
The most prevalent serogroup was B (58%) followed by group C (26%) and
non-groupable isolates (15%). The majority of isolates (58%) did not react
with any of the serotype antibodies. The most common serotype was 2b
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(9/31, 29%), and the most common subtype was P1.10 (11/31, 35%). The
most common serotype-subtype combination was 2b:P1.10 (7131, 23%)
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Table 5.1. Antigenic phenotypes of isolates from children with
meningococcal disease.
Antigenic Phenotype Number of isolates
B: - : - 3
B: - : P1.1 1
B: - : P1.9 4
B: - : P1.10 2
B: - : P1.14 1
B: 2b: P1.9 1
B: 2b: P1.10 4
B: 14: P1.15 1
B: 15: P1.6 1
C: - : P1.6 2
C: - : P1.10 3
C: - : P1.14 1
C: - : P1.16 1
C:2b: P1.2 1
NG : 2a : P1.16 1
NG : 2b : P1.10 3
NG : 14 : P1.10 1
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5.3.2. Carriers
Among school children there was no predominant antigenic phenotype. Of
the 19 (37%) serogroupable isolates, 10 belonged to group B, two to each of
serogroups A, C, W135 and Y and one to group Z. As with the isolates from
patients, the majority (65%) did not react with any of the serotype
antibodies; however, most (75%) reacted with one or more subtype reagents.
Two isolates (4%) obtained from secondary school pupils expressed the
2b:P1.10 combination found among those from patients (Tables 5.2 and
5.3).
Of the 496 isolates from recruits, 36% were serogroupable: 24% group B;
5% group C; and 4% group A. Most isolates (69%) were not serotypable, but
64% reacted with one or more of the subtype antibodies. The most common
subtype was P1.2 (16%) (Tables 5.2 and 5.3). The most prevalent
combination of serotype-subtype antigens was 14: P1.2 (n=24) followed by
14:P1.7 (n=13). None of the isolates from the recruits expressed the
2b:P1.10 combination predominant among children with meningococcal
disease. None of the 2a or 2b isolates from carriers reacted with any of
the subtype antibodies.
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Table 5.2. Comparison of serotypes of isolates from carriers in
Greece with those from carriers in northern Europe
Percentage of isolates
Recruits School children
Serotype Greece Norway Greece Scotland
(n =485) (n=133) (n=51) (n=121)
1 4 5 8 9
2a 1 5 6 0
2b 5 0 8 5
4 2 22 8 36
8* - 8 - -
14 16 16 2 13
15 3 8 4 8
21* - 8 - 7
Non- 69 28 64 22
typable
* Not tested in this study
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Table 5.3. Comparison of subtypes of isolates from carriers in
Greece with those from carriers in northern Europe.
Percentage of isolates
Recruits School children
Subtype Greece Norway Greece Norway
(n =489) (n=133) (n=51) (n=121)
P1.1 9 5 14 13
P1.2 16 16 8 17
P1.3* - 13 - -
P1.4 1 0 0 0
P1.6 6 0 8 8
P1.7 6 0 4 7
P1.9 9 0 18 0
P1.10 6 0 10 0
P1.12 2 0 4 0
P1.14 2 0 0 0
P1.15 4 19 8 23
P1.16 3 8 0 4
Non- 69 28 64 22
typable
* Not tested in this study
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5.3.3. Geographical distribution
The major regions of Greece are shown in figure 5.1 together with the
proportion of recruits from whom meningococci were isolated. Meningococci
were obtained most frequently from recruits from the north-east of Greece:
Thrace (37%), West Macedonia (33%) and East Macedonia (30%). Because
military service is compulsory, even for individuals who live abroad, there
were 33 subjects who were not normally resident in Greece. Among these,
33% were carriers.
There were no unusual distributions of serogroups among the different
regions. The most common serotype (14) was found in equal proportions
(15%) among the isolates from the major centres of population, greater
Athens and East Macedonia. Over 20% of the isolates from Thessaly (22%),
the Peloponnese (21%), Crete (25%) and the Aegean Islands (30%)
expressed the type 14 antigen. Isolates representative of all the type 11
subtypes examined were found among those from recruits from greater
Athens, East Macedonia and Crete. More isolates that did not react with the
subtype antibodies were obtained from recruits from the north of Greece:
Thrace, Macedonia and Epirus.
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The first objectives of the study were to determine if the serotype and
subtype reagents used for epidemiological studies in northern Europe and
the Americas could be used in epidemiological studies in Greece, and if
the serotype and subtype combinations associated with disease in other
populations were found in Greece. The proportion of non-serotypable
isolates from the Greek recruits (69%) and school children (64%) was
greater than the proportion of non-serotypable isolates obtained from
carriers among Norwegian recruits (28%) (Wedege et al., 1990) or Scottish
school children (22%) (Blackwell et al., 1990a) .The proportion of serotype
14 isolates was similar for Greek (16%) and Norwegian (16%) recruits and
Scottish school children (13%) but was much lower (2%) among Greek
children. The proportion of 2b serotypes was similar for the Greek
recruits and Scottish school children. Serotype 4 was the most prevalent type
among the Norwegian (22%) (Wedege et al., 1990) and Scottish (36%)
isolates compared with 2-8% of the Greek isolates. Serotype 15 was
found in 8% of isolates from north Europeans compared with 3-4% of the
Greek isolates. This suggests that other serotype reagents need to be
developed for epidemiological studies of meningococci from Greece and that
the serotypes associated with recent outbreaks in Britain and Scandinavia
are uncommon in Greece. Similar high proportions of non-serotypable isolates
have been obtained in studies in Czech Republic (Kriz et al., 1995).
The proportion of isolates from the Greek recruits (36%) and school children
(26%) that did not react with any of the subtype reagents was similar to that
of isolates from the Norwegian recruits (39%) (Wedege et al., 1990) and
from Scottish school children (38%). The proportion of subtype P1.2 isolates
was similar for Greek (16%) and Norwegian (16%) recruits and Scottish
schoolchildren (17%) but was lower among Greek schoolchildren (8%).
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The proportion of subtype P1.15 was similar among the Norwegian (19%)
(Wedege et al., 1990) and Scottish (23%) isolates but was greater than that
found in the Greek isolates (4-8%). The subtype reagents appear to
discriminate between strains from Greek carriers as effectively as between
carrier strains from northern Europe; however, the proportions of subtypes
associated with outbreaks in northern Europe are lower.
Combinations of serotype and subtype antigens 15: P1.16, 4:P1.15 and
2a: P 1.2 associated with outbreaks in northern Europe (Poolman et al., 1988;
Abdillahi et al., 1988; Blackwell et al., 1990a) were not found among any of
the isolates in this study. Although P1.2 was the most common subtype
found in the study, there was only one patient isolate with this type,
C:2b:P1.2 (Table 5.1). In contrast, the 2a:P1.2 and 2b:P1.2 combinations are
found frequently among Scottish group C (Fallon et al., 1991) and French
serogroup B isolates and 2a:P1.2 is found frequently among French
serogroup C isolates (Riou et al., 1989). The only report of meningococcal
serotypes from southeast Europe is that of the C:2a phenotype associated
with disease in Italy (Mastrantonio et al., 1990). None of the serogroup C
isolates expressed this serotype.
The third objective was to determine if there were antigenic phenotypes
associated with different areas of Greece, e.g., those in which there are
large numbers of foreign tourists or foreign military personnel or areas such
as the northeast were there is a significant Muslim population some of
which might have visited Saudi Arabia; however, there was no unusual
distribution of serogroups or serotypes in the different regions of Greece.
The results of the study suggest that vaccines based on serotypes and
subtype combinations associated with disease in northern Europe such as
the one being developed and tested in Norway will not be appropriate for
Greece.
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6. Antibiotic sensitivities of Neisseria meningitidis
isolated from patients and carriers in Greece
6.1. Introduction
As part of the surveys of isolates of meningococci from patients and
carriers in Greece, the antibiotic sensitivities of these bacteria to some
common antibiotics were determined. There are reports of N. meningitidis
with reduced sensitivity to penicillin isolated from patients in Spain (Saez-
Nieto et al., 1987; Saez-Nieto et al., 1990), South Africa (Botha et al., 1988)
and the United Kingdom (Sutcliffe et al., 1988; Jones et al., 1990). A small
proportion of these penicillin-insensitive isolates has also been found among
those obtained from carriers in the United Kingdom (Sutcliffe et al., 1988). In
view of the increasing prevalence of penicillin- insensitive isolates in
Spain and the similar antibiotic policies of both Spain and Greece, it was
predicted that there might be significant numbers of Greek isolates with
decreased sensitivity to penicillin and other antibiotics. The objectives of the
study were: (1) to compare levels of sensitivities for isolates obtained from
patients with those obtained from carriers, (2) to determine if the proportion of
penicillin-insensitive isolates is comparable to that reported for Spain; (3) to
assess the distribution of resistant isolates in the different regions of Greece
(4) to determine if antibiotic resistances are associated with particular
serogroups, serotypes or subtypes.
6.2. Materials and methods
Thirty-one isolates from children aged 1 month to 11 years were provided by
the microbiology laboratory of the "Aglaia Kyriakou" Paediatric Hospital. All
cases were sporadic and occurred during 1989-91. Four hundred and
seventy-two isolates were obtained during 1990-91 from healthy recruits aged
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16-31 years (Chapter 3 ) and a further 47 isolates obtained from the surveys
of school-children aged 6-18 years (Chapter 4).
Antibiotic sensitivities to penicillin (PN), erythromycin (ER), tetracycline (TC),
sulphamethoxazole (SU), rifampicin (RF), cefaclor (CF) and ciprofloxacin
(CP) were determined by the agar dilution method (Chapter 2). A range of
two-fold dilutions from 256 to 0.015 mg/l of each antibiotic in Mueller-Hinton
medium was examined. The breakpoints used for penicillin (> 0.125 mg/l),
tetracycline (>1 mg/l), erythromycin (> 0.5 mg/l), rifampicin (>1 mg/l,
ciprofloxacin (>1 mg/l) and the cefalosporin cefaclor (>4mg/l) were based on
those recommended by the working party of the British Society for
Antimicrobial Chemotherapy for Branhamella catarrhalis and Haemophilus
influenzae (AAC working party 1988). The break point of >10 mg/l for
sulphamethoxazole (SU) was that used by the Neisseria Reference
Laboratory (Scotland) [Dr. R.J. Fallon, personal communication]. Beta-
lactamase production was assessed during the rapid carbohydrate
fermentation test for identification of each isolate (Young 1978). Serogroups,
serotype and subtype of each isolate was determined as described in Chapter
2.
6.3. Results
6.3.1. Antibiotic sensitivities of isolates from patients and carriers
Table 6.1 compares the proportion of resistant isolates among the three
groups examined. Among 31 isolates obtained from children with
meningococcal disease, none was resistant to rifampicin or ciprofloxacin.
Nearly half the isolates were penicillin- insensitive (48.3%) and all grew on
1 or 2 mg/l tetracycline. Among the 47 isolates from schoolchildren the
pattern of resistance to ciprofloxacin, cefaclor and sulphamethoxazole was
similar to that of isolates from patients. The proportion resistant to
erythromycin (61.7%) was over twice that among isolates from patients
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(25.8%) (x2=8.27, df=1, P 0.005); and there were some rifampicin resistant
strains (6.4%). Compared with the isolates from patients, the proportion
resistant to tetracycline was much less (6.4%) (x2=62.83, df=1, P 0.0005) as
was the proportion with decreased sensitivity to penicillin (19.1%) (x2=7.61,
df=1, P< 0.01).
The proportions of 472 isolates from recruits resistant to tetracycline or
penicillin were similar to those of isolates from patients. The proportions
of isolates from recruits resistant to erythromycin or to rifampicin were
similar to that for isolates from children who were carriers. Compared with
the other two groups, there was a higher proportion of isolates from recruits
resistant to sulphamethoxazole and cefaclor. There were 112 isolates
(23.7%) with MIC> 4 mg/l cefaclor and 32 isolates (6.8%) with MIC> 8 mg/l.
Of the latter 32 isolates, 27 (84%) had decreased sensitivity to penicillin.
There was one isolate with MIC > 1 mg/l to ciprofloxacin. None of the 550
isolates from patients and carriers produced beta-lactamase.
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Penicillin G 48.3 19.1 36.7
Sulphamethoxazole 16.1 10.6 35.6
Rifampicin - 6.4 7.0
Tetracycline 100 6.4 91.0
Erythromycin 25.8 61.7 82.2
Cefaclor 9.7 6.4 23.7
Ciprofloxacin - - 0.2
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6.3.2. Geographical distribution of resistant isolates
In the two major population centers, Eastern Macedonia and Athens, the
proportions of penicillin-insensitive isolates were 33 and 40% respectively.
The highest proportions of such isolates were found in Thrace (50%), Crete
(52%) and the Aegean and Ionian Islands (50%). The lowest proportion was
obtained from recruits who lived abroad but had returned to Greece for their
compulsory military service (9%) (Table 6.2). Analysis of the serogroups,
serotypes, subtypes and sensitivities to other antibiotics indicate that the
isolates within a particular geographical area with decreased sensitivity to
penicillin are not related.
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Table 6.2. Proportion of antibiotic-resistant isolates obtained from




PN SU RF CP
Thrace 14 50 79 7 -
W. Macedonia 38 26 42 5 -
E. Macedonia 96 33 35 7 -
Epirus 23 48 30 4 -
Thessaly 46 34 48 6 -
Central Greece 32 32 44 9 -
Athens 127 40 39 7 0.8
Peloponese 40 35 30 10 -
Crete 31 52 39 3 -
Aegean Islands 10 50 70 10 -
Ionian Islands 2 50 - 50 -
Foreign 11 9 22 - -
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6.3.3. Analysis by antigenic phenotypes
Among the isolates from patients with meningitis, 9/18 (50%) of group B, 7/18
(37.5%) of group C; and 11/18(60%) of the non-groupable isolates were
penicillin-insensitive. Sulphonamide resistance was found in 3/18 (17%) of the
group B isolates and 4/18 (25%) of group C but in none of the non-
groupable isolates. Of the 9 2b serotype isolates, 7 (78%) were penicillin-
insensitive as were 8/18 (44%) of the non-typables. The 4 isolates
expressing other serotypes (2a, 14, and 15) were sensitive to penicillin and
to sulphamethoxazole. Resistance to sulphamethoxazole was found for only
2/9 (22.2%) serotype 2b isolates and 3/18 (16.6%) non-typable isolates. Of
the 9 isolates expressing the P1.10 subtype, 7 (78%) were penicillin-
insensitive though only 1 was resistant to sulphamethoxazole. The second
most common subtype was P1.9. Only 1 of the 5 P1.9 isolates was
penicillin-insensitive, but 2 were sulphonamide resistant.
There were sufficient numbers of isolates from the recruits for analysis of
antibiotic resistances by serogroup, serotype and subtype (Tables 6.3-6.5).
Among the serogroups, the highest proportion of penicillin-insensitive
isolates was found for group Y (62.5%) while rifampicin resistance was
greatest in groups A (12%) and C (10.5%) (Table 6.3).
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A 17 41 41 12
B 114 35 37 5
C 19 42 42 10.5
W-135 2 0 50 0
Y 8 62.5 25 0
Z 4 25 0 0
NG 300 36 40 7
Penicillin-insensitivity was highest among serotypes 2a and 15 and lowest in
type 4, which, however, had the highest proportion of strains resistant to
sulphamethoxazole. Rifampicin resistance was observed most frequently
among serotypes 4 and 15 (Table 6.4).
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Table 6.4. Antibiotic resistances of isolates from recruits analyzed by
serotype
Serotype No % resistant
PN SU RF
1 15 27 20 7.0
2a 7 57 43 0
2b 22 27 32 4.5
4 9 11 56 11.0
14 66 42 28 9.0
15 16 56 19 12.5
With the exception of a high proportion of sulphamethoxazole resistant
isolates associated with P1.7 (63%) and penicillin insensitive isolates
associated with serotype P1.14 (62.5%), no particular subtype antigen was
associated with an unusual degree of antibiotic resistance (Table 6.5).
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P1.1 41 39 34 2.5
P1.2 72 43 22 15.5
P1.4 7 43 29 0
P1.6 28 32 68 0
P1.7 30 43 63 13
P1.9 45 27 38 2.4
P1.10 29 45 28 14
P1.12 8 25 37.5 0
P1.14 8 62.5 25 0
P1.15 16 37.5 19 0
P1.16 13 38 70 23
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6.4. Discussion
Although sulphonamide resistance has been associated with strains
causing outbreaks of meningococcal disease in northern Europe (Cartwright
et ai, 1987; Poolman et at., 1986), only 16% of the isolates from Greek
patients had MIC> 10 mg/l of sulphamethoxazole; however nearly half had
reduced sensitivity to penicillin and all grew in the presence of 1 or 2 mg/l
tetracycline. In contrast, while the proportions of penicillin-insensitive and of
tetracycline resistant isolates from children who were carriers were both
significantly lower, the proportion of erythromycin isolates was significantly
increased.
Among isolates from the recruits, the proportion of penicillin insensitive strains
was significantly greater than that from children who were carriers (x2=5.126,
df=1, P<0.025) but not compared with those from children with disease. The
proportion of sulphonamide-resistant isolates among those recruits (35.6%)
was over twice that of the other two groups, carriers (10.6%) (y2 =10.882,
df=1, P<0.005) or patients (16%) (x2=4.06, df=1, P<0.05) (Table 6.1).
Although penicillinase-producing isolates of N. gonorrhoeae are not
uncommon in Greece (18%) (Tzanakaki et at., 1989), none of the 550
meningococcal isolates tested produced beta-lactamase. The levels of
resistance to erythromycin among isolates from carriers might reflect longer
exposure to the antibiotic as the mean ages of the carriers are higher,
school-children (12.8 years) and recruits (19.7 years) compared with a mean
age of 2.7 years for patients with meningitis. Only one isolate had MIC > 1
mg/l to ciprofloxacin. Since 6-7% of isolates from carriers were resistant to
rifampicin, ciprofloxacin might be considered for circumstances when
chemoprophylaxis would be appropriate as it has been found to eradicate
pharyngeal carriage of meningococci (Gaunt et a!., 1988).
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Sutcliffe and colleagues (Sutcliffe et ai, 1988) stated that in view of the
extensive use of penicillin in the community in Britain, emergence of
penicillin-insensitive meningococci is not unexpected. In Britain, the
proportion of isolates from patients and carriers with MIC >0.16 mg/l was
about 3% (Sutcliffe et at., 1988). In Spain in 1986, only 5% of isolates
examined had MIC> 0.1 mg/l; however, by 1990, this figure had risen to 46%
of isolates from patients. The antibiotic policies of Spain and Greece are
similar and the proportion of penicillin-insensitive isolates from Greek
children with meningococcal disease (48.3%) was similar to that reported
for Spain. In Britain, the proportion of penicillin-insensitive isolates from
carriers was slightly less than 3% (Sutcliffe et a!., 1988), much lower than the
proportion of penicillin-insensitive strains from carriers in this survey,
recruits (36%) or school-children (19.1%). Differences in MIC values to
tetracycline between isolates from patients and isolates from children who
were carriers was not expected. Although high level tetracycline resistance
mediated by a plasmid carrying the tetM determinant has been found in
meningococci (Knapp et a!., 1988), none of the isolates had MIC>8 and the
25.2 megadalton plasmid was not observed in any of the strains examined so
far. Strains were sent to Dr. M. Roberts of the University of Washington for
analysis of the chromosomal tetM. The gene was not identified in any of these
strains ( Dr. M. Roberts, personal communication).
The differences in the proportions of penicillin-insensitive isolates in the
different regions of Greece is under investigation (Table 6.2). That there
were fewer such isolates among recruits who lived outside Greece (mainly
Germany) might reflect differences in antibiotic policies referred to earlier.
Although 61% of the British isolates which were penicillin-insensitive were
also su)jbhonamide resistant, none were resistant to rifampicin, aminogly¬
cosides, erythromycin, tetracycline or chloramphenicol (Sutcliffe et at., 1988).
Only 37% of the penicillin-insensitive isolates in this study were
sulphonamide resistant; however, additional resistances were often
present: rifampicin (8%); erythromycin (33%); cefaclor (34%); tetracycline
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(96%). While none of the penicillin-insensitive strains in Britain was serogroup
A (Sutcliffe et al., 1988), 41% of the Greek group A isolates had reduced
sensitivity to penicillin. The highest proportion of penicillin-insensitive
isolates was among the 8 group Y isolates (62.5%). Analysis by areas
of residence of the recruits, serotype, subtype and sensitivities to other
antibiotics, suggest these group Y isolates are not related. Although
serogroup B was the most common among patient isolates, the greatest
proportion of isolates resistant to rifampicin was among those of groups A
and C.
The number of serotypable isolates was small and larger numbers need to be
examined to determine if the associations noted are significant (Table 6.4).
Most of the penicillin-insensitive isolates expressing subtype P1.14 do not
appear to be a single strain as assessed by the serogroup, serotype,
sensitivities to other antibiotics and the area of residence of the recruits from
whom the bacteria were isolated. Although the sulphonamide and rifampicin
resistances were highest among subtype P1.16, the two resistances were not
found together in the P 1.16 strains. The higher rate of rifampicin resistance
among isolates expressing P1.10, the subtype found frequently among
meningococci isolated from patients, and among isolates expressing P1.2
(the most common subtype among carriers), needs to be investigated.
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7. Investigation of the N. meningitidis strains isolated
in Romania
7.1. Introduction
The epidemiological investigation carried out in Greece the last 3 years on N.
meningitidis has shown that the majority of the meningococcal isolates
obtained from patients and carriers in Greece are not typable with the
reagents used in north-west Europe; therefore, vaccines based on these
antigens would be of little value in Eastern regions. The population
movements that have occurred among former Eastern Bloc countries since
the end of 1989 might have introduced strains not encountered outside
these countries whose residents have been isolated for over 40 years.
In addition, our studies indicated that the Greek meningococcal strains differ
from those in northern Europe is that there is an increase in the proportion of
isolates from both patients and carriers with reduced sensitivity to penicillin.
The above findings, prompted additional investigations of meningococcal
strains isolated in the Balkan area, since the serotype-subtype techniques as
well as the antibiotic susceptibility testing are not carried out these countries.
The objectives of the present study were: (1) to determine whether the
serotype and subtype reagents used in northern Europe can discriminate
between isolates of meningococci from south - eastern Europe ; (2) To
determine if the serogroups, serotypes and subtypes of Romanian isolates
are similar to those found in Greece (3) to assess the levels of antibiotic
sensitivities for strains isolated from patients and carriers (4) to determine if
there is an association between the antibiotic resistance with particular
serogroups, serotypes or subtypes.
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7.2. Materials and methods
7.2.1. Isolates
A total of 61 meningococcal isolates were received from the Meningococcal
Reference Laboratory from the Cantacusino Institute, Bucharest, Romania.
The isolates were received in a freeze-dried form, and from the 61 strains 30
were revived. From the above strains, 13 isolates were from carriers and 17
were from patients with meningococcal disease. The period of isolation was
from 1969-1993.
7.2.2. Methods
The isolates were reconstituted from the freeze-dried in distilled water and
cultured on Modified New York City medium. The isolation and identification
techniques, as well as the determination of the serogroup, serotype, subtype
are as described in Chapter 2. Sensitivities to antibiotics were assayed as
described in Chapter 7.
7.3. Results
7.3.1. Serogroup, serotype and subtype of Romanian isolates
A total of 30 meningococcal isolates from patients and carriers were
examined for their antigenic characteristics (Table 7.1). As for their antigenic
phenotypes of the isolates, the most prevalent serogroup was B (53.3%)
followed by group A (13.3%) and C (10%).The percentage of the non-
groupable isolates was 10% and 6.7% of the isolates were polyagglutinable
(Table 7.1).
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Table 7.1 Distribution of the serogroups among the Romanian isolates.
Serogroup Patients Carriers Total
(%) (%) (%)
A 2 (11.8) 2 (15.4) 4(13.3)
B 12 (70.5) 4 (30.7) 16 (53.3)
C 1 (5.9) 2 (15.4) 3(10)
Y 1 (5.9) 1 (7.7 ) 2 (6.7)
NG 1 (5.9) 2 (15.4) 3(10)
Polyvalent 0 2(15.4) 2 (6.7)
Total 17(100) 13(100) 30(100)
The majority of isolates (66.7%) did not react with any of the serotype
antibodies ; however, most (80%) reacted with the subtype reagents.
The most common serotype was 4 (5 / 30, 16.6%), and the most common
subtype was P1.15 (9/30, 30%) (Tables 7.2, 7.3) The most common
serogroup/serotype combination was B:NT:P1.15 (6/30) and A:4:P1.10 (Table
7.4).
124
Table 7.2 Serotypes of isolates from patients and carriers from Romania
isolates from (%)
Serotype Patients Carriers Total
1 1 (5.9) - 1 (3-3)
2a - 2 (15.4) 2 (6.7)
2b - - 0
4 4 (23.5) 1 (7.7) 5 (16.6)
14 1 (5.9) 1 (7.7) 2 (6.7)
15 - - 0
N.T. 11 (64.7) 9 (69.2) 20 (66.7)
Total 17 13 30
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Table 7.3 Comparison of subtypes of isolates from patients and
carriers in Romania.
isolates from (%)
Subtype Patients Carriers Total
P1.1 1 (5.9) 2 (15.4) 3(10)
P1.2 1 (5.9) - 1 (3.3)
P1.4
P1.6 1 (5.9) 1 (7.7) 2 (6.7)
P1.7 - 2 (15.4) 2 (6.7)
P1.9 - 1 (7.7) 1 (3.3)
P1.10 3 (17.6) - 3(10)
P1.13 - 1 (7-7) 1 (3.3)
P1.14 1 (5.9) 1 (7.7) 2 (6.7)
P1.15 6 (35.3) 3 (23.1) 9 (30)
P1.16 -
N.T. 4 (23.5) 2 (15.4) 6 (20)
Total 17 (100) 13 (100) 30 (100)
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Table 7.4 Antigenic phenotypes of isolates from Romania
Antigenic No of
Phenotype isolates
B: 1 : - 1
B: - : P1.1 1
B: - : P1.2 1
B: - : P1.6 2
B: - : P1.15 6
B: 14: P1.15 1
B:- : P1.7 1
p l TJ —X 1
C: 2a: P1.13 1
A: 4 :P1.10 2
A: 14 :P1.1 1
A: 2a :P1.1 1
N.T. 11
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7.3.2. Antibiotic sensitivities of Romanian isolates
Among the 30 Romanian isolates, none was resistant to rifampicin or
ciprofloxacin. The proportion resistant to tetracycline was 30%; the proportion
with decreased sensitivity to penicillin was 10%; and the proportion resistant
to erythromycin 16.7%. The majority were resistant to sulphamethoxazole
(63.3%) and to cefaclor (46.7%) (Table 7.5). None of the 30 isolates
produced beta-lactamase.
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Penicillin G 1 (5.9) 2 (15.4) 3(10)
Sulphamethoxazole 9 (53) 10 (76.9) 19 (63.3)
Rifampicin - - 0
Tetracycline 6 (35.3) 3 (23) 9 (30)
Erythromycin 2 (11.8) 3 (23) 5 (16.7)
Cefaclor 9 (53) 5 (38.5) 14 (46.7)
Ciprofloxacin - - 0
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7.3.3. Analysis by antigenic phenotypes
Among the isolates, 12.5% of group B, 25% of group A and all of the non-
groupables and polyvalent strains were penicillin-insensitive. Sulphonamide
resistance was found in 43.7% of the group B isolates and 75% of group A
and in all of the non-groupable and polyvalent isolates (Table 7.6).





A 4 25 75
B 16 12.5 43.7
C 3 - 100
Y 2 - -
Polyvalent 2 100 100
NG 3 100 100
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Of the 5 isolates belonging to 4 serotype, none was penicillin-insensitive. Both
strains belonging to serotype 1 were penicillin-insensitive. The rest of the
isolates expressing other serotypes (2a,2b,14,15) were sensitive to penicillin.
Resistance to sulphamethoxazole was found for both 2a isolates, for 40% of
the strains of the serotype 4 and 50% of the serotype 1 (Table 7.7).





1 2 100 50
2a 2 - 100
2b - - -
4 5 - 40
14 2 - -
15 - - -
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Of the 10 isolates expressing the P1.15 subtype, 7 (22.2%) were penicillin-
insensitive and 80% were resistant to sulphamethoxazole. The second most
common subtype was P1.1; and 25% of the isolates were penicillin-
insensitive, but none sulphonamide resistant (Table 7.8).







P1.1 4 25 -
P1.2 1 - -
P1.4 - - -
P1.6 2 - 50
P1.7 1 100 100
P1.9 1 - -
P1.10 3 - 33.3
P1.12 - - -
P1.14 2 - 50
P1.15 10 22.2 80
P1.16 - - -
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7.4. Discussion
The first objectives of the study were to determine if the serotype and
subtype reagents used for epidemiological studies in northern Europe and
the Americas could be used in epidemiological studies in Eastern Europe
and if the serotype and subtype combinations associated with disease in
other populations were found in Eastern Europe.
The proportion of non-serotypable isolates from the Romanian isolates
from patients (64.7%) was higher to that observed among the Greek isolates
from patients (58%) and still greater than the proportion of non-
serotypable isolates obtained from Northern Europe (Wedege et al., 1990).
The proportion of serotype 14 isolates (6.7%) was similar to Greek (6.4%)
isolates (Table 5.2). Although the 2b serotype was the predominant serotype
for the Greek isolates (29%), it was not observed among the Romanian
isolates. In contrast, serotype 4 (16.6%) (23.5% in patient and 7.7% in carrier
strains) was the most prevalent type among the Romanian isolates; a similar
pattern was observed among those from Norway (22%) (Wedege et al., 1990)
and Scotland (36%) (Blackwell et al., 1990a). Serotype 4 was observed only
among the Greek carrier strains where the proportion was 2-8% (Table 5.2).
Serotype 15 was found in 8% of isolates from north Europeans compared
with 6.4% of the Greek isolates and none of the Romanian strains. This
suggests that other serotype reagents need to be developed for
epidemiological studies of meningococci in the Eastern Europe and that the
serotypes associated with recent outbreaks in Britain and Scandinavia are
uncommon in these populations.
There was a lower proportion of isolates from the Romania (23.5%) as well as
the Greek patients' strains that did not react with any of the subtype reagents,
in contrast to the Greek carrier isolates (36%). The proportion of subtype P1.2
isolates was similar for Romanian (3.3%) and Greek (3.3%) isolates and was
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much lower than that found among the Greek (16%) and Norwegian recruits
(16%) and also lower than the Scottish and Greek schoolchildren (17% and
8% respectively). The most predominant subtype was P1.15 (30%) (35.3% in
patient and 21.3% in carrier isolates) and this was higher than the percentage
found among the Norwegian (19%) (Wedege et al., 1990) and Scottish (23%)
isolates but was much higher than that found in the Greek isolates (4-8%).
Combinations of serotype and subtype antigens 15: P1.16, 4:P1.15 and
2a:P1.2 associated with outbreaks in northern Europe (Poolman et al., 1988;
Abdillahi et al., 1988) were not found among any of the isolates in this study.
Although P1.15 was the most common subtype found in the study, none of
these isolates expressed the 4:P1.15 combination. The 2a:P1.2 and 2b:P1.2
combinations are found frequently among Scottish group C (Fallon et al.,
1991) and French serogroup B isolates and 2a:P1.2 is found frequently
among French serogroup C isolates (Riou et al., 1989). The only report of
meningococcal serotypes from south-east Europe is that of the C:2a
phenotype associated with disease in Italy (Mastrantonio et al., 1990). None
of the Romanian serogroup C isolates expressed this serotype.
Sulphonamide resistance has been associated with strains causing
outbreaks of meningococcal disease in northern Europe (Cartwright et al.,
1987; Poolman et al., 1986). Most of the Romanian strains were resistant;
19/30 strains (63.3%) had MIC> 10 mg/l of sulphamethoxazole (53% in
patients and 76.9% in carriers) in contrast to the strains isolated from Greek
patients where only 16% of the isolates were resistant to sulphamethoxazole.
Only 10% of the Romanian strains had reduced sensitivity to penicillin in
contrast to the Greek isolates (48.3%) and 30% grew in the presence of 1 or
2 mg/l tetracycline compared with higher levels found among Greek isolates
(Table 6.1). The levels of resistance to erythromycin was lower (16.7%) than
that found among the Greek strains (25.8%). The proportion of penicillin-
insensitive isolates from Greek children with meningococcal disease
(48.3%) was found to be similar to that reported for Spain, since the antibiotic
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policies of Spain and Greece are similar. The same pattern was not observed
among the Romanian strains; only 5.9% of the isolates were penicillin
insensitive. The percentage was not as low as of that in Britain (2%), but it
was certainly lower than that found in other Mediterranean countries (Greece,
Spain).
Among the Romanian strains, 75% of the penicillin-insensitive isolates
were sulphonamide resistant, a pattern similar to that found in Britain
(Sutcliffe et al., 1988). While none of the penicillin-insensitive strains in Britain
was serogroup A, (Sutcliffe et al., 1988), 25% of the Romanian group A
isolates had reduced sensitivity to penicillin. The highest proportion of
penicillin-insensitive isolates was among the non- groupable as well as the
polyagglutinable isolates (100%). The number of serotypable isolates was
small and larger numbers need to be examined to determine if the
associations noted are significant.
The results of the study suggest that as with the Greek isolates, that
vaccines based on serotypes and subtype combinations associated with
disease in northern Europe such as the one being developed and tested in
Norway will not be appropriate for the Eastern European countries. This
difference between the percentage of resistant strains between Romania and
Greece might be due to differences in antibiotic policies between the two
countries. At least until 1989 there were stricter policies on the use of
antibiotics in all Eastern European countries (Dr. P. Kriz and Dr. F. Mihalcu,
personal communication).
Although the antibiotic policy in Romania was more strict than in Greece, the
appearance of penicillin-insensitive strains as well as the high proportion of
sulphonamide resistance strains suggest that antibiotic sensitivities need to
be more closely studied in larger numbers of isolates.
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8. Genotypes of meningococci in Greece and Romania
8.1. Introduction
Meningococci are classified into serogroups, serotypes and subtypes on
the basis of phenotypic characteristics (Frasch et al., 1985). Studying the
distribution of these surface structures has proved to be useful for
analyzing the spread of meningococcal disease (Holten et al., 1979; de
Marie et al., 1986b; Poolman et al., 1986; Scholten et al., 1993). In recent
years it has been shown that meningococci have a clonal population
structure and the characterization of the chromosomal genotype of N.
meningitidis by multilocus enzyme electrophoresis has proved to be an
even more powerful tool for studying the epidemiology of meningococcal
disease. If closely related meningococcal clones are homogeneous with
regard to the phenotype, the results of the surface characterization of N.
meningitidis and genotyping will be similar and will lead to the same
inferences. Many isolates, especially those from carriers, do not react with
any of the presently available polyclonal or monoclonal reagents used to
determine phenotypic characteristics (Poolman 1980b; Bovre et al., 1983).
Most isolates from patients are serogroupable, but a large proportion of
isolates from sporadic cases are non-typable (NT) (Broud et al., 1979); and
epidemic strains are often of a single antigenic type.
In this part of the study multilocus enzyme electrophoresis technique was
used to assess of N. meningitidis from patients and carriers in both Greece
and Romania to determine if the phenotype differences reflected to genetic
differences.
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8.2. Materials and methods
8.2.1. Isolates
A total of 43 meningococcal strains isolated from children aged 1 month to 11
years with meningococcal disease were obtained from the microbiology
laboratory of "Aglaia Kyriakou" Paediatric hospital, Athens. The isolates were
from sporadic cases. Thirty isolates from the Cantacuzino Institute in
Bucharest were also examined, 17 strains from patients and 13 strains from
carriers (Table 8.1).





* 3 patient isolates from 1969
8.2.2. Serogroup and serotype identifications
The serogroups were determined by slide agglutination with serogroup-
specific sera as detailed in Chapter 2 as are the methods for the determination
of the serotypes and subtypes.
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8.2.3. Isolation and electrophoresis of the enzymes.
8.2.3.1. Reagents
8.2.3.1.1. Tris-HCI (pH 8.0)
For the preparation of 11 buffer, Tris 24.2 g was dissolved in 950 ml distilled
H20. After the pH was adjusted with concentrated HCI, the volume was
measured and distilled water was added to make the final volume of 1L (0.2 M
Tris).
8.2.3.1.2. MgCI2 solution
For the preparation of 11 buffer, MgCI2 (20.3 g) was dissolved in 1000 ml
distilled H20. (0.1 M MgCI2)
8.2.3.1.3. MnCI2 solution
For the preparation of 1L buffer, MnCI2 (49.0 g) was dissolved in 1000 ml
distilled HzO (0.25 M MnCI2)
8.2.3.1.4. Phenazine Methosulphate (PMS)
For the preparation of 100 ml staining solution, phenazine methosulphate (1.0
g) (Sigma P-9625) was dissolved in 100 ml deionized H20. The solution was
kept in a dark bottle at room temperature.
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8.2.3.1.5. Tetrazolium (MTT)
For the preparation of 100 ml staining solution, tetrazolium (1.0 g) (Sigma M-
2002) was dissolved in 125 ml deionized H20. The solution was kept in a
dark bottle at room temperature.
8.2.3.1.6. p- Nicotinamide Adenine Dinucleotide (NAD)
For the preparation of 100 ml NAD solution, NAD (1.0 g) (Sigma N-8881) was
dissolved in 100 ml distilled H20. The solution was kept at +4° C.
8.2.3.1.7. p- Nicotinamide Adenine Dinucleotide Phosphate (NADP)
For the preparation of 100 ml NADP solution, NADP (1.0 g) (Sigma N-0505)
was dissolved in 100 ml distilled Fl20. The solution was kept at +4° C.
8.2.3.1.8. Amarath -staining solution
Amarath (100 mg) (Sigma) was dissolved in 30 ml of distilled water, and 1 ml
of 96% ethanol was added.
8.2.3.1.9. Trypticase Soy Broth (TSB)
TSB (30 g) (BBL- Becton Dickinson) was dissolved in 11 of distilled water. The
contents were mixed thoroughly, warmed gently until the TSB was dissolved
and autoclaved at 121° C for 15 min.
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8.2.3.1.10. Tris-EDTA buffer (pH 6.8)
For the preparation of 11 of buffer, Tris (1.21 g) (Sigma) and EDTA (0.37 g)
(Fluca) were dissolved in 11 distilled water. The pH was adjusted by adding
concentrated HCI and 40 mg NADP was added to the solution.
8.2.3.2. Buffer systems for electrophoresis of bacterial enzymes
8.2.3.2.1. Tris-Citrate buffer (pH 8.0) (electrode buffer)
For the preparation of 4 I buffer, Tris (332.8 g)(Sigma) and citric acid
monohydrate (132.36 g) (Sigma) were weighted and dissolved in 4 I distilled
water. The pH was adjusted to 8.0 with 1N NaOH.
8.2.3.2.2. Borate buffer (pH 8.1) (electrode buffer)
For the preparation of 4 I buffer, boric acid (74 g)(Merck) and NaOFl (9.6 g)
(Fluca) were dissolved in 4 I of distilled water and the pH was adjusted to 8.1
with 1N NaOH.
8.2.3.2.3. Lithium hydroxide buffer (pH 8.1) (electrode buffer)
For the preparation of 4 I buffer LiOH.H20 (4.8 g)(Sigma) and boric acid
(Merck)(47.56 g) were dissolved in 4 I of distilled water and the pH was
adjusted to 8.1 with 1N NaOH.
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8.2.3.2.4. Tris-Citrate buffer (pH 8.0) (gel buffer)
The buffer was prepared by diluting the tris-citrate buffer (8.2.3.2.1) in distilled
water in a 1:29 dilution (i.e. 100 ml of tris-citrate buffer was added to 2.9 L
distilled water).
8.2.3.2.5. Poulik -Tris-Citrate buffer (pH 8.7) (gel buffer)
For the preparation of 2 I buffer, Tris (18.42 g)(Sigma) and citric acid (Sigma)
monohydrate (2.1 g) were dissolved in 2 I of distilled water ; the pH was
adjusted to 8.7 with 1N NaOH.
8.2.3.2.6. Lithium hydroxide buffer (pH 8.3) (gel buffer)
For the preparation of 2 I buffer, Tris (11.16 g)(Sigma) and citric acid (2.88 g)
(Sigma) were dissolved in 1.8 I of distilled water. Lithium hydroxide buffer
(200 ml) (8.2.3.2.3.) was added and the pH was adjusted to 8.3 with 1N
NaOH.
The buffers used for the electrophoresis of the enzymes, electrode and gel
buffers, and the voltage used for each enzyme respectively are shown in
Table 8.2.
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8.2.3.3. Enzyme-staining solutions
The 14 enzymes examined were the following : aconitase (ACO); adenylate
kinase (ADK); isocitrate dehydrogenase (IDH); glutamate dehydrogenase
(GDH); malic enzyme (ME); glucose-6-phosphate dehydrogenase (G6P);
peptidase (PEP); alcohol dehydrogenase (ADH); alkaline phosphotase (ALK);
fumarase (FUM); idophenyl oxidase (IPO); unknown dehydrogenase (UDH)
8.2.3.3.1. Aconitase (ACO).
To detect the enzyme, 30 mg Cis-aconitic acid (Sigma A-3412) were added
to the following : 15 ml of 0.2 M Tris-HCI (pH 8.0); 10 ml of 0.1 M MgCI2; 1 ml
NADP; 0.1 ml isocitrate dehydrogenase; 0.5 ml PMS and 1.0 ml MTT.
For the above staining solution, an agar overlay was applied to the gel. The
agar was prepared by dissolving 500 mg agar (Oxoid) in 25 ml 0.2 M tris-HCI
(pH=8).
8.2.3.3.2. Adenylate Kinase (ADK)
For detection of the enzyme, 25 mg of ADP (Sigma), 100 mg glucose and 1
mg hexokinase (Sigma) were mixed in a 250 ml beaker.
When the gel was ready to be stained, 25 ml Tris-HCI (0.2 M; pH 8.0), 1 ml
MgCI2 (0.1 M ), 1 ml NADP (Sigma) and 1.5 ml G-6-PDH solution (10 units/ml,
(Sigma) were added. For staining, 0.6 ml PMS and 0.6 ml MTT were added.
For the above staining solution an agar overlay was applied to the gel. The
agar was prepared as in 8.2.3.3.1.
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8.2.3.3.3. Alcohol dehydrogenase (ADH)
For the detection of the enzyme, 50 ml Tris-HCI (0.2 M, pH 8.0) were mixed
with 3 ml ethanol (95%) and 2 ml isopropyl alcohol. When the gel was ready to
be stained, 2 ml NAD (Sigma), 0.5 ml PMS and 1.0 ml MTT were added.
8.2.3.3.4. Alkaline phosphatase (ALK)
To detect ALK, reagents were added to: 100 mg PVP (Polyvinyl-pyrolidase -
enzyme stabilizer) (Sigma); 50 mg (B-naphthyl acid phosphate; 1.0 g NaCI and
50 mg fast blue salt (FBS) (Sigma). For staining the gel, 50 ml Tris-HCI (0.2
M- pH 8.5); 2.0 ml MgCI2 (0.1 M) and 2.0 ml MnCI2 (0.1 M) were added to the
above reagents.
8.2.3.3.5. Fumarase (FUM)
To detect FUM, 50 mg of fumaric acid was added to the following: 50 ml Tris-
HCI (0.2 M- pH 8.0); 15 pi malic dehydrogenase (Sigma), 2.0 ml NAD (Sigma);
0.5 ml PMS and 1.0 ml MTT. The solution was mixed and added to the gel.
8.2.3.3.6. Glucose-6-phosphate dehydrogenase (G6P)
To detect G6P, 100 mg of Glucose-6-phosphate was added to : 50 ml Tris-
HCI (0.2 M- pH 8.0); 1 ml MgCI2 (0.1M); 1.0 ml NADP (Sigma); 0.5 ml PMS
and 1.0 ml MTT. The solution was mixed and added to the gel.
8.2.3.3.7. Glutamate dehydrogenase (GDH)
To detect GDH, 2.1 g of L-glutamic acid (Na salt) (Sigma) were dissolved in 20
ml phosphate buffer (pH 8.9), 30 ml H20 ; 2 ml NAD ; 1 ml NADP (Sigma);
0.5 ml PMS and 1.0 ml MTT. The solution was mixed and added to the gel.
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8.2.3.3.8. Indophenyl oxidase (IPO)
To detect IPO, 40 ml Tris-HCI (0.2M- pH 8.0) were mixed with 1.0 ml MgCI2
(0.1M); 0.5 ml PMS and 1.0 ml MTT were added to the above solution.
8.2.3.3.9. Isocitrate dehydrogenase (IDH)
To detect IDH, 50 ml Tris-HCI (0.2M - pH 8.0) were mixed with 2.0 mi isocitric
acid solution (0.1 M), 1.0 ml NADP and 2.0 ml MgCI2 (0.1 M). When the gel
was ready for staining, 0.5 ml PMS and 1.0 ml MTT were added to the above
solution.
8.2.3.3.10. Malic enzyme (ME)
To detect ME, 40 ml of Tris-HCI (0.2M - pH 8.0) were mixed with 6 ml D-L
malic acid (2M- pH 7.0); 1.5 ml NADP and 2.0 ml MgCI2 (0.1M). When the gel
was ready for staining, 0.5 ml PMS and 1.0 ml MTT were added to the above
solution.
8.2.3.3.11. Peptidase (PEP)
To detect PEP, 20 mg of peptidase-2 (L-phenylalanyl-L-leucine)(Sigma) was
mixed with 10 mg peroxidase (Sigma), 10 mg O-dianisidine di-HCI (Sigma)
and 10 mg snake venom (Sigma). When the gel was ready for staining, 25 ml
Tris-HCI (0.2M - pH 8.0) and 0.5 ml MnCI2 (0.25 M) were added and mixed
with the above reagents. In the above staining solution an agar overlay was
applied to the gel as described in 8.2.3.3.1.
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8.2.3.3.12. Unknown dehydrogenase (UDH)
For detection of the unknown dehydrogenase, the preparation is as described
for the enzyme Adenylate kinase (ADK) (8.2.3.3.2).
When the gel was ready to be stained, 25 ml Tris-HCI (0.2 M; pH 8.0), 1 ml
MgCI2 (0.1 M ), 1 ml NADP (Sigma) and 1.5 ml G-6-PDH solution (10 units/ml,
(Sigma) were added. For staining, 0.6 ml PMS and 0.6 ml MTT were added.
For the above staining solution an agar overlay was applied to the gel. The
agar was prepared as in 8.2.3.3.1.
8.2.4. Method
8.2.4.1. Protein extract preparation
To prepare the protein extracts, isolates were grown overnight at 37°C in 100
ml tryptic soy broth (TSB) (Difco). The bacteria were harvested by
centrifugation and the bacterial pellets were re-suspended by vortex mixing
with 1 ml buffer (0.01 M tris-HCI and 0.001 M EDTA, pH 6.8). The cells
were disrupted by freezing at -25°C for 48-72 h followed by thawing at room
temperature. The bacterial suspensions were then centrifuged at 27000 g
for 30 min at 4°C. The supernatants were sterilized by filtration and stored
at -70°C until used for electrophoresis.
8.2.4.2. Electrophoresis
An apparatus for horizontal starch-gel electrophoresis was used. Starch
gels over polyacrylamide gels were used because of the ease by which
horizontal slices can be cut for independent assays of several different
enzymes.
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To prepare a gel, a suspension of starch (48 g) (Connaught) in 420 ml of gel
buffer (Table 8.2.) in a 1 I Erlenmeyer flask was heated with constant
vigorous swirling over a Bunsen burner to boiling point. The suspension
was aspirated for 1 min. (or until every large bubble disappeared) and
immediately poured into a gel mold. After the gel had cooled at room
temperature for 2 h, it was wrapped in plastic film to prevent desiccation.
Gels were used within 24 hr of preparation.
In loading a gel, pieces of Whatman No 3 filter paper were individually
dipped into samples of lysate, blotted on filter paper to remove excess
liquid and then inserted at 3-mm intervals in a continuous slit cut in the gel.
Up to 20 lysates were tested on a single gel.
Pieces of filter paper dipped in Amaranth dye (Sigma) were inserted at one
or both ends of the slit to mark the migration front of the buffer line. During
electrophoresis, a constant voltage was maintained depending on the gel
(Table 8.2) and the gel was cooled by running it at 4° C surrounded by an
ice bath.
Following electrophoresis, three or four horizontal slices (1 to 2 mm thick)
were cut from the gel with a thin wire and incubated individually at 37°C in the
various enzyme staining solutions. For some enzymes (ADK, ACO and PEP),
the staining solution was applied to the gel in an agar overlay.
Gels were incubated at 37°C in the dark until bands appeared. For different
enzymes this can be from 10 min to several hours. The staining solution was
then poured off, the gel slice rinsed with tap water and fixed in a 1:5:5
mixture of acetic acid, methanol and water.
Isolates were characterized by the relative electrophoretic mobilities of
enzymes. Because the net electrostatic charge, and hence, the rate of
147
migration of a protein during electrophoresis was determined by its amino
acid sequence. Mobility variants (electromorphs or alloenzymes) of an
enzyme can be directly equated with alleles at the corresponding structural
gene locus. Electromorphs (alloenzymes) of each enzyme, numbered in order
of decreasing anodal mobility. Absence of the enzyme activity was attributed
to a null allele (denoted 0). Distinctive combinations of alleles over the 14
enzyme loci (multilocus genotypes) were designated as electrophoretic types,
ETs (Caugant et al., 1981). The electrophoretic mobilities of the enzymes
strains were compared with two reference strains with very different
electromorph combinations (ET-5 and ET-18). All isolates that differed from
the reference strains were next compared to each other, side by side on a gel
for all the enzymes assayed. Electromorphs were numbered in order of
decreasing anodal mobility and the combination of electromorphs at the 14
enzyme loci was determined for all isolates. Although the genes coding for
these enzymes have not been mapped on the chromosome of N. meningitidis,
it is assumed that the enzymes are coded by chromosomal genes and so
electromorphs were equated with alleles at each locus.
8.2.5. Statistical analysis
Genetic diversity at an enzyme locus among either ETs or isolates was
calculated from the allele frequencies among ETs or isolates as h= (1- Ixi2)
(n/n - 1), where Xi is the frequency of the /'-th allele and n is the number of ETs
or isolates (Selander et al., 1986). Mean genetic diversity (H) is the arithmetic
average of the h values for all of the loci. Genetic distance between pairs of
ETs was expressed as the proportion of enzyme loci at which dissimilar alleles
occurred (mismatches) and clustering of ETs was performed from a matrix of
genetic distances by the average-linkage method (Sneath et al., 1973). The
analysis of the genetic diversity and the relationships among bacterial strains




In the collection of 105 isolates, all the 14 enzyme loci were polymorphic for
from 3 to 11 alleles (Table 8.3). The average number of alleles per locus was
5.5 (Table 8.4).
A total of 63 distinctive genotypes were identified (Table 8.3) among which
mean genetic diversity per locus was 0.471. Eighteen ETs were represented
by multiple isolates (range 2 to 13). There was less genetic diversity among
the ETs of strains from patients in Greece than among the strains from
Romania and the carrier strains (Table 8.4). The number of ETs among each
group of strains is shown in Table 8.5. The patient strains from Greece were
much more homogeneous than the two other groups as reflected by the
relatively high ratio of isolates/ET, low mean number of alleles per locus and
low mean genetic diversity in both isolates and ETs.
The genetic relationships among the 63 ETs are shown in the dendogram
(Figure 8.1). Of the 63 ETs, 59 clustered together within a genetic distance of
0.5. The remaining four ETs, represented by a single isolate each, included
one strain from Romania and three strains from carriers in Greece. Only one
ET was represented by strains from both patients and carriers in Greece (ET-
26) and one ET was found in Greece and Romania (ET-5). There were 3
strains isolated in Romania of serogroup A (A:4,21:P1.10), 2 obtained from
patients in 1969 and the third from a patient in 1992. The 1969 isolates
belonged to the ET 51 complex, but the 1992 isolate differed at 4 different loci
compared with the earlier strains (Table 8.6).
ETs 9 through 12 represented clones of the cluster A4 and were exclusively
found among patients in Greece (19 of the 43 isolates). The ET-37 complex
was represented by two patient isolates from Greece, but by none of the
carrier strains or the Romanian strains. None of the isolates belonged to the
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ET-5 complex which has been an important source of disease in western
Europe.
8.4. Discussion
Genetic analysis of the Romanian and Greek strains by MLEE complemented
the results obtained for analysis of serogroups, serotypes and subtypes
(Chapters 5 and 7). Both phenotypically and genetically, the strains from
Greece and Romania differed from those causing disease in northwest
Europe. The monoclonal antibodies successfully used for typing of
meningococcal strains were not useful for isolates from eastern Europe.
Similar results have been reported for isolates from the Czech Republic; 50-
80% of Czech strains were non-typable [Musilek et al., 1994],
Since Romania and the Czech Republic were relatively closed populations
until 1989, it was predicted that the isolates in these countries might be
significantly different from those in western Europe. Greece, however, is a
major holiday destination for residents of northwest Europe and it was
predicted that some of the Greek strains, particularly those from areas where
there are large numbers of tourists might be similar to those found in other
parts of Europe. This was not the case; the Greek isolates were more like
those from Eastern European countries. The strains from Romania and
Greece were quite different genetically, both in degree of genetic diversity and
in their clonal composition. The clones associated with disease in western
Europe (e.g. ET-5, ET-37) (Caugant, 1994) were not present in isolates from
either Balkan country.
Although the three serogroup A isolates had similar serotype and subtype
characteristics, the strain obtained in 1992 differed at 4 different loci compared
J with those isolated in the 1960rs. This indicates that within this period there
have been changes within what appear to be homogenous clones of
meningococci.
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Analysis of the dendrogram has shown that only one ET was included in
strains from both patients and carriers in Greece. Only one ET was identified
in both Greece and Romania; both were serogroup B isolates from patients.
The ETs 9-12 represented clones of the cluster A4; and were found
exclusively among patients on Greece (19/43). ET 37 was represented by only
2 patient isolates from Greece; this was not found among the Greek carrier
strains or many of those from Romanian. None of the isolates were of the ET-
5 complex associated with disease in western Europe.
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Table 8.4. Genetic diversity in ETs of isolates of N. meningitidis from













ME 6 0.680 0.593 0.727
G6P 6 0.477 0.506 0.643
PEP 11 0.595 0.788 0.783
IDH 10 0.817 0.913 0.813
ACO 5 0.503 0.502 0.457
GD1 3 0.209 0.091 0.227
GD2 6 0.386 0.619 0.230
ADH 6 0.294 0.532 0.607
FUM 3 0.307 0.255 0.420
ALK 8 0.647 0.762 0.710
IP1 3 0.111 0.173 0.080
IP2 4 0.386 0.325 0.660
ADK 3 0.000 0.247 0.080
UDH 3 0.111 0.325 0.397
Mean 5.5 0.394 0.474 0.488
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Table 8.5. Genetic diversity in isolates and ETs of N. meningitidis
from patients and carriers in Greece and from Romania
Strains from Greece Strains from
Romania
patients carriers
No of isolates 43 34 28
No of ETs 18 22 25
Ratio isolates / ET 2.39 1.54 1.12
Mean No of alleles 2.93 4.21 4.14
Mean H in isolates 3.17 4.17 4.80
Mean H in ETs 0.394 0.474 0.488
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Figure 8.1. Genetic relationships among the 63 ETs of N. meningitidis
isolates from patients and carriers from Greece and Romania
Genetic distance
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9. General discussion
In this thesis several aspects of the epidemiology of meningococcal disease
in Greece have been addressed. The core theme was to assess the
various characteristics of meningococci isolated from patients and carriers,
as well as the factors that affect the carriage in closed populations such as
recruit camps and in primary and secondary school children. The ultimate
goal was to provide information which could assist the Ministry of Health in
formulation of policies to prevent meningococcal disease.
The original objectives of the study were to answer the following questions
1. Are genetic and environmental factors associated with carriage among
Greek children and young adults similar to those found in northwest
Europe?
2. Are strains with serogroups, serotypes and subtypes associated with
disease in north west Europe isolated from patients and carriers in Greece?
3. Are the antibiotic sensitivities of meningococci isolated from patients and
carriers in Greece similar to those observed in northwest Europe?
4. Are the genetic clones associated with disease in northwest Europe present
among meningococcal strains in Greece and other Balkan countries?
9.1. Factors affecting meningococcal carriage
The major findings of each of these factors which affect meningococcal
carriage is summarized below (Table 9.1) with reference to information
obtained from other countries:
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Secretor status - -
1N.A. : Not Applicable
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9.1.1. Smoking
Among recruits, active smoking was found to be an important factor
affecting meningococcal carriage in both univariate and multivariate
analyses and the carriage rate increased in relation to cigarette consumption.
This is in agreement with other studies which suggest that the higher
proportion of smokers and heavy smokers among military personnel might
contribute to the increased prevalence of meningococcal disease and to
higher rates of carriage among military recruits (Crowdy 1981).
The percentage of smokers in the two camps investigated in the present
study, were 57.7% and 63.4%, much higher than the 47% found in a
previous study among male Greek patients referred for gastroscopy (Mentis
et ai, 1990). It has been established that in Britain, smoking is associated
with socio-economic status; unskilled individuals are more likely to smoke
than those in professional groups (Wald et at., 1988). A similar pattern was
observed among the recruits; those with fewer years of education were more
likely to be smokers.
9.1.2. Passive exposure to smoke.
In the study of schoolchildren, it was noted that for the fathers in this study,
there was a positive correlation between educational level and smoking
similar to that observed and the Greek military recruits. For Greek women,
33-38% were smokers regardless of socioeconomic background. There were
significantly more men who were smokers in area A where educational levels
were lower, but carriage was not associated with father's smoking by either
univariate or multivariate analysis. Carriage was associated with maternal
smoking or smoking by other members of the household. The structure of
many Greek families in which grandparents often live with families with young
children and are closely involved with child care, might be the reason for the
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significant association between meningococcal carriage and smoking by
adults. If maternal smoking is a significant risk factor these observations help
to explain the lack of association between carriage and socioeconomic
background as discussed below.
9.1.3. Age
Multiple logistic regression analysis identified the 15-19 year age range to be
a significant variable. This agrees with the findings in the Stonehouse survey
in which the highest proportion of carriers was found in this age group
(Cartwright et al., 1987). Although the carriage rate was higher among the
recruits (25%) compared to that found among the schoolchildren (5-8%),
the majority of patients in this study and those reported to the Ministry of
Health were less than 5 years of age. This is probably associated immunity to
the meningococcus acquired by repeated colonization of both pathogenic
and non-pathogenic Neisseria spp (Goldschneider 1969a).
9.1.4. Sex and meningococcal carriage
In the Stonehouse study (Cartwright et al., 1987) and in the Faroe Islands
(Olsen et al., 1991), there was a higher proportion of males among carriers,
but this was not observed among children in a Scottish study (Blackwell et al.,
1990a) or among Greek schoolchildren. It was suggested that the similar
proportion of males and females among Scottish children who were carriers
might be due to the significantly higher proportion of girls who were smokers
(Blackwell et al., 1990a; Moore et al., 1990); however, the proportion of Greek
boys who smoked was slightly higher than that of girls who smoked.
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9.1.5. Viral infection.
Another important factor proposed to enhance meningococcal carriage is viral
infections. Parental smoking, particularly smoking by the mother, has been
associated with upper and lower respiratory infection (Fleming et al., 1987) as
well as with impairment of ventilatory function (Pederira et al., 1985; Tager et
al., 1983). If the mother's smoking is a significant factor contributing to
carriage among children, this might explain the similar carriage rates for the
two areas of Athens compared in this study.
There is evidence that viral infections can predispose individuals to
carriage of potentially pathogenic bacteria (Musher et al., 1981) In an
experimental model with a human epithelial cell line, infection with RSV was
found to enhance binding of meningococci (Raza et al., 1994).
In the recruit study carried out during July when there was a low prevalence
of upper respiratory viral infections (19.8%), there was no association
between symptoms of viral infection and carriage. During the study of
schoolchildren carried out in the winter there was a higher proportion of
participants with symptoms of virus infections (33%), but there was no
association with carriage. These results indicate that viral infection in
general might not lead to enhanced carriage of meningococci. Alternatively,
the association noted between meningococcal disease and influenza infection,
might be due to impaired immunological responses associated with influenza
(Jakab, 1982).
9.1.6. Lower socio-economic conditions.
In a longitudinal survey in Belgium (de Wals et al., 1983), carriage rate was
greater in the area where socio-economic indicators were lower. In the recruit
study, it was found that lower socio-economic conditions might influence
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meningococcal carriage in relation to smoking and age as recruits from less
well educated families were more likely to do their military service early. While
there was good agreement between the two indicators used to assess socio¬
economic levels, there was little difference in carriage rates among
schoolchildren in the two areas of Athens with significantly different
socioeconomic backgrounds.
9.1.7. Secretor status
A previous study of staff and pupils in a Scottish secondary school following
an outbreak of meningitis found an association between non-secretion and
carriage of meningococci (Blackwell et at., 1990a). There was no association
between secretor status and carriage in the studies of recruits or
schoolchildren. The studies on phenotypic and genotypic characteristics of
the Greek isolates indicate that they differ significantly from those in the
Scottish population.
When the results were analyzed according to the geographic area, it was
found that a significally higher proportion of recruits from Eastern
Macedonia were non-secretors. The above findings, are in agreement with
the annual reports from the Ministry of Health showing that meningococcal
disease is more prevalent in the region of Macedonia. Further studies are
needed to confirm these observations.
9.2. Phenotypic characteristics of meningococcal strains in Greece.
Another objective of the study was to determine if the serotype and subtype
reagents used for epidemiological studies in northern Europe and the
Americas could be used in epidemiological studies in Greece and other
Balkan countries, and if the serotype and subtype combinations associated
with disease in other populations were found in southeast Europe. The
proportion of non-serotypable isolates from Greek recruits (69%), and
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school children (64%) and isolates from Romania (54.8%) was greater than
the proportion of non-serotypable isolates obtained from Norwegian recruits
(28%) (Wedege et al., 1990) or Scottish school children (22%). This
indicates that other serotype reagents need to be developed for
epidemiological studies of meningococci from Greece as well as from the
Balkan. The serotypes associated with recent outbreaks in Britain and
Scandinavia are uncommon in Greece and Romania.
The proportion of isolates from the Greek recruits (36%) and school children
(26%) and Romanian isolates (20%) that did not react with any of the subtype
reagents was slightly lower than that of isolates from the Norwegian
recruits (39%) (Wedege et al., 1990) and from Scottish school children
(38%). The subtype reagents appear to be useful for studies of Greek and
Romanian strains however, the proportions of subtypes associated with
outbreaks in northern Europe were lower.
Combinations of serotype and subtype antigens 15: P1.16, 4:P1.15 and
2a:P1.2 associated with outbreaks in northern Europe (Poolman et al., 1988,
Abdillahi et al., 1988) were not found among any of the isolates in this study.
Although P1.2 was the most common subtype found in the study there was
only one patient isolate with this type, C:2b: P1.2. In contrast, the 2a:P1.2
and 2b:P1.2 combinations are found frequently among Scottish group C
(Fallon et al., 1991) and French serogroup B isolates, and 2a:P1.2 is found
frequently among French serogroup C isolates (Riou et al., 1989). The only
report of meningococcal serotypes from southeast Europe is that of the C:2a
phenotype associated with disease in Italy (Mastrantonio et al., 1990). None
of the serogroup C isolates expressed this serotype from both studies.
The third objective was to determine if there were antigenic phenotypes
associated with different areas of Greece, e.g., those in which there are
large numbers of foreign tourists or foreign military personnel or areas such
as the northeast were there is a significant Muslim population some of
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whom might have visited Saudi Arabia. There was no unusual distribution
of serogroups or serotypes in the different regions of Greece.
The results obtained from this study on strains isolated from patients and
carriers in Greece and Romania and a report from the Czech Republic
(Musilek et at., 1994) indicate other serotype reagents need to be
developed for epidemiological studies of meningococci in central and eastern
Europe. Antigenic phenotypes associated with recent outbreaks in Britain and
Scandinavia are uncommon in Greece and Romania.
Genotype analysis confirmed phenotypic analysis, as none of the isolates
from either Greece or Romania belonged to the ET-5 complex associated with
disease in northern Europe. In contrast, the majority of these strains belonged
to a group of clones designated as cluster A4 which was associated with
disease in several European countries in the 1970s but it has not been a
major cause of disease recently in other parts of Europe.
9.3. Antibiotic sensitivities of meningococcal strains in Greece
In Britain, the proportion of penicillin insensitive isolates from patients and
carriers was about 3% (Sutcliffe 1988). In Greece, 46% of patient isolates
were penicillin insensitive similar to the figures reported from Spain. Since the
antibiotic policies of Spain and Greece are similar, these observations were
not unexpected. The proportion of Romanian penicillin insensitive isolates
(20%), an intermediate value between those from Britain and southern
Europe, might reflect recent changes in antibiotic policy related to political
changes. This difference between the percentage of penicillin-insensitive
strains in Romania and Greece might be due to differences in antibiotic
policies in the two countries. There were strict policies on the use of
antibiotics in all Eastern European countries prior to the break up of the Soviet
Union (F. Mihalcu and P. Kriz, personal communications).
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Although penicillinase-producing isolates of N. gonorrhoeae are not
uncommon in Greece (18%) (Tzanakaki et al., 1989), none of the 550
meningococcal isolates tested produced beta-lactamase.
Sulphonamide resistance has been associated with strains causing
outbreaks of meningococcal disease in northern Europe (Cartwright et al.,
1987; Poolman et al., 1986), but only 16% of the isolates from Greek patients
had MIC> 10 mg/l of sulphamethoxazole while the majority of the Romanian
strains were sulphonamide resistant (66.6%).
Among carrier isolates, 6-7% were resistant to rifampicin. This increase might
be due to rifampicin treatment of tuberculosis in the community; however,
there were no significant associations between resistant strains and
socioeconomic background. Strains of rifampicin resistant (Rif*)
meningococci have been recovered from recipients of the drug (Blackwell et
al., 1990a; Yagupsky, 1993); and these strains can cause systematic
disease (Yagupsky, 1993). Recent studies in the United Kingdom have
shown that a single clone of (Rif*) N. meningitidis widespread throughout the
United Kingdom is due to a single mutation (Carter et al., 1994). The spread
of (RifR) meningococcal strains may pose serious problems in the
management of the meningococcal infections.
Significant development of rifampicin resistance might require an alteration in
public health policy regarding control of secondary cases similar to that used
by the Scandinavians in which close contacts are given penicillin to prevent
disease rather than rifampicin to eliminate carriage.
Although high level tetracycline resistance mediated by a plasmid carrying
the tetM determinant has been found in meningococci (Knapp et al., 1988)
none of the Greek or Romanian isolates had MIC>8 and the 25.2 megadalton
plasmid was not observed in any of the strains examined so far. Strains were
sent to Dr. M. Roberts of the University of Washington for analysis of the
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chromosomal tetM. The gene was not identified in any of these strains ( Dr.
M. Roberts, personal communication).
The higher levels of resistance to erythromycin among isolates from Greek
carriers might reflect longer exposure to the antibiotic, as the mean ages
of the carriers are higher, school-children (12.8 years) and recruits (19.7
years) compared with a mean age of 2.7 years for patients with meningitis.
If N. meningitidis follows the course of N. gonorrhoeae and Streptococcus
pneunoniae, the prevalence and magnitude of penicillin resistance
among meningococci will increase worldwide over the next decade (Saez-
Nieto et al., 1992; Tan et at., 1992). Countries with less stringent antibiotic
policies have high prevalence of penicillin-insensitive strains already. The
high level tetracycline resistant (MIC>16 mg/l) oropharyngeal, genital and
anorectal isolates carrying the tet-M conjugative plasmid have been described
in the past (Ison et al., 1988; Knapp et al., 1988, Spott et al., 1988;
Winterscheid et al., 1994). The role of N. gonorrhoeae as a possible
reservoir for the mobilization of resistance plasmids into N. meningitidis
has been suggested (Roberts et al., 1988).
The high percentage of resistance to antibiotics comes as no surprise if one
considers that in Greece, antibiotics can be bought without a medical
prescription. The numbers are quite alarming indicating that antibiotic
policies in Greece, have to be more seriously considered by the Ministry of
Health and new strict legislation introduced.
9.5. Major contribution of the present work and further studies.
1. The study on the recruits has provided further evidence that active
smoking is a risk factor for meningococcal carriage.
2. The results obtained from the epidemiological studies (recruits and
schoolchildren) showed that viral upper respiratory tract infection in general
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is not a predisposing factor for colonization and that perhaps specific viral
infections {e.g., RSV and influenza) needed to be investigated.
3. Low socio-economic factors are not associated with carriage in Greek
school children but with smoking habits of members of the house closely
involved in child care in Greece.
4. The studies on meningococcal strains isolated from patients in Greece and
Romania were the first to identify significant differences between
meningococcal strains isolated in northwest and southeast European
countries. These results have also shown that there is a need to develop
new reagents for further epidemiological work. This might have important
consequences for the future development of vaccines against serogroup
B since major efforts are directed towards further development vaccines
based on the serotype/ subtype antigens.
5. The identification of increased levels of penicillin insensitive isolates (46%)
in Greece probably reflects the lack of control of antibiotic usage. The
intermediate values of 20% for Romania might reflect changes in
prescribing patterns or availability of antibiotics following political changes
since 1989.
6. This work provided a major basis for monitoring meningococcal disease in
Greece and in other Balkan countries and resulted in the establishment of a
National Meningococcal Reference Laboratory at the National School of
Public Health.
The systematic collection of data on the issues mentioned above, has
provided the basis for monitoring meningococcal disease in Greece and
provision of information to the Ministry of Health which can be used to
formulate policies for prevention of meningococcal disease.
Future work includes:
1. monitoring of antibiotic resistance especially to penicillin and rifampicin;
2. the development of new typing reagents;
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3. assessment of immigrant populations for carriage and factors associated
with carriage;
4. regional studies on carriage in regions such as Macedonia and Epirus with
reference to influx of Albanian;
5. the assessment of bactericidal activities to Albanian strains in sera collected
during the summer 1990 and winter 1991 surveys, after the increase of
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SUMMARY
Greek military recruits (993) were examined for carriage ofmeningococci during
July 1990. Blood, saliva and throat swab specimens were obtained and each
recruit answered a questionnaire providing information on age, education (a
measure of socioeconomic level), place of residence, smoking habits and recent
infections.
The overall carriage rate was 25% but differed between the two camps: 79/432
(18%) in Camp A and 168/561 (30%) in Camp B (P < 0-0005). In Camp B, there
were significantly higher proportions of recruits who were non-secretors
(P < 0-0005), and/or heavy smokers {P < 0-0005). They were also younger (< 19
years old) (P < 0-001), and on the whole had fewer years of education (P < 0-0005).
By univariate analysis, carriage was significantly associated with smoking. By
multiple logistic regression analysis, carriage was associated with smoking
(P < 0-001), age (P<0-01) and the camp in which the recruits were based
{P < 0-01). Among recruits in Camp B, 15/38 (40%) of those with recent viral
infections were carriers compared with 30% for the camp in general.
INTRODUCTION
Following the epidemic of meningitis during the 1960s, the incidence of
meningococcal disease in Greece declined steadily until 1988. Since 1988, the
number of cases reported to the Ministry of Health has increased; in the first 6
months of 1990, there were 102 cases compared with 87 for all of 1989 (Table 1).
This apparent increase in disease due to Neisseria meningitidis prompted the
present work as the last study of meningococcal carriage in a Greek population
was carried out before elucidation of some of the genetic and environmental
factors affecting carriage [1],
Epidemiological studies have shown that non-secretors, individuals incapable of
secreting the glycoprotein form of their ABO blood group antigens, are
significantly over-represented among patients with meningococcal disease [2, 3]
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Table 1. Incidence of meningococcal disease in Greece
Deaths
Year No. cases no. (%)
19(38 1064 48 (4-5)
1973 765 39(5-1)
1978 286 18 (6-3)
1983 102 9 (8-8)
1985 105 6 (5-7)
198(3 88 7 (7-9)
1987 85 4 (4-7)
1988 76 2 (2-6)
1989 87 (3 (6-9)
1990 102
(1st 6 months)
and among carriers in a school population [4J. Prolonged outbreaks have occurred
in countries such as Iceland and in areas of Britain [5, 6] where the proportion ol
non-secretors is significantly higher than the proportion (20-25%) predicted for
European populations [7],
Environmental factors have also been suggested as playing a role in
susceptibility to meningococcal disease [8. 9] or carriage of the bacteria. Smoking
or passive exposure to cigarette smoke has been associated with isolation ol
Neisseria meningitidis from healthy asymptomatic adults and teenagers [4, 10J.
Virus infections have been suggested as predisposing factors for susceptibility to
meningococcal disease [11] and to carriage of potentially pathogenic bacteria [ 12],
In the study reported here we wished to determine: (1) if isolation oi
meningococci was associated with non-secretion in the populations examined ; (2)
if smoking was associated with carriage in a closed population; (3) if an uppei
respiratory tract or other infection might be a factor contributing to carriage ol
meningococci; (4) if there might be geographical regions in Greece in which there
are higher proportions of non-secretors and if the prevalence of meningococcal
disease was increased in these areas.
SUBJECTS AND METHODS
Greek military recruits (993) from two camps, one at Athens and another at
Avlona. were examined for carriage of meningococci during the third week of .Jul\
1990. Ethical permission for the study was granted by the Ministry of Defence. An
explanation of the purpose of the study and the specimens required was part of the
questionnaire and each subject signed his consent to participate in the study. The
recruits came from all regions of Greece except the Ionian islands, and hael been
in the camps from 3 to 5 elays at the time of the study. Throat swabs, blood anel
saliva specimens were obtained. Throat swabbing was carried out by the same foui
members of the team on both occasions (C.C.B., G.T.. A. M.. 1). M.W.). Blood was
not obtained from a number of recruits who fainted because of the unusually high
temperature (41 °C). Each recruit filled in a questionnaire providing information
on age, occupation, educat ion level, places of residence and birth, smoking habits
and recent infections. A member of the research team cheeked the form to ensure
all categories had been completed and to answer any questions. This informatior
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and results of laboratory examinations were coded for confidentiality and stored
in a Database 3 plus data base. The information on the data base was recalled and
checked with the original questionnaire.
ABO blood group was determined by slide agglutination with monoclonal anti-
A and anti-B antibodies (Scottish National Blood Transfusion Service); Lewis
blood group was determined by tube agglutination with monoclonal anti-Lewisa
(Lea) and anti-Lewis6 antibodies (Scottish National Blood Transfusion Service).
Non-secretors can express only Lea, but secretors express Leb. The blood
specimens were centrifuged on the day of collection and the plasma stored at
-20 °C.
Throat swabs were plated directly onto modified New York City medium [13]
and incubated for 48 h. Colonies were examined for oxidase production, Gram
stain and carbohydrate utilization.
Two-way frequency tables were analysed by y2 tests with Yates' correction in
the case of 2x2 tables. Multiple logistical regression was used to examine the
association between carriage rates and other factors adjusted for each other.
RESULTS
Isolation of N. meningitidis
N. meningitidis was isolated from 247 (25%) of the 993 recruits examined. The
carriage rate differed significantly between the two camps. There were 79 isolates
obtained from 432 recruits (18%) in the camp at Athens compared with 168 from
the 561 (30%) at Avlona (y2 = 17-54; P < 0-0005).
Characteristics of the two populations
Distribution of ABO and Lewis blood group phenotypes
There was no difference in the distribution of the ABO blood groups between the
two camps. Among the recruits who expressed Lewis antigen, there was a
significantly higher proportion of Lea/non-secretors in the camp at Avlona,
140/534 (26%), compared with that in the camp at Athens. 60/390 (15%)
(y2 = 14-96. P < 0 0005).
Age and education
The ages of the two populations differed significantly. The median age was 19
for both camps: however, there was a higher proportion of recruits under 19 in the
camp at Avlona (4%) than in that at Athens (1 %) (y2 = 12*96. P < 0-001).
There was also a significant difference in the level of education of the recruits in
the two camps, particularly at the two extremes. Among the recruits at Avlona
14% had only 6 years of schooling compared with 7% among those at Athens;
and. only 2% of the recruits at Avlona had attended university while 7 % of those
at Athens had done so (y2 = 30 32, df = 4, P < 0-0005).
Smoking
There was no significant difference between the proportion of smokers in the
Athens camp (62%) and in Avlona (68%); but there were significantly more
heavy smokers (> 30 cigarettes a day) in Avlona (y2 = 27-64, df = 4. P < 0-0005)
(Table 2).
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Table 2. Cigarette consumption in the two recruit groups
Athens Avlona
(n = 431) (n = 560)
cigarettes/day No. (%) No. (%)
0 166 (38) 182 (32)
1-10 53 (12) 63 (11)
11-20 127 (29) 133 (24)
21-30 62 (14) 96 (17)
> 30 23 (5) 86 (15)
Table 3. Carriage rates and cigarette consumption
cigarettes/ Carriers Non-carriers
day Total no. (%) no. (%)
0 355 56 (16) 299 (84)
1-10 116 29 (25) 87 (75)
11-20 260 66 (25) 194 (75)
21-30 157 44 (28) 113 (72)
> 30 109 40 (37) 69 (63)
Prevalence of other infectious diseases
Only 59 of the recruits reported symptoms of upper respiratory tract infections
(URTI) within the previous 2 weeks, 21 of the 432 at Athens (4-9%) and 38 of the
561 (6'7%) at Avlona.
Factors associated with carriage of meningococci
There was no difference in the proportions of carriers among the four ABO blood
groups. The proportion of carriers among Lea/non-secretors (22% at Athens, 32%
at Avlona) was higher than that among Leb/secretors (17% at Athens, 30% at
Avlona), but the difference was not significant.
The proportion of carriers was significantly higher among smokers and was
greatest among those smoking more than 30 cigarettes per day (Table 3)
(y2 = 23-19, df = 4, P < 0-0005). Although the proportion of carriers was
significantly increased among smokers in both camps (Athens, y2 = 5-42, df = 1,
P < 0-05; Avlona y2 = 9-05, df = 1, P < 0 01), when the data for carriers were
analysed by y2 test, there was no significant difference between the two camps
associated with numbers of cigarettes per day (y2 = 9-482, df = 4, P > 0-05)
(Table 4).
Meningococci were isolated from 17 (29%) of the 59 recruits who had symptoms
ofURTI, 2 of the 21 (9-5%) at Athens and 15 of the 38 (39-5%) at Avlona. Among
the 15 at Avlona from whom meningococci were isolated, 6 (40%) were Lea/non-
secretors compared with 4 (20%) Lea/non-secretors among the 20 with recent
symptoms of URTI but from whom no meningococci were isolated. The numbers
of recruits with symptoms of URTI were too small for statistical analysis.
Multiple logistic regression analysis identified three main factors which were
significantly associated with carriage: smoking (P < 0-001); age less than 19 years
(P < 0-01) and the camp in which the recruits were based (P < 0-01). Various
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Table 4. Smoking patterns and carriage of N. meningitidis in the two camps
Athens (n
A
= 431) Avlona (n
A
= 560)
No. cigarettes/ Total Carriers Total Carriers
day No. (%) No. (%) No. (%) No. (%)
0 166 (38) 20 (27) 182 (32) 36 (22-5)
1-10 53 (12) 10 (13) 63 (11) 19 (12)
11-20 127 (29) 26 (35) 133 (24) 40 (25)
21-30 62 (14) 15 (20) 96 (17) 29 (18)
> 30 23 (5) 4(15) 86 (15) 36 (22-5)
Total 431 75 560 160
combinations of categories were tested for difference in carriage rate when
adjusted for these three factors but no other variables were found to be significant.
Regional variations in ABO and Lewis blood group antigens
There was no difference in the distribution of the ABO blood groups in the two
major population centres, Athens and Eastern Macedonia. There was, however, a
significantly higher proportion of Lea/non-secretors, 54/183 (29-5%) among the
recruits from Eastern Macedonia compared with those from Athens, 35/235
(15%) (x2 = 12-25, P < 0-0005).
DISCUSSION
As expected, compared with carriage rates reported for civilian populations
(5-8% for Greek secondary school children), there was a higher proportion of
carriers (25%) among the recruits examined in this study. This figure is similar to
that found for a British military establishment (23%) [14] but slightly lower than
that found in the 1970s for Greek military recruits (33%) [1]. The significant
difference in the proportion of carriers between the two camps, 18% at Athens
compared with 30% at Avlona (P < 0-0005), was not anticipated.
Smoking [4, 10], passive exposure to cigarette smoke [10], secretor status [4]
and age [15] have all been reported to be associated with carriage ofmeningococci.
The distribution of the ABO blood group phenotypes did not differ between the
two camps and were similar to those we found in a previous study [16] and that
reported by Hirzfeld and Hirzfeld in 1919 [17]. Several of the factors examined in
the study varied between the two camps. Compared with the recruits at Athens,
among those at Avlona where there was a significantly higher proportion of
carriers of meningococci, there were significantly more heavy smokers, non-
secretors, younger recruits (less than 19 years old), and recruits of lower
socieconomic groups as assessed by years of education.
Smoking was the factor most strongly associated with carriage in both
univariate and multivariate analyses. It has been suggested that the higher
proportion of smokers and heavy smokers among military personnel [18] might
contribute to the increased prevalence of meningococcal disease and the higher
rates of carriage among military recruits. The proportions of smokers in the two
camps, 62 and 68%, were higher than the 47% found in a previous study among
Greek male patients referred for gastroscopy [15]. In Britain smoking is associated
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with socioeconomic status; unskilled individuals are more likely to smoke than
those in professional groups [19]. A similar pattern was observed among the
recruits; those with fewer years of education were more likely to be smokers.
In a previous study of teachers and pupils in a Scottish secondary school
following an outbreak of meningitis, we found an association between non-
secretion and carriage of meningococci [4], In the present study, in both camps,
the proportions of non-secretors were increased among carriers; but, these
differences were not significant compared with the secretors among carriers.
Assessment of both host and parasite characteristics might elucidate the
differences in association with secretor status. The majority (35-5%) of serotypable
strains among the 121 isolates in the Scottish study were serotype 4; and 55% of
the carriers of this serotype were non-secretors. Only 9 (T8%) isolates in the
present study were serotype 4. but 37-5% of the carriers were non-secretors. The
proportion of non-secretors among carriers of serotype 14 isolates was 25 and 22%
for the Scottish and Greek populations. A similar pattern was observed for non-
serotypable isolates.
The multiple logistic regression analysis identified age (those less than 19 years
of age) to be a significant variable (P < OOl). This agrees with the findings for
carriers in the Stonehouse survey. The highest proportion of carriers was found in
the 15-19 year age group [15].
There is evidence that viral infections can predispose individuals to carriage of
potentially pathogenic bacteria [12]; and binding of streptococci and staphy¬
lococci to cell surfaces is enhanced in experimental models examining infection
with influenza virus [20, 21], The present study was carried out in July when there
is a low prevalence of upper respiratory viral infections; however, of the 59
recruits with symptoms of virus infection, 29% were carriers. This was particularly
apparent among recruits at Avlona where the carriage rate was 30% overall but
nearly 40% among those with virus infections. In a recent study, a higher
proportion of patients with meningococcal disease had a history of flu-like illness
than age- and sex-matched controls; however, the differences were not statistically
significant [22]. A second study of recruits was undertaken in January 1991 to
assess carriage when viral infections are more prevalent; the analysis of this study
is not complete at present.
In two areas of Britain where there have been prolonged outbreaks of
meningococcal disease, the proportions of non-secretors have been reported to be
higher than the 20-25% predicted for European populations [5, 6], In this study
we found a significantly higher proportion of recruits from Eastern Macedonia
were non-secretors (29-5%) compared with the other major centre of population,
Athens (15-3%). As there are anecdotal reports that meningococcal disease is more
prevalent in Macedonia, the numbers of cases reported to the Ministry of Health
from these two areas is now being closely monitored.
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SUMMARY
Usage of antibiotics in southern Europe is less well regulated than in northern
countries. The proportion (48%) of meningococci in Spain insensitive to penicillin
MIC ^ 01 mg/1) prompted this investigation of antibiotic sensitivities of isolates
?rom Greek patients with meningitis (31) and carriers (47 school-children and 472
•ecruits). The agar dilution method was used to determine MIC to penicillin G
PN), sulphamethoxazole (SU), rifampicin (RE), cefaclor (CF) and ciprofloxacin
CP).
The proportion of isolates insensitive to PN was 48% for isolates from patients,
19% from school-children and 36-6% from recruits. Resistance to SU
MIC ^ 16 mg/1) was found in 16% of those from patients, 10-6% from children
md 40% from recruits. None of the isolates from patients was resistant to RE
^ 1 mg/1) but 6% of those from carriers were. Resistance to CF (^ 4 mg/1) was
"ound in 9-2% of patient isolates, 6-4% from children and 23-7 % from recruits. All
solates except one were sensitive to CP (MIC range < 0-0015 —0-125 mg/1).
Resistances to PN, SU and RF were analysed by serogroup, serotype and
lubtype of the bacteria. The proportion of resistant isolates showed some
variation between different areas of Greece, but it was not statistically significant.
INTRODUCTION
As part of the surveys of isolates of meningococci from patients and carriers in
Ireece, the antibiotic sensitivities of these bacteria to some common antibiotics
vere determined. There are reports of Neisseria meningitidis with reduced
ensitivity to penicillin isolated from patients in Spain [1, 2], South Africa [3], and
he United Kingdom [4, 5], A small proportion of these penicillin-insensitive
solates has also been found among those obtained from carriers in the United
xingdom [4]. In view of the increasing prevalence of penicillin-insensitive isolates
* Author for correspondence.
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in Spain and the similar antibiotic policies of both Spain and Greece, it was
predicted that there might be significant numbers ofGreek isolates with decreased
sensitivity to penicillin and other antibiotics.
The objectives of the study were: (1) to compare levels of sensitivities foi
isolates obtained from patients with those obtained from carriers; (2) to determine
if the proportion of penicillin-insensitive isolates is comparable to that reported
for Spain : (3) to assess the distribution of resistant isolates in the different regions
of Greece; (4) to determine if antibiotic resistances are associated with particulai
serogroups, serotypes or subtypes.
ISOLATES
Meningitis cases
Thirty-one isolates from children aged 1 month to 11 years were provided by the
microbiology laboratory of the 'Aglia Kyriakou' Paediatric Hospital. All cases
were sporadic and occurred during 1989-91.
Carriers
Four hundred and seventy-two isolates were obtained during 1990-1 froir
healthy recruits aged 16-31 years [6J and a further 47 from children aged 6-l£
years who did not have meningococcal disease.
METHODS
Antibiotic sensitivities to penicillin (PN), erythromycin (ER), tetracycline (TC)
sulphamethoxazole (SG), rifampicin (RF), cefaclor (CF) and ciprofloxacin (CP
were determined by the agar dilution method. A range of twofold dilutions fron
256 to 0 015 mg/1 of each antibiotic in Mueller Hinton medium was examined. Th<
breakpoints used for penicillin 0T25 mg/1), tetracycline 1 mg/1), erythro
mycin (^0-5 mg/1), rifampicin mg/1), ciprofloxacin (^ 1 mg/1) and the
cephalosporin cefaclor (^4 mg/1) were based on those recommended by th(
working party of the British Society for Antimicrobial Chemotherapy foi
Branhamella catarrhalis and Haemophilus influenzae [7]. The break point o:
A 10 mg/1 for sulphamethoxazole (SU) was that used by the Neisseria Reference
Laboratory (Scotland) [Dr R.J.Fallon, personal communication]. Beta
lactamase production was assessed during the rapid carbohydrate fermentatior
test for identification of each isolate [8].
Serogroup was determined by slide agglutination with commercially available
antisera (Wellcome Diagnostics); serotype and subtype were determined by whole
cell enzyme-linked immunosorbent assays with monoclonal antibodies from I)i
J. T. Poolman (RLVM Bilthoven, The Netherlands) [9].
RESULTS
Table 1 compares the proportion of resistant isolates among the three groups
examined. Among 31 isolates obtained from children with meningococcal disease
none was resistant to rifampicin or ciprofloxacin. Nearly half the isolates wen
penicillin-insensitive (48-3%) and all grew on I or 2 mg/1 tetracycline.
Among the 47 isolates from school-children the pattern of resistance t(
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(m = 31) (n — 47) (n = 472)
Penicillin G 48-3 19 1 36-7
Sulphamethoxazole 16 1 10-6 35-6
Rifampicin — 6-4 7
Tetracycline 100 6-4 91
Erythromycin 25-8 617 82-2
Cefaclor 9-7 6-4 23-7
Ciprofloxacin — — 0-2
ciprofloxacin, cefaclor and sulphamethoxazole was similar to that of isolates from
patients. The proportion resistant to erythromycin (617%) was over twice that
among isolates from patients (25-8%) (y2 = 8-27, df = 1, P = < 0-005); and there
were some rifampicin resistant strains (6-4%). Compared with the isolates from
patients, the proportion resistant to tetracycline was much less (6-4%) (y2 = 62-83,
df = 1, P = < 0-0005) as was the proportion with decreased sensitivity to
penicillin (19-1 %) (y2 = 7-61, df = 1, P = < 0-01).
The proportions of 472 isolates from recruits resistant to tetracycline or
penicillin were similar to those of isolates from patients. The proportions of
isolates from recruits resistant to erythromycin or to rifampicin were similar to
that for isolates from children who were carriers. Compared with the other two
groups, there was a higher proportion of isolates from recruits resistant to
sulphamethoxazole and cefaclor. There were 112 isolates (23-7%) with
MIC ^ 4 mg/1 cefaclor and 32 isolates (6-8%) with MIC ^ 8 mg/1. Of the latter 32
isolates, 27 (84%) had decreased sensitivity to penicillin. There was one isolate
with MIC ^ 1 mg/1 ciprofloxacin. None of the 550 isolates from patients and
carriers produced beta-lactamase.
Geographical distribution of resistant isolates
In the two major population centres, Eastern Macedonia and Athens, the
proportions of penicillin-insensitive isolates were 33 and 40% respectively. The
highest proportions of such isolates were found in Thrace (50%), Crete (52%) and
the Aegean and Ionian Islands (50%). The lowest proportion was obtained from
recruits who lived abroad but who had returned to Greece for their compulsory
military service (9%). Analysis of the serogroups, serotypes, subtypes and
sensitivities to other antibiotics indicate that the isolates within a particular
geographical area with decreased sensitivity to penicillin are not related (Table 2).
Analysis by antigenic phenotypes
Meningitis strains
Among the isolates from patients with meningitis, 50% of group B, 37-5% of
group C and 60% of the non-groupables were penicillin-insensitive. Sulphonamide
resistance was found in 17% of the group B isolates and 25% of group C but in
1" HYCJ 108
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Table 2. Pro-portion of antibiotic-resistant isolates obtained from recruits from
different regions of Greece
Percent
resistant
Region Number tested PN su RF CP
Thrace 14 50 79 7 —
W. Macedonia 38 26 42 5 —
E. Macedonia 96 33 35 7 —
Epirus 23 48 30 4 —
Thessaly 46 34 48 6 —
Central Greece 32 32 44 9 —
Athens 127 40 39 7 0-8
Peloponnese 40 35 30 10 —
Crete 31 52 39 3 —
Aegean Islands 10 50 70 10 —
Ionian Islands 2 50 — 50 —
Foreign 11 9 22 — —
Table 3. Antibiotic resistances of serogroups
Percent
resistant
Serogroup No. PN SU RF
A 17 41 41 12
B 114 35 37 5
C 19 42 42 10-5
W135 2 0 50 0
Y 8 62-5 25 0
Z 4 25 0 0
NG 300 36 40 7
none of the non-groupable isolates. Of the 9 2b serotype isolates, 7 (78%) were
penicillin-insensitive as were 8/18 (44%) of the non-typables. The 4 isolates
expressing other serotypes (2a, 14 and 15) were sensitive to penicillin and to
sulphamethoxazole. Resistance to sulphamethoxazole was found for only 2/9
serotype 2b isolates and 3/18 non-typable isolates. Of the 9 isolates expressing the
PI. 10 subtype, 7 (78%) were penicillin-insensitive though only 1 was resistant to
sulphamethoxazole. The second most common subtype was PI.9. Only 1 of the 5
PI.9 isolates was penicillin-insensitive, but 2 were sulphonamide resistant.
Carrier strains
There were sufficient numbers of isolates from the recruits for analysis of
antibiotic resistances by serogroup, serotype and subtype (Tables 3-5). Among the
serogroups, the highest proportion of penicillin-insensitive isolates was found for
group Y (62-5%) while rifampicin resistance was greatest in groups A (12%) and
C (10-5%) (Table 3).
Penicillin-insensitivity was highest among serotypes 2a and 15 and lowest in
type 4, which, however, had the highest proportion of strains resistant to
sulphamethoxazole. Rifampicin resistance was observed most frequently among
serotypes 4 and 15 (Table 4).
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Serotype No. PN su RF
1 15 27 20 7
2a 7 57 43 0
2b 22 27 32 4-5
4 9 11 56 11
14 66 42 28 9
15 16 56 19 12 5
Table 5. Antibiotic resistances among subtypes
Percent
resistant
Serogroup No. PN SU RF
1 41 39 34 2-5
2 72 43 22 15-5
4 7 43 29 0
6 28 32 68 0
7 30 43 63 13
9 45 27 38 2-4
10 29 45 28 14
12 8 25 37-5 0
14 8 62-5 25 0
15 16 37-5 19 0
16 13 38 70 23
No particular subtype antigen was associated with an unusual degree of
antibiotic resistance (Table 5).
DISCUSSION
Although sulphonamide resistance has been associated with strains causing
outbreaks of meningococcal disease in northern Europe [10, 11], only 16% of the
isolates from Greek patients had MIC > 10 mg/1 to sulphamethoxazole ; however,
nearly half had reduced sensitivity to penicillin and all grew in the presence of
1 or 2 mgm/1 tetracycline.
In contrast, while the proportions of penicillin-insensitive and of tetracycline-
resistant isolates from carrier children were both significantly lower, the
proportion of erythromycin isolates was significantly increased.
Among isolates from the recruits, the proportion of penicillin-insensitive strains
was significantly greater than that from children who were carriers (y2 = 5-126,
df = 1, P < 0-025) but not compared with those from children with disease. The
proportion of sulphonamide-resistant. isolates among those from recruits (35-6%)
was over twice that of the other two groups, carriers (10-6%) (y2 = 10-882, df = 1,
P < 0-005) or patients (16%) (y2 = 406, df = 1, P < 0-05) (Table 1).
Although penicillinase-producing isolates of Neisseria gonorrhoeae are not
uncommon in Greece (18%) [12], none of the 550 meningococcal isolates tested
produced beta-lactamase.
17-2
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The levels of resistance to erythromycin among isolates from carriers might
reflect longer exposure to the antibiotic as the mean ages of the carriers were
higher, school-children (12-8 years) and recruits (19-7 years) compared with a
mean age of 2-7 years for patients with meningitis. Only one isolate had
MIC ^ 1 mg/1 to ciprofloxacin. Since 6 7 % of isolates from carriers were resistant
to rifampicin, ciprofloxacin might be considered for circumstances when
chemoprophylaxis would be appropriate as it has been found to eradicate
pharyngeal carriage of meningococci [13].
Sutcliffe and colleagues [4] stated that in view of the extensive use of penicillin
in the community in Britain, emergence of penicillin-insensitive meningococci is
not unexpected. In Britain, the proportion of isolates from patients and carriers
with MIC > 0'16 mg/1 was about 3% [4]. In Spain in 1986, only 5% of isolates
examined had MIC ^ 04 mg/1; however, by 1990, this figure had risen to 46% of
isolates from patients. The antibiotic policies of Spain and Greece are similar and
the proportion of penicillin-insensitive isolates from Greek children with
meningococcal disease (48-3%) was similar to that reported for Spain. In Britain,
the proportion of penicillin-insensitive isolates from carriers was slightly less than
3% [4], much lower than the proportion of penicillin-insensitive strains from
carriers in this survey, recruits (36%) or school-children (194%).
Differences in MIC values to tetracycline between isolates from patients and
isolates from children who were carriers was not expected. Although high level
tetracycline resistance mediated by a plasmid carrying the MM determinant has
been found in meningococci [14] none of the isolates had MIC > 8 and the 25-2
megadalton plasmid was not observed in any of the strains examined so far
[unpublished observations].
The differences in the proportions of penicillin-insensitive isolates in the
different regions of Greece is under investigation (Table 2). That there were fewer
such isolates among recruits who lived outside Greece (mainly in Germany) might
reflect differences in antibiotic policies referred to earlier.
Although 61 % of the British isolates which were penicillin-insensitive were also
sulphonamide-resistant, none were resistant to rifampicin, aminoglycosides,
erythromycin, tetracycline or chloramphenicol [4]. Only 37% of the penicillin-
insensitive isolates in this study were sulphonamide-resistant; however, additional
resistances were often present: rifampicin (8%); erythromycin (33%); cefaclor
(34%); tetracycline (96%).
While none of the penicillin-insensitive strains in Britain was serogroup A [4],
41 % of the Greek group A isolates had reduced sensitivity to penicillin. The
highest proportion of penicillin-insensitive isolates was among the 8 group Y
isolates (62-5%). Analysis by areas of residence of the recruits, serotype, subtype
and sensitivities to other antibiotics suggest these group Y isolates are not related.
Although serogroup B was the most common among patient isolates, the greatest
proportion of isolates resistant to rifampicin was among those of groups A and C.
The number of serotypable isolates was small, and larger numbers need to be
examined to determine if the associations noted are significant (Table 4). Most of
the penicillin-insensitive isolates expressing subtype PI.14 do not appear to be a
single strain as assessed by the serogroup, serotype, sensitivities to other
antibiotics and the area of residence of the recruits from whom the bacteria were
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isolated. Although the sulphonamide and rifampicin resistances were highest
among subtype PI.16, the two resistances were not found together in the PI.16
strains. The higher rate of rifampicin resistance among isolates expressing PI. 10,
the subtype found most frequently among meningococci isolated from patients,
and among isolates expressing PI.2, the most common subtype among carriers,
needs to be further investigated.
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Serogroups, serotypes and subtypes of Neisseria
meningitidis isolated from patients and carriers in Greece
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Summary. The increase in the number of cases of meningococcal disease reported to the
Ministry of Health in Athens since 1989 prompted the present study to determine if isolates
from patients or carriers expressed the same phenotypic characters as those in other parts of
Europe. None of the isolates from patients (31) or carriers (547) expressed the antigenic
combinations associated with outbreaks in northern Europe, i.e., B: 15: P1.16 or B:4: PI. 15.
The majority of the Greek isolates did not react with any of the six monoclonal serotype
reagents tested; however, most reacted with one or more of the 11 monoclonal subtype
antibodies. The results suggest that additional serotype reagents are needed for epi¬
demiological studies in southeastern Europe and that vaccines based on serotype antigens
developed against outbreak strains in northern Europe would not be effective in Greece.
Introduction
The increase in the number of cases of meningo¬
coccal disease reported to the Ministry of Health in
Athens prompted the present study.1 As the last major
epidemiological survey of Neisseria meningitidis in
Greece was published in the 1970s before the avail¬
ability of serotype and subtype reagents,2 the study
had three main objectives: firstly, to determine
whether the serotype and subtype reagents used in
northern Europe and America can discriminate
between isolates of meningococci from south-eastern
Europe; secondly, to find out if serogroups, serotypes
and subtypes of isolates from patients with meningo¬
coccal disease or carriers in northern Europe3'7 are
prevalent among Greek isolates; and thirdly to see if
particular phenotypes are associated with different
regions of Greece.
Materials and methods
Thirty-one isolates from children aged 1 month-11
years with meningococcal disease were obtained from
the microbiology laboratory of Aglaia Kyriakou
Paediatric Hospital, Athens. The isolates were from
sporadic cases that occurred during 1989-1991. Fifty-
one isolates from school children aged 5-18 years who
Received 4 March 1992; accepted 21 April 1992.
""Correspondence should be sent to Dr C. C. Blackwell.
were carriers were obtained in surveys undertaken in
Athens between Dec. 1990 and Jan. 1991.8 A series of
496 isolates from military recruits aged 16-30 years
were obtained during July 1990 and Jan. 1991' within
3-5 days of the arrival of the recruits at the camps;
recruits from all regions of Greece were represented.
The isolates were grown on modified New York
City medium9 and characterised by Gram's stain, the
oxidase test and by the rapid carbohydrate utilisation
test (RCUT).10 Serogroups were determined by slide
agglutination with polyclonal antisera to serogroups
A, B, C, W135, X, Y and Z (Wellcome Diagnostics).
Serotype and subtype were determined by a whole-cell
enzyme-linked immunoassay (ELISA) with mono¬
clonal antibody" reagents supplied by Dr J. T.
Poolman (RIVM, Bilthoven, The Netherlands).
Information obtained from each recruit regarding
area of residence and socio-economic status was coded
and entered into a Data Base 3 Plus program together
with the results of the throat swab and the serogroup,
serotype and subtype of the isolates.1 Similar data
bases were prepared for information obtained from
questionnaires returned by parents of school children
participating in the surveys.8 Written informed consent
was obtained from each of the recruits or from the
parent or guardian of the children.
The results from the school children were compared
with those obtained in a Scottish secondary school,
where there was an outbreak of disease caused by a
sulphonamide-resistant serogroup B serotype 4 sub¬
type 15 (B: 4: P1.15) strain,7 and results from the
recruits were compared with published results for 133
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isolates obtained from carriers among Norwegian
military recruits.6





The antigenic phenotypes of isolates from patients
are shown in table I. The most prevalent serogroup
was B (58%) followed by group C (26%) and non-
groupable isolates (15%). The majority of isolates
(58%) did not react with any of the serotype anti¬
bodies. The most common serotype was 2b (9 of 31,
29%), and the most common subtype was PI. 10 (11 of
31, 35%). The most common serotype-subtype com¬
bination was 2b:PI. 10 (7 of 31, 23%).
Carriers
Among school children there was no predominant
antigenic phenotype. Of the 19 (37%) serogroupable
isolates, 10 belonged to group B, two to each of
serogroups A, C, W135 and Y and one to group Z. As
with the isolates from patients, the majority (65 %) did
not react with any of the serotype antibodies; however,
most (75%) reacted with one or more subtype re¬
agents. Two isolates (4%) obtained from secondary
school pupils expressed the 2b:PI. 10 combination
found among those from patients (tables II and III).
Of the 496 isolates from recruits, 36% were sero¬
groupable: 24% were group B, 5% group C and 4%
group A. Most isolates (69 %) were not serotypable,
but 64% reacted with one or more of the subtype
antibodies. The most common serotype was 14(16%),
and the most common subtype was P1.2 (16%) (tables
II and III). The most prevalent combination of
serotype-subtype antigens was 14:PI.2 (n = 24) fol¬
lowed by 14: PI.7 (n = 13). None of the isolates from
the recruits expressed the 2b:PI. 10 combination pre¬
dominant among children with meningococcal disease.
None of the 2a or 2b isolates from carriers reacted with
any of the subtype antibodies.
Geographic areas
The major regions of Greece are shown in the figure
together with the proportion of recruits from whom
meningococci were isolated. Meningococci were ob¬
tained most frequently from recruits from the north¬
east ofGreece: Thrace (37 %), West Macedonia (33%)
and East Macedonia (30%). Because military service
is compulsory, even for individuals who live abroad,
there were 33 subjects who were not normally resident
in Greece. Among these, 33 % were carriers.
There were no unusual distributions of serogroups
among the different regions. The most common
serotype (14) was found in equal proportions (15%)




B . Pl.l 1
B - PI.9 4
B - PI.10 2
B - PI.14 1
B 2b: PI.9 1
B 2b: PI. 10 4
B 14:PI. 15 1
B 15: P1.6 1
C - PI.6 2
C - PI.10 3
C - PI.14 1
C - PI.16 1
C 2b: PI.2 1
NG :2a:P1.6 1
NG :2b: PI. 10 3
NG 14:PI. 10 1
Table II. Comparison of serotypes of isolates from carriers in
Greece with those from carriers in northern Europe
Percentage of isolates from
Serotype
recruits school children
Greece Norway Greece Scotland
(n = 485) in = 133) in = 51) (« = 121)
1 4 5 8 9
2a 1 5 6 0










15 3 8 4 8
21* 8 7
Non-typable 69 28 64 22
*Not tested in this study.
Table III. Comparison of subtypes of isolates from carriers
in Greece with those from carriers in northern Europe
Percentage of isolates from
Subtype
recruits school children
Greece Norway Greece Scotland
{n = 489) in = 133) in = 51) in = 121)
Pl.l 9 5 14 3
PI.2 16 16 8 17
PI.3* 13
PI.4 1 0 0 0
PI.6 6 0 8 8
PI.7 6 0 4 7
PI.9 9 0 18 0
PI.10 6 0 10 0
PI.12 2 0 4 0
PI.14 2 0 0 0
PI.15 4 19 8 23
PI.16 3 8 0 4
Non-typable 36 39 26 38
*Not tested in this study.







Figure. Proportion of carriers among recruits from different regions
of Greece.
population, greater Athens and East Macedonia. Over
20% of the isolates from Thessaly (22%), the Pelo-
ponnese (21 %), Crete (25%) and the Aegean Islands
(30%) expressed the type 14 antigen.
Isolates representative of all the 11 subtypes ex¬
amined were found among those from recruits from
greater Athens, East Macedonia and Crete. More
isolates that did not react with the subtype antibodies
were obtained from recruits from the north ofGreece:
Thrace, Macedonia and Epirus.
Discussion
The first two objectives of the study were to
determine if the serotype and subtype reagents used
for epidemiological studies in northern Europe and the
Americas could be used in epidemiological studies in
Greece, and if the serotype and subtype combinations
associated with disease in other populations were
found in Greece. The proportion of non-serotypable
isolates from the Greek recruits (69%) and school
children (64%) was greater than the proportion of
non-serotypable isolates obtained from carriers among
Norwegian recruits (28 %)6 or Scottish school children
(22%). The proportion of serotype 14 isolates was
similar for Greek (16%) and Norwegian (16%)
recruits and Scottish school children (13%) but was
much lower (2%) among Greek children. The pro¬
portion of 2b serotypes was similar for the Greek
recruits and Scottish school children. Serotype 4 was
the most prevalent type among the Norwegian (22 %)6
and Scottish (36%) isolates compared with 2-8% of
the Greek isolates. Serotype 15 was found in 8% of
isolates from north Europeans compared with 3^1%
of the Greek isolates. This suggests that other serotype
reagents need to be developed for epidemiological
studies of meningococci from Greece and that the
serotypes associated with recent outbreaks in Britain
and Scandinavia are uncommon in Greece.
The proportion of isolates from the Greek recruits
(36%) and school children (26%) that did not react
with any of the subtype reagents was similar to that of
isolates from the Norwegian recruits (39 %)6 and from
Scottish school children (38%). The proportion of
subtype PI.2 isolates was similar for Greek (16%)
and Norwegian (16%) recruits and Scottish school
children (17%) but was lower among Greek school
children (8%). The proportion of subtype PI. 15 was
similar among the Norwegian (19 %)6 and Scottish
(23%) isolates but was greater than that found in the
Greek isolates (4-8 %). The subtype reagents appear
to discriminate between strains from Greek carriers as
effectively as between carrier strains from northern
Europe; however, the proportions of subtypes asso¬
ciated with outbreaks in northern Europe are lower.
Combinations of serotype and subtype antigens
15:PI. 16, 4:P1.15 and 2a:P1.2 associated with out¬
breaks in northern Europe4,5 were not found among
any of the isolates in this study. Although PI .2 was the
most common subtype found in the study there was
only one patient isolate with this subtype, C:2b:PI.2
(table I). In contrast, the 2a:PI.2 and 2b:PI.2 com¬
binations are found frequently among Scottish group
C12 and French serogroup B isolates and 2a:PI.2 is
found frequently among French serogroup C iso¬
lates.13 The only report of meningococcal serotypes
from southeast Europe is that of the C:2a phenotype
associated with disease in Italy.14 None of the sero¬
group C isolates expressed this serotype.
The third objective was to determine if there were
antigenic phenotypes associated with different areas of
Greece, e.g., those in which there are large numbers of
foreign tourists or foreign military personnel or areas
such as the northeast were there is a significant Muslim
population some of which might have visited Saudi
Arabia; however, there was no unusual distribution of
serogroups or serotypes in the different regions of
Greece.
The results of the study suggest that vaccines based
on serotypes and subtype combinations associated
with disease in northern Europe such as the one being
developed and tested in Norway will not be appro¬
priate for Greece.
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Parental Smoking and Carriage of Neisseria meningitidis
among Greek Schoolchildren
ENNY KREMASTINOU1, CAROLINE BLACKWELL2,
3eorgina tzanakaki', constantina kallergi3,
iobert elton4 and donald weir2
7rom the 'National Meningitis Reference Laboratory, Athens School of Public Health and
he 2Department of Medical Microbiology and the 3Aglaia Kyriakou Paediatric Hospital,
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n December 1990 and January 1991, primary (320) and secondary (697) pupils in 2 areas of
Ithens were screened to determine the rate of carriage of Neisseria meningitidis and to determine
r the genetic and environmental factors associated with carriage of meningococci in Greece were
imilar to those observed for northern European populations. In 1 area, socioeconomic indicators
iere significantly lower than in the other (p < 0.0005), but the isolation rates from pupils in the
reas were similar, 5.3% and 6.3%. In contrast to studies in northwest Europe, carriage was not
ssociated with lower socioeconomic conditions, sex, numbers of individuals per household, upper
espiratory tract infection, or secretor status. By univariate analysis, carriage was associated
vith age (15-18 years) (/> < 0.05) and mother's or other carer's smoking habits (p < 0.05) - but
ot father's smoking. Although the proportion of fathers who smoked was greater in the area
diere socioeconomic indicators were lower (61%) vs. (47%) (p <0.0005), the proportions of
.omen smokers were similar (33% vs. 38%). By multiple regression analysis, the only significant
actors were age (p <0.01) and carer's smoking (p <0.05).
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NTRODUCTION
!ince 1989 there has been a steady increase in the numbers of cases of disease due to
•Jeisseria meningitidis reported to the Ministry of Health in Athens (1). In contrast to
ountries in northern Europe, there were no reports on carriage rates of meningococci among
chool children in Greece or assessment of factors associated with carriage of these bacteria
mong children in any country in southeast Europe. The present study had 2 objectives: to
etermine the carriage rate of meningococci among schoolchildren in Athens, particularly the
! :2b: PL 10 phenotype frequently isolated from Greek children with meningitis (2); and to
xamine genetic and environmental factors associated with meningococcal disease and/or
arriage in northern Europe: age (3); sex (3, 4); secretor status (5); smoking or passive
xposure to cigarette smoke (5-7); lower socioeconomic conditions (3, 8); upper respiratory
ract infections (9-11).
ubjects and methods
"hildren (1,038) were screened for pharyngeal carriage of meningococci during December 1990 and
anuary 1991. Four schools were included in the study: a primary school and a secondary school in area
A) where housing costs were low; and a primary school and a secondary school in area (B) where
ousing costs were high.
Saliva and a throat swab were obtained from each child. Methods for culture and identification of N.
leningitidis were the same as those reported previously (1, 12, 13). The saliva was frozen within 3 h of
ullection and secretor status determined by ELISA for H, Lewis" and Lewisb antigens (14, 15).
The parent or guardian of each child gave written consent for participation in the survey and provided
le following information: age and sex of child; respiratory illness in the past week; number of
idividuals/household; smoking habits of members of the household; education level of parents. In
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Greece, for epidemiological studies, socioeconomic category is assessed by the number of years of
education and the highest level of school attended (16). Secondary schoolchildren were asked if they
smoked.
Two-way frequency tables were anslysed by x2-tests with Yates' correction. Multiple logistic regression
was used to examine the association between carriage and other factors adjusted for each other.
RESULTS
The 2 socioeconomic indicators used, cost of housing and educational level of the parents,
were in agreement. Educational level of each parent was assigned to one of the following 5
categories based on the number of years of attendance and the type of school attended for
categories I -3: 1 = "demotico" (1 -6 years); 2-"gymnasio" (6-9 years); 3 = "lykio" (9-12
years); 4 = technical college; 5= university. Compared with area A. in area B there was a
significantly lower proportion of parents in categories 1 and 2 and higher proportions of
parents who had received technical training or attended university (p <0.0005) (Table I).
The carriage rate was 60/1038 (5.8%), and the proportion of isolates from the 2 areas was
similar: area A 30/565 (5.3%); area B 30/473 (6.3%) (Table II). Only 2 isolates, both
obtained from secondary school pupils, expressed the B :2b: PI. 10 phenotype (2).
Univariate analyses found no association between carriage and 2 genetic factors examined,
sex or secrctor status. There was no association between carriage and educational level of
parents, numbers of individuals per household, area of residence, or symptoms or respiratory
infection.
Among children in secondary schools, 14% of 50 smokers were carriers compared with
6.2% of 661 non-smokers (p > 0.05). In secondary school A, 7.6% of children were smokers,
and 5/30 (17%) smokers were carriers compared with 16/352 (4.5%) non-smokers
(p < 0.025). In secondary school B. 6% of children were smokers, but only 2/20 (10%)
smokers were carriers compared with 25/305 (8.2%) non-smokers.
Compared with the proportion of carriers from households in which no adult smoked
(11/311, 3.5%), the proportion of carriers was significantly higher in those in which the
Table I. Educational level of parents in area A and area B
Educational category
no. (%)
N 1 2 3 4 5
Area A 1,107 572 (52) 239 (21) 215 (19) 57 (5) 24 (2)
Area B 937 165 (18) 134 (14) 289 (31) 78 (8) 271 (29)
p < 0.0005.
Table II. Isolation of meningococci from pupils in primary and secondary schools
Meningococci isolated
School N n (%)
Primary A 180 9 (5.0)
Primary B 144 3 (2.1)
Secondary A 385 21 (5.5)
Secondary B 328 27 (8.2)
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Table III. Sex, smoking and educational level
Educational category, no. (%)
1 2 3 4 5
Women a
Smoker/total 130/395 68/177 117/299 14/47 30/109
(38) (38) (39) (30) (28)
Menb
Smoker/total 222/357 115/196 113/205 47/88 71/186




mother or other carers smoked (33/431, 7.7%, p <0.05). Father's smoking was not associ¬
ated with carriage. Carriage rates in households where the mother or other carers smoked did
not depend significantly on whether only the mother, only the other carers, or both smoked.
There were 15 carriers under 13 years, and in 5 cases (33%) the mothers smoked. There
were 45 carriers over 12 years, and in 23 cases (51 %) the mothers smoked (p < 0.025). When
the figures were corrected for the children who were smokers, 20/38 (52.6%) carriers who
were non-smokers had mothers who smoked (p <0.025).
Smoking was more prevalent among fathers with fewer years of education (p <0.0005),
but this association was not found for mothers (p >0.05) (Table 111). In area B where the
educational level was higher, the proportion of fathers who smoked was significantly lower
223/472 (47%) compared with area A 345/560 (61%) (p <0.0005). These differences were
not found for mothers in the 2 areas (A = 33% and B = 38%).
Following analysis by multiple logistic regression with reference to age, sex, school
attended, respiratory infection, parental smoking and the children's smoking habits, only age
(p < 0.01) and maternal or other carers' smoking (p < 0.05) remained significant. Older
children and those whose carers smoked were more likely to be carriers. Although the trend
with age appeared stronger in those whose carers smoked, this was not significant (interac¬
tion test in multiple logistic regression).
DISCUSSION
The proportion of carriers among children in this study did not differ from that usually
found during non-epidemic periods, and the proportion of strains expressing the B : 2b : PI. 10
phenotype was not high.
This was the first study to assess factors associated with carriage of meningococci in a
population in southeast Europe. Several factors identified in studies of meningococcal
carriage in northern Europe did not appear to influence carriage in the Greek schoolchildren:
sex; secretor status; socioeconomic status; numbers of individuals per household; upper
"espiratory tract infections.
The isolation rate in different age bands followed a pattern similar to that found in the
stonehouse survey (3), and age was the most significant variable identified by multiple
"egression analysis.
In contrast to the Stonehouse survey (3) and a longitudinal survey in Belgium (8), carriage
"ate was no greater in the area where socioeconomic indicators were lower. For the fathers
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in this study and in our previous study of Greek military recruits (1), there was a significant
correlation between educational level and smoking. Carriage was not, however, associated
with father's smoking by either univariate or multivariate analysis. In Great Britain, the
pattern for socioeconomic groups and smoking are similar for men and women (17);
however, there were no differences in smoking patterns of Greek women associated with
educational levels or in the percentage of mothers who smoked in the 2 areas of the city.
Among studies on exposure to cigarette smoke and infection, the strongest associations are
usually with smoking habits of the mother (18, 19). If the mother's smoking is a significant
factor contributing to carriage among children, this might explain the similar carriage rates
for the 2 areas of Athens. The observation that carriage was also significantly associated with
smoking by adults other than the father might reflect the structure of many Greek families;
grandmothers often live with families with young children and are closely involved in child
care. Our study suggests that in Greece, smoking by mothers or other family members
traditionally involved in child care might contribute to the carriage of meningococci.
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